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Sertoli cells provide nutrients and growth factors for developing germ cells. Each Sertoli cell can 
support a finite number of developing germ cells. During development of the testis, cessation of 
Sertoli cell proliferation and the onset of differentiation establishes the final number of Sertoli 
cells and hence the number of sperm that can be produced. Studies in this dissertation explore the 
hypothesis that the transition from proliferation to differentiation is facilitated by E-box 
transcription factors that induce the expression of differentiation-promoting genes. The relative 
activities of E-box proteins were studied in primary Sertoli cells isolated from 5, 11, and 20 day-
old rats, representing proliferating, differentiating, and differentiated cells, respectively.  DNA 
binding by E-box proteins is nearly undetectable at 5 days after birth but peaks with initiation of 
differentiation at 11 days after birth and remains elevated. Upstream Stimulatory Factors 1 and 2 
(USF1, USF2) were the predominant E-box proteins present within DNA-protein complexes 
formed after incubating E-box containing probes with nuclear extracts from developing Sertoli 
cells. Increased USF binding activity corresponded with elevated Usf1 mRNA and USF1 protein 
levels 11 days after birth. The potentiator of Sertoli cell differentiation, thyroxine, induces USF 
DNA binding in Sertoli cells prior to differentiation. Decreased nuclear expression of ID proteins 
may permit increased USF DNA binding during Sertoli cell differentiation. Several genes 
required for Sertoli cell differentiation and differentiated Sertoli cell functions have USF binding 
sites within their promoters. Two potential USF target genes, Nr5a1 and Shbg, were induced in 
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11 day-old Sertoli cells when compared with 5 day-old Sertoli cells. DNA binding studies of 
Nr5a1 and Shbg promoter sequences determined that USF1 and USF2 binding to E-box motifs 
increased during differentiation. In vivo binding assays confirmed that USF1 and USF2 occupy 
the E-box within the Nr5a1 promoter. These data support the ideas that increased USF protein 
expression induces differentiation-associated gene expression and that USF-mediated alterations 
in gene transcription are responsible for the onset of differentiation in developing Sertoli cells. 
These USF-mediated processes would then determine the final number of Sertoli cells present 
within the testes and the upper limit of fertility. 
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 1 
1.0  THE SERTOLI CELL 
1.1 STRUCTURAL ORGANIZATION OF THE TESTIS 
The major reproductive organ within the mammalian male is the testis (Figure 1A).  The 
testes are contained within the scrotal sac and are surrounded by a thick capsule, the tunica 
albuginea (reviewed in [1]). Within the testis, sperm are produced in the seminiferous tubules 
(Figure 1B). Seminiferous tubules are surrounded by layers of peritubular cells [2, 3]. The 
interstitial space between the seminiferous tubules contains fibroblasts, nerves, blood vessels, 
lymphatics and clusters of Leydig cells that secrete the steroid hormone, testosterone (T) [3]. 
Seminiferous tubules contain the germ cell progenitors, and spermatogonia that lie at the 
basement membrane of the seminiferous tubule [1, 4]. Sertoli cells, non-dividing somatic cells of 
the seminiferous tubules, also lie on the basement membrane and support these progenitors 
outside the blood-testis barrier in the germinal epithelium [5] (Figure 1C).  Sertoli cells extend 
the radius of the tubule with irregular projections of cytoplasm that envelope developing germ 
cells [1, 4, 6]. Sertoli cells surround germ cells throughout their development and provide 
necessary maturation factors. This close association allows nutrients and growth factors to be 
supplied by Sertoli cells to the germ cells.  
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Figure 1. Organization of the Testis.  
A) A cross-section through a testis, showing the location of the seminiferous tubules, the vas deferens and the 
epididymis. B) A diagrammatic cross-section through a testicular tubule, showing the germ cells (green) at different 
stages of maturation developing embedded in somatic Sertoli cells (each Sertoli cell is outlined in red). Leydig cells 
(LC), where testosterone is synthesized, are present in the interstitium. Maturing sperm are shown in the lumen of 
the tubules. PTM, peritubular myoid cell. C) A single Sertoli cell with its associated germ cells. Note that tight 
junctions between Sertoli cells (arrowhead) define two compartments: the stem cells and the pre-meiotic cells 
(spermatogonia) are found on one side of the junction, whereas the meiotic (spermatocytes) and the post-meiotic 
(round and elongating spermatids) cells are found organized in strict order of maturation towards the lumen 
(cytoplasm is shown in dark green, DNA is shown in pink, Sertoli cell nucleus is shown in orange). Reprinted by 
permission from Macmillan Publishers Ltd: Nature Reviews Genetics [7], Copyright 2002. 
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1.2 SPERMATOGENESIS 
As spermatogonia enter meiosis, they move through the blood-testis barrier created by 
the Sertoli cells [1].  Germ cells migrate toward the center of the tubule as they progress through 
the stages of spermatogenesis and spermiogenesis. Spermatogenesis is the process during which 
diploid germ cells undergo meiosis in order to become haploid round spermatids [8].  The 
spermatids then undergo cytoplasmic reduction, nuclear condensation, and flagella formation in 
the process of spermiogenesis [8]. Mature spermatozoa are then released, through the process of 
spermiation, into the lumen of the seminiferous tubules [4, 8]. Once released, mature 
spermatozoa travel down the seminiferous tubules into the rete testes and then to the epididymis 
where sperm maturation is completed [1, 4]. 
The process of spermatogenesis is a complex and highly ordered process to produce 
mature spermatozoa from spermatogonia. Spermatogenesis occurs in a regular repeating pattern 
that can be arranged into stages. Each stage has a unique complement of developing germ cells 
associated with the Sertoli cells and each other at a given time. In the rat, the complement of 
germ cells can be classified into 14 stages (I through XIV) that create one cycle of the 
seminiferous epithelium [8]. Complete maturation of spermatozoa from spermatogonia requires 
4.5 cycles of the seminiferous epithelium [8, 9]. Spermatogenesis requires a variety of hormonal 
signals in a stage-specific manner; therefore, multiple cycles allow proper hormonal signaling at 
key points in germ cell development [9]. T and follicle stimulating hormone (FSH) are the main 
regulators of spermatogenesis [1, 10]. Testicular T levels remain relatively constant throughout 
spermatogenesis but T actions are regulated through the availability of the androgen receptor 
(AR). T is essential for initiation and maintenance of spermatogenesis [11]. During 
spermatogenesis in the rat, AR levels in the Sertoli cell are maximal at stages VII-VIII after 
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which time the AR levels decrease [12, 13]. During stages VII and VIII, T is required for the 
meiotic progression from preleptotene to pachytene spermatocytes and to maintain step 8 and 9 
round spermatids during spermiogenesis [14, 15]. T is not required for spermatogonial 
development [16]. FSH is necessary for quantitatively normal spermatogenesis [17]. FSH 
binding to Sertoli cells and FSH receptor (Fshr) mRNA in Sertoli cells is highest in stages XIII, 
XIV, and I of the seminiferous epithelium while FSH binding and Fshr mRNA levels are lowest 
in stages VII and VIII  [16, 18-21]. The regulation of spermatogenesis by T and FSH has been 
extensively reviewed elsewhere [1, 16, 22]. 
1.3 SERTOLI CELL FUNCTION 
Fully-differentiated Sertoli cells carry out a variety of functions within the testis.  Sertoli 
cells maintain tight junctions with each other to sustain the blood-testis barrier [5].  Formation of 
the blood-testis barrier by mature Sertoli cells allows the secretion of tubular fluid that allows 
nourishment and transport of sperm throughout the rest of the excurrent duct system [23]. The 
blood-testis barrier functions to separate the seminiferous tubule into a basal and luminal 
compartment [5].  The basal compartment contains spermatogonia and is exposed to components 
from the blood supply including plasma proteins, blood-borne antibodies, and potentially 
harmful chemicals [24]. The luminal compartment contains germ cells undergoing the 
progressive stages of spermatogenesis.  
The main function of Sertoli cells is to support and protect the developing germ cells. 
Sertoli cells provide key metabolites to developing germ cells in the form of inositol [25], 
pyruvate [26], lactate [26, 27]. Sertoli cells secrete several binding proteins for the transport of 
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key vitamins and ions to germ cells. These binding proteins include transferrin for iron [28], 
ceruloplasmin for copper [29], and retinoid binding protein for vitamin A [30]. Sertoli cells also 
secrete Kit ligand, which is necessary for germ cell viability and migration [31] as well as glial 
cell-derived neurotrophic factor that acts on spermatogonia to promote proliferation and 
development [32].  
Sertoli cells maintain constant contact with developing germ cells through specialized 
junctions and are thought to aid in the shaping of developing germ cells [33]. The attachment of 
Sertoli cells to germ cells and the release of spermatozoa into the lumen of the seminiferous 
tubule is controlled through the actions of T through AR (reviewed in [34]). Sertoli cells also 
secrete plasminogen activators (serine proteases) in a stage-dependent manner to aid in germ cell 
morphological changes [33]. Excess cytoplasm that is shed by germ cells as residual bodies is 
phagocytosed by Sertoli cells. [35].  
1.4 HORMONAL CONTROL OF SERTOLI CELL FUNCTIONS 
Appropriate control of testicular function and spermatogenesis requires a tightly 
regulated feedback mechanism regulated by the hypothalamo-pituitary-testicular axis. 
Gonadotropin-releasing hormone (GnRH) is secreted in a pulsatile manner from GnRH neurons 
within the hypothalamus [36, 37]. GnRH travels through the blood via a portal system to the 
pituitary where it can bind to GnRH receptors (GnRHR) on gonadotrophs within the anterior 
pituitary [4, 38]. Gonadotrophs are capable of secreting the gonadotropins, FSH and luteinizing 
hormone (LH) [4]. GnRH secreted at a high pulse frequency (30 minute intervals) stimulates LH 
and α gonadotropin subunit biosynthesis and secretion [39, 40]. Lhb and Gnrhr mRNAs can only 
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be induced when the amplitude of GnRH is between 10 and 75 ng/pulse [41-43]. GnRH secreted 
at a low pulse frequency (2 hour intervals) tends to favor FSH biosynthesis and secretion [39, 
40]. Fshb mRNA increases with all pulse amplitudes of GnRH [44]. These gonadotropins are 
then carried by the blood to their site of action within the testis.  
The site of FSH action within the testis has been localized to Sertoli cells [4]. One report 
suggests that FSHR is located on spermatogonia [45], but this result w[44]as not confirmed in 
other studies [18, 46]. FSH binding to FSHR can lead to the stimulation of adenyl cyclase to 
increase cyclic adenosine monophosphate (cAMP) concentrations within the cell [4].  Prolonged 
FSH stimulation (≥ 24 hours) results in the down-regulation of FSHR, cAMP, and the up-
regulation of phosphodiesterase inhibitors [4, 47-49]. FSHR down-regulation is discussed in 
greater detail in Chapter 8. Also, FSH binding to FSHR activates calcium channels within the 
cell membrane to up-regulate intracellular calcium concentrations [4, 50]. FSH stimulation leads 
to an increase in glucose transport [51] and the conversion of glucose to lactate [52], a source of 
energy for germ cells [4]. The specific genes and processes under the control of FSH to support 
developing germ cells are not fully understood.  
LH is secreted in an episodic and pulsatile manner in accordance with GnRH secretions 
[4, 53].  The LH receptor (LHR) is found on Leydig cells within the testis [54] and is essential 
for the synthesis of T through the regulation of necessary steroidogenic enzymes [55]. An 
increase in pulse frequency of LH leads to an increase in T production [56]. Excess LH can act 
through negative feedback to down-regulate LHR on the surface of Leydig cells [54]. T can 
feedback to act at the level of the hypothalamus to decrease LH pulse frequency without 
changing the pulse amplitude [4]. 
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Sertoli cells also secrete the hormones inhibin [57] and activin [58], which are also 
involved in the feedback control of hormone production in the pituitary [4, 59]. Inhibin decreases 
FSH production in pituitary, whereas activin can stimulate FSH production [4, 35, 59-61].  
Inhibin down-regulates Fshb mRNA within 2 hours [61]. Inhibin does not regulate GnRH [4, 
37]; however, inhibin has been suggested to act on GnRHR number [62]. In contrast, activin 
induces Fshb mRNA production [60, 61]. Additionally, estrogen produced by Sertoli cells during 
development or in Leydig cells in the adult may suppress Fshb gene transcription [63]. The 
ability of T to inhibit FSH secretion is difficult to distinguish from the effects of inhibin [4].  In 
rat, low doses of T inhibit Fshb through the suppression of GnRH release [43]. A high dose of T 
can activate Fshb through direct action on the pituitary [43]. This tightly regulated mechanism of 
hormonal feedback allows proper control of germ cell development. 
1.5 PRENATAL SERTOLI CELL DIFFERENTIATION 
Testis development begins in the early embryo. Development of the prenatal testis and 
Sertoli cell differentiation has been elucidated predominantly by studies in mice although similar 
events occur in other species albeit on a different time scale (Table 1) [64]. The genital ridge 
begins as a single layer of coelomic epithelium around 9-9.5 days post coitus (dpc) in mouse 
[65]. During this time (9-10 dpc), primordial germ cells migrate to colonize the urogenital ridge 
forming the bipotential gonad [66]. Sex determination in the male requires the expression of sex 
determining region Y (SRY) around 11 dpc to allow the pre-Sertoli cells to differentiate, 
proliferate, and aggregate with primordial germ cells [67, 68]. Pre-Sertoli cells originate from the 
coelomic epithelium between 11.2 and 12.5 dpc [69]. During the peak of Sry gene expression 
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[70], pre-Sertoli cells double in number. Pre-Sertoli cells produce anti-mullerian hormone 
(AMH) to inhibit Mullerian ducts, the precursors to the female reproductive tract (11-13 dpc) 
[71]. Mesonephric cells, pre-peritubular cells, migrate into the developing gonad and enclose 
pre-Sertoli cell and primordial germ cell aggregates to form seminiferous cords [72]. During the 
development of the seminiferous cords, pre-Sertoli and primordial germ cells cease to proliferate 
[64]. During cord formation, pre-Sertoli cells undergo morphological changes from a 
mesenchymal cell type to an epithelial cell type and must adhere to each other and the 
surrounding extracellular matrix [73, 74]. Immature Leydig cells differentiate and, in rat, 
steroidogenesis begins at approximately 14.5 dpc [75]. Steroidogenesis allows the production of 
testosterone to stabilize the Wolffian duct for further differentiation of the male excurrent duct 
system [76, 77]. Once cord formation is complete, pre-Sertoli cells again proliferate. Pre-Sertoli 
cell proliferation occurs at its greatest rate from 18 dpc to birth in the rat and continues until 
puberty (Figure 2) [78]. 
 
Table 1. Prenatal Testicular Developmental Time Points. 
Species Genital Ridge Formation 
Bipotential Gonad 
Formation Cord Formation Sry expression 
Human 5 weeks 6 weeks 7-8 weeks 7 weeks 
Rat 10-11 dpc 11.5-12.5 dpc 13.5-14 dpc 12 dpc 
Mouse 9-10 dpc 10-11.5 dpc 11.5-12.5 dpc 10.5 dpc 
Adapted from A.S. Cupp and M.K. Skinner (2006) [64]. 
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1.6 POSTNATAL SERTOLI CELL DIFFERENTIATION 
1.6.1 Proliferation of Postnatal Sertoli Cells 
Each Sertoli cell is 
only capable of supporting a 
finite number of germ cells 
and the number of Sertoli 
cells in the adult is established 
after puberty [79]. Thus, the 
final number of Sertoli cells 
sets the upper limit for 
testicular sperm production 
and influences the level of 
male fertility [1, 80].  The 
number of Sertoli cells is primarily determined by the expansion of Sertoli cells prior to the 
completion of puberty [78, 81]. Apoptosis of Sertoli cells is rare [81].  In rodents, Sertoli cells 
begin to proliferate during fetal development, but after birth the rate of Sertoli cell proliferation 
decreases steadily in rats and mice from 5 to 15 days after birth with mitotic activity ceasing 
after days 15 to 21, depending on the strain studied (Figure 2) [78, 82-84]. The decrease in 
Sertoli cell proliferation during the differentiation period has been well documented in rats [78, 
82, 85] and mice [86].  The percentage of thymidine labeled Sertoli cells is 33% at birth and 32% 
5 days after birth in the rat, but decreases to 18% and 7% at 10 and 11 days, respectively (Table 
2) [82].  By 16 days after birth in the rat, labeled Sertoli cells can no longer be detected [8, 82]. 
 
Figure 2. Proliferation of Sertoli Cells in Fetal and Postnatal Rats.  
Graph is recreated from J. Orth (1982) [78] who determined the percentages 
of Sertoli cell nuclei that had incorporated 3H-thymdine and were labeled in 
autoradiographs. Each point is a mean of six animals from two litters (±SE). 
Significant increases occurred prior to birth and decreased during the 
postnatal period. No labeled Sertoli cells were found on day 21 after birth.  
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During the period in which proliferation ceases, the Sertoli cell undergoes a developmental 
process that results in a fully-differentiated, non-proliferating cell that is capable of supporting 
spermatogenesis.   
Table 2. Percentage of Postnatal Rat Sertoli Cells with 3H-Thymidine Incorporation. 
Age of Rat (Days) % Labeled Sertoli cells Age of Rat (Days) % Labeled Sertoli cells 
0-1 33 ± 5 11 7.0 ± 2 
2 32 ± 4 12 4.0 ± 1 
3 29 ± 6 13 3.5 ± 2 
4 30 ± 6 14 2.5 ± 2 
5 32 ± 5 15 1.0 ± 1 
6 31 ± 6 16 0 
7 23 ± 4 25 0 
8 20 ± 3 35 0 
9 17 ± 5 45 0 
10 18 ± 4 60 0 
BIOLOGY OF REPRODUCTION. ONLINE by A. Steinberger and E. Steinberger. Copyright 1971 by Society for 
the Study of Reproduction. Reproduced with permission of Society for the Study of Reproduction in the format of a 
Dissertation via Copyright Clearance Center [82]. 
1.6.2 Hormonal Control of Postnatal Sertoli Cell Differentiation 
Several hormones are involved in the onset of Sertoli cell differentiation. FSH induces 
Sertoli cell proliferation postnatally [87, 88]. FSH with activin stimulates the prepubertal 
proliferation of Sertoli cells and gonocyte proliferation [35, 89]. Estrogens are produced within 
Sertoli cells due to the expression of aromatase prepubertally, which may also function to inhibit 
prepubertal androgen production [35]. The expression of aromatase in Sertoli cells decreases 
during development although aromatase continues to be expressed by Leydig cells [35].  FSH 
can also inhibit estrogen production [90]. Despite the maintenance of FSH expression throughout 
puberty and into adulthood, Sertoli cells stop dividing [88]. FSH actions in fully-differentiated 
Sertoli cells are described in Chapter 8. T can suppress proliferation and induce differentiation in 
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Sertoli cells (reviewed in [87]). Thyroid hormone actions during Sertoli cell proliferation and 
differentiation are discussed in detail in Chapter 6. 
1.6.3 Molecular Markers of Postnatal Sertoli Cell Differentiation 
Once maturation of Sertoli cells ensues, the progression of differentiation can be 
characterized by the levels of proteins expressed at a given time. Genes expressed during the 
proliferative phase of Sertoli cell development include Amh and cytokeratin 18 (Loc681147) [91, 
92]. AMH is expressed in premature Sertoli cells, starting 15 dpc and continues to be expressed 
until the onset of puberty [91, 93]. AMH expression declines as meiotic germ cells appear and as 
Sertoli cells gain increased androgen sensitivity [94-97]. FSH is thought to lead to the down-
regulation of the Amh gene during puberty [35]. Loc681147 mRNA is expressed beginning in 
fetal life and decreases throughout postnatal development, disappearing by 14 days after birth 
[98]. Differentiation markers for Sertoli cells include sex hormone binding globulin [SHBG, also 
known as androgen binding protein (ABP)], FSHR, AR, transferrin (TRF), and cell cycle 
inhibitors [99, 100]. Sertoli cells secrete SHBG that functions to maintain a high concentration of 
testosterone within the testis and throughout the rest of the excurrent duct system [101]. SHBG is 
present 14 days after birth and levels continue to rise until 40 days after birth when they plateau; 
however, the greatest increase in SHBG levels is between the second and third weeks after birth 
[102-104]. FSHR is present prior to birth but levels do not peak in Sertoli cells until the initiation 
of spermatogenesis, between 7 and 21 days after birth in the rat [18, 105-107]. AR is not 
detectable during the fetal or neonatal life of rats; however, Sertoli cells do express AR starting 4 
to 8 days after birth, prior to the end of proliferation [13]. TRF, a common marker for Sertoli cell 
differentiation, is present 10 days after birth and its levels continue to rise into adulthood [28, 
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108]. Cell cycle inhibitors also inhibit proliferation within Sertoli cells; therefore, the onset of 
their expression coincides with the onset of differentiation [109]. In addition to components of 
the basement membrane and the blood-testis barrier, these proteins provide ideal molecular 
markers that can be utilized to study the progression of Sertoli cell development. 
1.7 CONCLUSION 
In the testis, Sertoli cells are the targets of hormonal signals that regulate 
spermatogenesis.  Sertoli cells translate hormonal signals into the production of factors that are 
required by germ cells. The cytoplasm of a Sertoli cell surrounds germ cells during all stages of 
germ cell development and this close association allows nutrients and growth factors to be 
supplied by Sertoli cells to the germ cells. Sertoli cells only divide until the onset of puberty and 
then never divide again [1, 100]. Sertoli cell death is also rare.  Therefore, after puberty, the 
number of Sertoli cells in the adult testis is fixed. Each Sertoli cell can support only a given 
number of germ cells [79]. Thus, the number of Sertoli cells establishes the total number of 
developing sperm that can be supported and the upper level of male fertility [1, 100]. The goal of 
this dissertation is to understand the mechanism by which Sertoli cells regulate the timing of 
their differentiation and establish their final number. 
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2.0  MODEL SYSTEMS TO STUDY SERTOLI CELLS 
The choice of an appropriate research model, whether it is animal or cell based, can alter 
the application and relevance of the research.  In studies of Sertoli cells, the appropriate model is 
dependent on the aspect of Sertoli cell physiology in question. Primate models are the closest 
animal model to humans. In primates and humans, Sertoli cells divide during the neonatal period 
and then proliferation slows in the absence of gonadotropins during the juvenile period [110]. 
Proliferation of Sertoli cells resumes during puberty when gonadotropin secretion increases to 
obtain the final number of Sertoli cells prior to differentiation [110]. However, primate models 
have challenges.  First, the animals are expensive to raise and house.  Secondly, primates have a 
long lifespan extending experiments over months or years.  
Rodents have the advantages of growing rapidly, reproducing frequently, are easy to 
handle, and are relatively inexpensive. The most striking difference between the use of a rodent 
model and that of a primate is the absence of the juvenile hiatus of gonadotropin secretion in the 
rodent model [111, 112]. In rats, the neonatal, juvenile, and pubertal periods of development 
occur within a two week period in a relatively constant gonadotropin environment [112]. In rats, 
Sertoli cells divide throughout the postnatal period until approximately 15 to 20 days after birth 
[78, 82]. Rat testes descend into the scrotal sac approximately 15 days after birth, around the 
time of seminiferous tubule maturation [112]. In the rat, the first spermatozoa can be detected 
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between 40 and 45 days after birth [9]. The first mature sperm reach the vas deferens between 54 
and 59 days after birth [113].  
The onset of Sertoli cell differentiation and thus the onset of puberty occur in both 
primates and rodents in the presence of gonadotropins. Studies presented in this dissertation are 
concerned with establishment of the final number of Sertoli cells during the pubertal period when 
gonadotropins are present. Therefore, the rat is a suitable model for study of the onset of Sertoli 
cell differentiation because the endocrine background in both rat and primate are similar during 
this period of Sertoli cell development. 
2.1 SERTOLI CELL CULTURES   
Studying any cell outside of the organism can pose a challenge to recreating an artificial 
environment reflecting the cell’s in vivo environment. However, the use of cell culture allows the 
study of direct actions of substances on the cells without interference of other cell types.  Results 
from cultured Sertoli cells should be carefully interpreted as “what the cell is capable of doing” 
rather then what it is doing in vivo [114]. The development of defined culture media and 
specialized support matrices enable the study of cells in “in vivo”-like conditions. 
The study of Sertoli cells has traditionally been performed using a variety of culture 
methods. Several isolation methods have been reviewed elsewhere [114-117]. First, the testes 
must be removed from the body and then be decapsulated to expose the seminiferous tubules.  
Next, the tubules are incubated in an enzyme solution to dissociate the cells of the interstitium 
from the tubules which are removed through differential sedimentation at unit gravity. The 
tubules are then incubated with a second enzymatic solution to disperse the cells of the 
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seminiferous tubules. Isolated cells are seeded on glass or plastic surfaces coated with an 
extracellular matrix component.  Cells are maintained in a serum-free media containing essential 
vitamins, amino acids, and hormones.  Hypotonic shock or incubation at 37˚ C can be used to 
remove germ cells from culture [118]. Cultured Sertoli cells can be maintained for several weeks 
but may lose responsiveness to known stimuli, such as T, after 6-10 days in culture due to the 
loss of expression of the Sertoli cell genes (i.e. Ar) with prolonged culture [114]. 
2.2 CAVEATS TO SERTOLI CELL CULTURE 
Sertoli cell isolations present specific challenges.  Because the Sertoli cell cytoplasm has 
many extensions to maintain contact with all stages of developing germ cells, it is common to get 
breakage of these cytoplasmic processes during isolation [119, 120].  The close association of 
Sertoli cells with germ cells also makes it difficult to obtain a pure culture of cells.  As the 
animal ages to adulthood, more germ cells are present and the junctions between the germ cells 
and the Sertoli cells become more developed [121].  For this reason, most studies of cultured 
Sertoli cells involve cells isolated between 15 and 20 days after birth.  At this age, the percentage 
of germ cells is minimal and the Sertoli cells have acquired many of their adult characteristics 
[116].  Some labs have developed methods to remove germ cells through the use of nylon mesh 
[122]. Another factor that may inhibit complete dissociation of Sertoli cells from one another are 
components of the blood-testis barrier.  The tight junctions between Sertoli cells may result in 
isolation of clusters of Sertoli cells rather than a single cell suspension [121]. Despite these 
problems, Sertoli cells can be isolated regularly with 90% or greater purity from mature animals 
[122, 123]. 
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Sertoli cells cultured on glass or plastic form a flat “dedifferentiated” morphology.  In an 
attempt to maintain Sertoli cell structure in culture cells are normally maintained on a coating of 
extracellular matrix components (i.e. Matrigel) [115, 122].  Alternatively, bicameral chamber 
systems have been used to allow growth and polarization of Sertoli cells on a solid support while 
maintaining two different media conditions for the luminal and basolateral aspects of the Sertoli 
cell [115]. These methods are of particular use when studying Sertoli cell secretion or effects of 
pulsatile hormone release on the Sertoli cell.  Any of these methods can be used to study Sertoli 
cell-germ cell interactions through co-culture of germ cells onto Sertoli cells [124]. 
Transillumination techniques were developed to study adult Sertoli cell-germ cell interactions 
specific to a stage of spermatogenesis [125, 126]. Seminiferous tubule fragments containing 
specific stages isolated from transillumination have also been used in explant cultures to 
maintain the tubule integrity [126]. To the author’s knowledge, only one group, Anway et al. 
(2003), has isolated Sertoli cells directly from an adult animal without culturing cells [127]. 
Using this method of isolation, an 80% pure population of adult Sertoli cells was obtained [127].  
This method allows the study of Sertoli cells without changes that may occur in culture. 
Studies of pre-Sertoli cells from the developing embryo [128] and pre-pubertal Sertoli 
cells are not as common as those from pubertal animals. Although similar methods are used, the 
number of cells obtained is more limited despite evidence that immature Sertoli cells are able to 
divide in culture [129]. A recent paper suggests that even adult Sertoli cells removed from the 
intact tubule result in the appearance of dividing cells in culture [130]. The predominant 
challenge with culturing Sertoli cells from neonate and immature rats is the lack of starting 
material due to the limited size of the undeveloped testis. As a result, a large number of animals 
must be used to obtain enough Sertoli cells to conduct biochemical assays.  
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2.3 ISOLATION OF SERTOLI CELLS FROM POSTNATAL RATS FOR 
IMMEDIATE BIOCHEMICAL ANALYSIS 
To examine Sertoli cell biochemical properties as close to in vivo conditions as possible, 
enriched fractions of Sertoli cells were assayed immediately after isolation from the rat testes 
using a protocol adapted from Anway and colleagues [127].  Sertoli cells were isolated from the 
testes of 5 and 11 day-old rats representative of proliferating and differentiating Sertoli cells, 
respectively. Using this protocol, approximately 1.7 x 107 cells were obtained from ten 5 day-old 
rat pups and 9.0 x 107 cells from ten 11 day-old rat pups. Imaging analysis confirmed that the 
isolation procedure resulted in highly enriched Sertoli cell fractions (Figure 3A).  Approximately 
85 ± 2% of the cells were positive for the Sertoli cell-specific marker vimentin (Figure 3B). 
Approximately 9 ± 3% were positive for the peritubular cell marker α-smooth muscle actin and 
2.5 ± 2.0% to 4.3 ± 3.1% (5 and 11 days after birth respectively) stained positive for the Leydig 
cell marker Oil Red O (Figure 3B).  The remaining 1.5 ± 1.7% of cells were not labeled and are 
most likely immature germ cells. 
To facilitate studies of factors that may regulate Sertoli cell differentiation, Sertoli cells 
from 5 and 11 day-old rats were studied after being placed in culture.  In addition, fully-
differentiated Sertoli cells from 20 day-old rats were cultured.  By using a gentler isolation 
procedure, lacking a hypotonic shock, and maintaining the Sertoli cells in culture for three days 
prior to manipulation, cell survival was increased compared to the Anway protocol [127]. 
Culture of the Sertoli cells for three days allows the detachment of germ cells from Sertoli cells, 
resulting in a purer population of Sertoli cells. Previous studies have shown that Sertoli cell 
populations are greater then 95% pure four days after initiating the cultures [123]. 
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2.4 CONCLUSION 
Studies in rat Sertoli cells are an appropriate model for the studies conducted in this 
dissertation because the establishment of the final number of Sertoli cells during the pubertal 
period occurs in both rats and primates when gonadotropins are present to promote the onset of 
puberty.  To study processes most closely to the in vivo situation, Sertoli cells will be assayed 
 
Figure 3. Enriched Fractions of Sertoli Cells Obtained Immediately after Isolation. 
Cell suspensions obtained immediately after enzymatic digestion of rat testes were cultured on coverslips for 2 h and 
then fixed. A) Sertoli cells were detected using antisera against vimentin (red, left column), peritubular cells were 
detected by antisera against alpha smooth muscle actin (red, white arrows, middle column), and nuclei were stained 
with Hoechst dye (blue). Leydig cells were stained with the lipid stain Oil Red O (red stain, right column). Bar = 20 
µm. B) Quantitation of the mean (±SE) percentage of cell-specific markers of 10 random fields from multiple 
coverslips is provided. 
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immediately after isolation using a modified protocol from Anway, et al. [127]. Additionally, 
cultured Sertoli cells will be used for studies whose goal is to determine protein localization or 
for studies investigating hormonal regulators of Sertoli cell differentiation.  Sertoli cells will be 
isolated from 5, 11, and 20 day-old rats, representative of proliferating, differentiating, and 
differentiated cells, respectively. 
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3.0  BASIC HELIX-LOOP-HELIX PROTEINS: IDENTIFICATION OF USF1 AND 
USF2 AS POTENTIAL MEDIATORS OF SERTOLI CELL DIFFERENTIATION 
Hypothesis: The DNA binding of bHLH proteins increases during Sertoli cell differentiation. 
3.1 INTRODUCTION 
3.1.1 Basic Helix-Loop-Helix Proteins 
Basic helix-loop-helix (bHLH) proteins function in cell differentiation, growth control, 
and transcription regulation (reviewed in [131]). bHLH proteins are evolutionarily conserved 
transcription factors that contain a basic DNA binding motif and a helix-loop-helix protein 
binding motif [132, 133]. The HLH domain contains two amphipathic helices with conserved 
hydrophobic residues on one side of the helix to facilitate dimerization between bHLH proteins 
[132]. A loop between the two helices is essential for proper spacing between the helical 
domains [132, 134-136]. Mutation of hydrophobic residues or substitution of helical domains 
from other bHLH proteins can eliminate proper dimer formation [133]. The bHLH transcription 
factors bind to specific DNA sequence motifs known as E-boxes (CANNTG) [137, 138] and 
closely related N boxes (CACNAG) [139, 140].  Flanking DNA sequences on either side of the 
consensus sites confirm specificity among proteins that share binding sites [131]. Conservation 
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of arginines within the DNA binding domain of E-box proteins is critical for proper interaction 
with the major groove of the DNA [135]. Contacts with the phosphate backbone also stabilize 
the interactions of the dimer with the DNA [132, 134-136]. Although bHLH proteins bind to E-
boxes with relatively low affinity, they act with great biological specificity suggesting a need for 
additional regulators to facilitate their actions. Several bHLH proteins contain additional protein 
binding motifs that are always positioned carboxy-terminal to the HLH portion of the protein 
(reviewed in [141]). 
bHLH proteins were originally classified according to their functions [131] (Table 3). 
Group I contained ubiquitously expressed proteins that could form homodimers or heterodimers 
with those members in the tissue-restricted Group II [131]. Group I proteins included 
transcription factor E2A (TCFE2A; E12 and E47) [142, 143] and transcription factor 4 (TCF4) 
[144] which are involved in B cell-, muscle-, and pancreatic-specific gene regulation.  Another 
Table 3. Classification of bHLH Proteins.  
Phylogenetic 
Group 
Preferential Binding 
Site 
Additional 
Protein 
Interaction 
Domains 
Original 
Classification 
Examples of Classified 
Proteins 
A CAGCTG or 
CACCTG 
 I, II MYOD1 , Twist, Net, 
TCFE2A (E12 and E47), 
TCF4, HEB, daughterless, 
myogenin, MYF5 
 
B CACGTG or 
CATGTTG 
bZIP III, IV MAX, MXD1, USF1, USF2, 
TFE3, MYC, TFEB 
 
C ACGTG or GCGTG PAS  Arnt, HIF, Clock, single-
minded 
 
D Lack a basic domain 
and hence do not bind 
DNA 
 
 V ID, emc 
E CACGCG or 
CACGAG 
(N-box sequences) 
 
Orange domain, 
WRPW peptide 
VI Hairy, enhancer of split 
F  COE domain  Coe (Col/Olf-1/EBF) 
Adapted from C. Murre, et al. (1994) [131] and S. Jones (2004) [141]. 
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member, daughterless, is involved in sex determination and neurogenesis in Drosophila 
melanogaster [145-147]. Group II proteins included myogenic differentiation 1 (MYOD1), 
myogenin, and myogenic factor 5 (MYF5), all involved in muscle development [148-150], and 
the achaete-scute complex of Drosophila, which is involved in formation of peripheral nerves 
[151, 152]. Group III contained myelocytomatosis oncogene (MYC)-related proteins involved in 
growth control: neuroblastoma derived MYC (MYCN), lung carcinoma derived MYC 
(MYCL1), transcription factor binding to immunoglobulin heavy chain enhancer 3 (TFE3), and 
transcription factor EB (TF-EB) [153]. Group IV contained the MYC interactors MYC-
associated factor X (MAX) and MAX dimerization protein 1 (MXD1) [154].  Members of Group 
V lacked a basic DNA binding domain and included inhibitor of DNA binding (ID) proteins 
[155] and the Drosophila extra macrochaetae (emc) protein [156, 157] whereas Group VI 
members contained proline residues within their basic DNA binding domain (hairy, enhancer of 
split) [139, 158].   
The bHLH proteins were reclassified according to evolutionary conservation of the 
genetic sequence and accounted for the consensus sequence bound by the proteins as well as any 
additional protein dimerization domains that may be present (reviewed in [141]) (Table 3). Class 
A contains proteins bind to CAGCTG or CACCTG motifs and comprise of members from the 
old Groups I and II [159]. Class B contains proteins that bind CACGTG or CATGTTG motifs 
and are comprised of members from the old groups III and IV [159].  Many members of Class B, 
including upstream stimulatory factors 1 and 2 (USF1 and USF2), also contain additional leucine 
zipper motifs [159, 160]. Class C members bind to ACGTG or GCGTG domains and contain an 
additional Per/Arnt/Sim (PAS) protein binding domain [160].  This class includes the proteins 
single-minded, Arnt, Hypoxia inducible factor (HIF), and Clock [159, 160]. Class D members 
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lack a basic DNA binding domain and include the old Group V members [159]. Class E 
members bind to closely related N-boxes, CACGCG or CACGAG [160].  Additionally, Class E 
proteins contain an orange protein binding domain and a WRPW peptide [160]. The members of 
this group originally fell into Group VI; as such they contain proline residues in their DNA 
binding motif. The final class, Class F, contain proteins with a COE (Col/Olf-1/EBF) domain 
that is involved in dimerization and DNA binding [160]. This currently accepted bHLH 
classification allows room for newly discovered proteins and is not restrictive to new members 
based on location or function of the protein. 
3.1.2 Basic Helix-Loop-Helix Proteins in Sertoli Cells 
The bHLH transcription factors previously shown to be expressed in Sertoli cells include 
TCF4 (also known as ITF2 or E2-2)[161], scleraxis (SCX) [162], USF1, USF2 [163], REBα (the 
rat homologue of the human HeLa E-box binding protein, HEB (TCF12)) [164], and E47 but not 
E12 proteins that are derived from the Tcfe2a gene (formerly known as E2A) [165]. 
Additionally, ID proteins, members of Class D, are also expressed within Sertoli cells and will be 
discussed in Chapter 5 [166]. Class A bHLH proteins bind to CAGCTG motifs and contain E47, 
ITF2, and REBα [167, 168]. The E47 E-box protein has been implicated in numerous activities 
in Sertoli cells, including FSH-induced regulation of Trf and the influencing of hormone-induced 
activation of the Fos gene promoter through the serum response element [168, 169].  TRF is a 
marker of Sertoli cell differentiation and is essential for differentiated Sertoli cell function. Class 
B proteins include USF1, USF2, and MYC and bind to CACGTG motifs [170]. Class B E-box 
motifs are known to regulate the promoters of the steroidogenic factor 1 (Nr5a1) and the Fshr 
genes [109, 171-173].  Both of these genes are critical for Sertoli cell differentiation; however, 
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only Fshr is Sertoli cell-specific.  Due to the importance of transferrin and FSHR expression 
within differentiated Sertoli cells, consensus binding sequences for both the Class A and Class B 
bHLH proteins were used to study the activities of the bHLH proteins during postnatal Sertoli 
cell differentiation. 
3.2 RESULTS 
3.2.1 DNA Binding of the E47 E-box Protein Is Low in 5 and 11 Day-old Sertoli Cells 
To investigate the binding activity of E47 and the related E12 E-box factors in Sertoli 
cells during differentiation, electrophoretic mobility shift assays (EMSA) were performed. 
Nuclear extracts from Sertoli cells immediately after isolation from 5 and 11 day-old rats were 
incubated with probes that were previously shown to bind E47, including a consensus binding 
site for E47 (Figure 4A), the Trf promoter E-box (Figure 4B), or the E-box region from the Id2 
promoter (Figure 4C) [168, 169, 174]. Incubation of the E47-selective probes with Sertoli cell 
nuclear extracts did not result in detection of any DNA-protein complexes. In contrast, all the 
probes formed complexes with nuclear extracts derived from splenic origin CD19+ B cells, 
activated with lipopolysaccharide, that are known to contain high levels of E47 and E12 binding 
activity (Figure 4A-D) [132, 144, 175]. In addition, E47 was over-expressed in COS7 cells and 
incubation of these extracts with a probe containing the E-box region of the Trf promoter 
resulted in a DNA-protein complex (Figure 4E, lane 2).  The DNA-protein complex formed with 
the transfected COS7 cells was disrupted by an anti-E47 antibody (Figure 4E, lane 4). The 
protein binding activity of the Sertoli nuclear extracts was confirmed by the finding that DNA- 
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protein complexes were formed 
using a probe containing a 
binding site for the CREB1 
transcription factor (Figure 4D).  
CREB binding is generally stable 
under most conditions and is not 
altered during differentiation 
[176]. Together, these studies 
indicate that E47 binding activity 
is below detectable limits in the 
nuclei of 5 and 11 day-old Sertoli 
cells.  
3.2.2 The DNA Binding of 
USF1 and USF2 Increase 
During Sertoli Cell 
Differentiation 
To investigate the binding 
of Class B E-box factors, 
including USF1, USF2, and 
MYC, EMSA studies were again conducted with nuclear extracts of Sertoli cells assayed 
immediately after isolation from 5 and 11 day-old rats. For probes containing either a consensus 
USF binding site or a region of the Fshr promoter containing an E-box known to bind USF [163, 
 
Figure 4. E47 DNA Binding is Not Detected in Proliferating or 
Differentiating Sertoli Cells.  
EMSAs using probes containing a consensus E-box selective for E47 
binding (A), the Trf promoter E-box (B), the Id2 promoter E-box (C), 
or a CREB-binding site (D) were incubated with nuclear extracts from 
Sertoli cells assayed immediately after isolation from 5 and 11 day-old 
testis or with CD19+ B cells isolated from mouse spleen. The DNA-
protein complexes formed by E47, E12, and CREB1 are indicated. The 
complexes were identified from the results of separate supershift assays 
using E47- and E12-selective antisera (data not shown). Assays for 
E47-selective binding probes were exposed for 7 days, while CREB1 
binding complexes were detected after 12 h. (E) EMSAs using a probe 
containing the E-box region of the Trf promoter was incubated with 5 
mg of COS7 cell extracts without (lanes 1 and 3) or with (lanes 2 and 
4) over-expressed E47.  Supershift analysis indicated that the detected 
band was E47 (lanes 3 and 4).  Free probe was run off of the gels. 
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177], protein binding was low or undetectable in extracts from 5 day-old Sertoli cells but binding 
activity increased at least 2-fold at 11 days (Figure 5A). As expected, CREB1 binding to a 
consensus CREB binding motif (CRE) was unchanged at 5 and 11 days (Figure 5A).  
To identify E-box binding proteins that are responsible for forming the DNA-protein 
complexes, supershift studies were performed.  Sertoli cell nuclear extracts assayed immediately 
after isolation from 11 day-old testes were preincubated with non-immune sera or antisera 
against USF1, USF2, E47, E2A, or MYC before incubation with the E-box region of the Fshr 
promoter (Figure 5B). The supershift assay demonstrated that both USF antisera partially 
supershifted and disrupted DNA-protein complexes, whereas the E47, E2A, and MYC antisera 
had little effect.   These data suggest that USF1 and USF2 proteins are the major E-box factors 
 
Figure 5. USF DNA Binding Increases During Differentiation in Nuclear Extracts Prepared from Sertoli Cells 
Immediately After Isolation.  
Nuclear extracts isolated from Sertoli cells were immediately assayed for DNA-protein interactions. A) In EMSAs, 
radiolabeled probes containing 1) a consensus E-box that is selective for USF binding, 2) a region of the Fshr 
promoter containing an E-box known to bind USF proteins, or 3) a CREB-binding site (CRE) were incubated with 
Sertoli cell nuclear extracts from 5 and 11 day-old rats. Representative images of the resulting DNA-protein 
complexes are shown, and quantitation of the mean (±SE) of five independent experiments is provided. The relative 
binding for each probe is normalized to that of 11 day-old Sertoli cells (=1). Statistically significant differences (p < 
0.05) are indicated by an asterisk (*). B) Nuclear extracts of enriched Sertoli cells from 11 day-old rats were 
incubated with non-immune sera or antisera against USF1, USF2, E47, E2A, or MYC. Supershifted DNA-protein 
complexes containing USF1 or USF2 are indicated. Exposure times for all complexes are less than 48 h. Free probe 
was run off of the gels. 
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that account for increased binding to E-box motifs 
during Sertoli cell differentiation. 
3.2.3 USF DNA Binding is Similar in Nuclear 
Extracts Prepared from Sertoli Cells Immediately 
After Isolation or from Cultured Sertoli Cells 
EMSA analysis of nuclear extracts of cultured 
Sertoli cells isolated from 5 and 11 day-old rats 
revealed that the levels of E-box protein binding to the 
USF consensus and Fshr promoter probe were low at 
5 days but increased 5- to 10-fold at 11 days (Figure 
6A, B).  E-box binding activity decreased at 20 days 
but was still 6.98 ± 0.13 (p < 0.05)- or 2.78 ± 0.17-fold 
greater than the E-box binding activity present in 5 
day-old Sertoli cells at the USF consensus and Fshr 
promoter E-box probes respectively.  In agreement with the results obtained from Sertoli cells 
assayed immediately after isolation (Figure 4A-C), E47 DNA binding was below the level of 
detection using three E47 selective probes and extracts from cultured 5, 11, or 20 day-old Sertoli 
cells (data not shown). Together, these data confirm that the developmental profile of E-box 
protein binding activities and the prevalence of USF binding activity are similar in Sertoli cells 
assayed immediately after isolation and after three days in culture. 
 
Figure 6. USF DNA Binding Increases in 
Cultured Sertoli Cells During 
Differentiation. 
In EMSAs, radiolabeled probes containing a 
consensus E-box that is selective for USF 
binding (A) or a region of the Fshr promoter 
containing an E-box known to bind USF 
proteins (B) were incubated with nuclear 
extracts isolated from cultured 5, 11, and 20 
day-old Sertoli cells. Representative images of 
the resulting DNA protein complexes are 
shown, and quantitation of the mean (±SE) of 
three independent experiments is provided. 
Free probe was run off the gel. All bands 
shown for each age were resolved on the same 
gel. The relative binding for each condition is 
normalized to that of 11 day-old Sertoli cells 
(=1). Values with different lowercase letters 
differ significantly (p < 0.05).  
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3.3 CONCLUSIONS 
The DNA binding of bHLH proteins was hypothesized to increase during Sertoli cell 
differentiation because E-box proteins are known to contribute to differentiation in other cell 
types and had previously been shown to regulate genes important for Sertoli cell differentiated 
functions [163, 167, 168, 177-179]. The bHLH protein E47 was previously shown to be 
important in the regulation of Trf and Id2 genes in Sertoli cells [167, 168, 178]. However, E47 
binding to E-box motifs was undetectable between 5 and 11 days after birth in the rat (Figure 4 
A-C). The inability to detect E47 binding at any of three E47-selective E-box probes agrees with 
results from Skinner and colleagues in which E47 binding to the Trf promoter E-box was not 
observed except after stimulation for 48 hours by FSH in 20 day-old rat Sertoli cells [168]. In 
contrast, binding of USF1 and USF2, key regulators of the Fshr gene, increases to E-box motifs 
between 5 and 11 days after birth (Figure 5A-B). These results are consistent with those of the 
Heckert laboratory that found USF proteins bound to the Fshr promoter E-box in fully-
differentiated rat Sertoli cells (27 or 50 days-old) [163, 177, 179].  The ability of USF1 or USF2 
antisera to supershift the protein binding complex at the E-box in the Fshr promoter is 
incomplete, but when both antisera are incubated with 20 day-old Sertoli cell extracts, the 
complex formation is completely ablated [179]. This result supports the idea that both USF1 and 
USF2 are present in the DNA protein complex present at the Fshr promoter E-box. The binding 
activity of E47, USF1, and USF2 is similar in both Sertoli cells assayed immediately after 
isolation and in cultured Sertoli cells (Figure 5 vs. Figure 6). In cultured Sertoli cells, USF1 and 
USF2 binding decreased between 11 and 20 days after birth to levels at or above the levels of 
binding seen from 5 day-old cells (Figure 6). Together, these data indicate that the binding of 
USF1 and USF2, but not E47, E-box proteins increases during Sertoli cell differentiation, 
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supporting the hypothesis and identifying USF1 and USF2 as potential regulators of Sertoli cell 
differentiation.  
The findings that USF proteins are the predominant E-box transcription factors that are 
able to bind E-box motifs during Sertoli cell differentiation and that USF proteins are the major 
E-box regulators of the Fshr is consistent with previous studies showing that male fertility is 
compromised in the absence of FSHR and USF2 [180-182]. Fshr-/- mice are fertile but present 
with a smaller testis weight by 20 days after birth through adulthood due to a reduced number of 
Sertoli cells when compared with wild-type littermates [180, 181]. Usf2-/- mice have a distinct 
growth defect and males have compromised fertility as only one in three males are able to sire a 
litter [182]. Further analysis of the Usf2-/- mice to determine the male fertility deficiency has not 
been conducted.  
The data presented here suggest that between 5 and 11 days after birth the DNA binding 
of USF proteins increases. It is assumed that the increase in USF DNA binding will promote 
transcription of genes regulated by USF1 and USF2. Therefore, USF proteins may integrate 
regulatory signals to ensure that the correct differentiation-associated genes are expressed [163, 
177, 179] in a time-course consistent with the onset of differentiation in Sertoli cells. Presently, 
the molecular mechanisms of USF1 and USF2 regulation in Sertoli cells are unknown.  
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4.0  EXPRESSION OF USF1 AND USF2 WITHIN PROLIFERATING AND 
DIFFERENTIATING SERTOLI CELLS 
Hypothesis:  USF1 and USF2 mRNA and protein expression levels increase during 
differentiation and correspond with increased USF DNA binding at E-box motifs. 
4.1 INTRODUCTION 
4.1.1 USF1 and USF2: Properties of the Genes and Proteins 
USF proteins were originally identified as regulators of the adenoviral major late 
promoter (MLP).  These 43 and 44 kilodalton (kD) proteins, USF1 and USF2 respectively, were 
found to bind to the MLP equally well and at an optimum of 75 mM KCl [183]. The 44 kD 
USF2 was originally thought to be a splice variant or regulator of the 43 kD USF1 form as the 
two proteins were immunologically distinct but were routinely associated with one another 
[184]. Purified 43 kD USF was found to reside in solution as a dimer and was efficient in 
inducing MLP activity in the absence of the 44 kD form [184].  
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Figure 7. USF Protein Structure and Homology.  
A) Three dimensional structure of USF1 dimer of the bHLH motif (cyan) with the additional bZIP domain (purple) 
[135, 136]. DNA is colored orange. Reprinted from [136] with permission from Elsevier. B) Comparison of Usf1 
and Usf2 genes and C) protein structure. Usf1 and Usf2 genes constitute 10 exons. Sequences in color correspond to 
the basic domain (orange), the helix-loop-helix (cyan) and leucine-zipper (purple) (b-HLH-LZ) domains.  USF 
Specific Region (USR) is denoted in blue (adapted from [170] with permission from Wiley-Blackwell). D) Protein 
alignment of USF1 from Rat (NP_113965.1), Mouse, (NP_033506.1), Human (NP_009053), and Monkey 
(XP_001117700) using ClustalW [185]. Boxes indicate motifs within protein. E) Protein alignment of USF2 from 
Human (NP_003358.1), Rat (NP_112401.1), and Mouse (NP_035810.1) using ClustalW  [185]. Boxes indicate 
motifs within protein.  The protein sequence of Monkey USF2 is not currently available. 
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Crystallization of the USF dimer by Ferre-D’Amare et al. [135] revealed detailed 
information on the formation of the dimer and protein-DNA contacts (Figure 7A). USF contains 
three functional domains: 1) the basic DNA binding domain, 2) the helix-loop-helix (HLH) 
domain, and 3) the leucine zipper (ZIP).  The basic DNA binding domain specifically interacts 
with the DNA consensus sequence, GGCCACGTGACC [135, 186]. The HLH motif and loop 
domain mediates protein-protein interactions and stabilizing the homodimer’s DNA binding 
domain [135].  The presence of the leucine zipper is required for efficient DNA binding to the 
recognition motif [141, 186].  USF binding to DNA does not induce DNA bending, but the 
presence of the leucine zippers allows USF to function as a homotetramer that can 
simultaneously bind two spatially distinct DNA recognition sites, allowing for chromatin looping 
[135].  Activation of transcription by USF was found to require the HLH-ZIP domain and a 
small region of 43 kD USF close to the N-terminus, amino acids 93-156 [187].  
E 
 33 
With the cloning of the gene for the 44 kD USF2 protein in the 1990s, comparisons 
between the genes and distinct functions of USF1 and USF2 could be ascertained (Figure 7B) 
[188, 189]. Both genes are closely related and the USF1 and USF2 proteins are highly conserved 
between mouse, rat, monkey, and human (Figure 7D,E). The structure of the genes are such that 
small introns separate exons that correspond to functional domains of the proteins (Figure 7C) 
[190, 191]. Both Usf1 and Usf2 lack a TATA box motif, however, an initiator sequence is 
present in the promoters for both genes [170, 191, 192]. The Usf1 promoter has regulatory 
binding sites for the transcription factor 1 SP1 (SP1), GATA factors, YY1 transcription factor, 
neurofibromatosis 1 (NF1), CCAAT/enhancer binding protein (C/EBP), and transcription factor 
AP-2 whereas Usf2 contains two E-box motifs within its promoter suggestive of auto-feedback 
[191, 192]. Both Usf1 and Usf2 are expressed ubiquitously although the ratio of Usf1 to Usf2 
varies between cell types [193]. Usf1 is not thought to have functional alternative transcripts, 
whereas Usf2 encodes two transcripts due to alternative splicing and alternative poly(A) site 
usage [190, 191, 193]. The alternatively spliced USF2 (USF2b) lacks exon 4 that encodes a 
positive regulatory domain and fails to induce transactivation.  As such, USF2b can act as a 
dominant negative dimerization partner [170]. USF1 and USF2 have highly conserved 
dimerization and DNA binding motifs while varying at the N-terminus [193].  This high level of 
conservation allows the two proteins to have similar DNA binding properties [193]. The 
conserved nature of USF1 and USF2 has made it difficult to distinguish between specific actions 
of each protein. 
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4.1.2 Usf Knockout Mice Suggest an Involvement of USF Proteins in Male Fertility 
The Sawadogo laboratory created Usf knockout mice to determine the biological role of 
USF1 and USF2 [182].  Usf1-/- mice were viable and fertile.  These mice had only slight 
behavioral abnormalities with excessive trimming behavior resulting in mice lacking whiskers 
and nasal fur. These mice displayed a dose-dependent elevation of Usf2 with heterozygotes 
expressing 24% more Usf2 and homozygotes expressing 66% more. Usf1-/- mice, especially 
females, had spontaneous epileptic seizures suggesting a role in brain function. Usf2-/- mice had 
an obvious growth defect as these mice were routinely 20-40% smaller then their wild-type or 
heterozygote littermates.  A large percentage of Usf2-/- pups died shortly after birth.  The mice 
that survived maintained a small stature throughout postnatal development. The fertility of Usf2-/- 
males was affected with only one third of males able to sire a litter with wild-type females.  The 
males also had a shortened lifespan on average of 2.5-4.5 months and no males have lived longer 
than 6 months. Usf1-/-Usf2-/- and Usf1+/-Usf2-/- are embryonic lethal.  These phenotypes suggest 
that whereas USF2 can compensate for most of USF1’s functions, USF1 is unable to compensate 
for USF2’s effects on growth, male fertility, and male lifespan.   
4.1.3 USF1 and USF2: Ubiquitous Transcription Factors 
USF1 and USF2 are ubiquitously expressed transcription factors. USF binding to DNA 
recruits general transcription complexes and can enhance the transactivation by SP1 transcription 
factor and metal regulatory transcription factor-1 [194-196]. Also, USF binding to DNA can 
recruit chromatin modifying enzymes. USF proteins preferentially interact with nucleosomes 
containing highly acetylated histone 4 and USF1 is present in complexes with histone 
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acetyltransferases, histone acetylases, and histone methylases [197, 198]. Additionally, USF2, 
but not USF1, is capable of initiating transcription of human Top3a (topoisomerase DNA III α) 
contributing to the removal of supercoils within chromatin strands [199]. Finally, USF1 and 
USF2 have been implicated in cell cycle regulation.  USF1 and USF2 regulate the expression of 
genes required for differentiation in multiple cell types including in osteoclasts [200, 201], 
osteoblasts [202], adipocytes [203], and trophoblasts [204]. USF proteins are known to regulate 
the expression of cell cycle inhibitors CDKN1B (p27KIP1)[205, 206], CDKN1A (p21CIP1) [206], 
and Tp53 [206] as well as CCNB1 (cyclin B1) [206, 207] and cyclin dependent kinases [205, 
208]. USF1 and USF2 may function as general transcription factors that are important in cell 
cycle control and may provide regulation of essential genes in all cells, including Sertoli cells. 
However, USF1 and USF2 actions in Sertoli cells have not been extensively studied.  This 
chapter will characterize USF1 and USF2 expression in Sertoli cells during postnatal 
differentiation. 
4.2 RESULTS 
4.2.1 Usf1 mRNA Levels Increase Between 5 and 11 Days After Birth in Isolated Sertoli 
Cells 
To determine whether increased USF DNA binding during Sertoli cell differentiation 
corresponded with increased Usf mRNA expression, mRNAs encoding E-box proteins were 
assayed during Sertoli cell development using quantitative PCR (qPCR) with ∆∆Ct analysis. 
Assays of mRNA preparations from Sertoli cells immediately after isolation from 5 and 11 day-
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old rat testes, revealed a significant 1.73 ± 0.32-fold (p < 0.05) increase in Usf1 mRNA levels 11 
days after birth (Figure 8A). Usf2 and Tcfe2a (E47) mRNA levels also trended higher (1.23 ± 
0.19 and 1.27 ± 0.14) but did not reach a level of statistical significance (Figure 8B, C). Trf 
mRNA levels increased 2.88 ± 0.76-fold (p < 0.05) from 5 to 11 days in agreement with previous 
studies showing that Trf mRNA levels increase during differentiation (Figure 8D) [28, 108].  The 
mRNA levels of the housekeeping gene Ppia (peptidylprolyl isomerase A, commonly known as 
cyclophillin) did not change over the course of differentiation (data not shown) and were used to 
normalize mRNA expression levels.  
The efficiency-corrected ∆Ct analysis of qPCR was used to determine the differences in 
the relative quantity of mRNA present for each gene of interest [209].  Average fold-changes in 
relative quantity between 5 and 11 days for 
Usf1, Usf2, and Tcfe2a (E47) were very similar 
to the relative-fold changes obtained from the 
∆∆Ct analysis; however, the average fold 
changes in relative quantities did not reach 
statistical significance (Table 4, Rows 5-6). Trf 
mRNA levels increased 2.66 ± 0.63 (p < 0.05) 
significantly between 5 and 11 days as 
expected (Table 4, Rows 5-6). Usf2 mRNA 
relative quantities in 5 day-old Sertoli cells are 
7.31 ± 2.08-fold (p < 0.05) greater than that of 
Usf1 mRNA relative quantities (Table 4, Row 
7). However, by 11 days after birth, relative  
 
Figure 8. Usf1 mRNA Levels Increase During 
Development in Sertoli Cells Assayed Immediately 
After Isolation. 
The mRNAs isolated from 5 and 11 day-old Sertoli 
cells were analyzed by qPCR using primers for Usf1 
(A), Usf2 (B), Tcfe2a (E47) (C), and Trf (D).  Data 
were analyzed using the ∆∆Ct method and quantitation 
of the mean (±SE) of three individual experiments for 
each condition is provided for each primer set.  The 
relative mRNA levels were normalized to Ppia levels 
and were made relative to 5 day-old Sertoli cells (=1). 
Statistically significant differences (p < 0.05) are 
indicated by an asterisk (*). 
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quantities of Usf1 and Usf2 are not statistically different (Table 4, Row 8). Tcfe2a (E47) and Trf 
are expressed at levels comparable to Usf1 5 days after birth and only Trf is expressed in greater 
relative quantities then Usf1 11 days after birth (Table 4, Row 8). Together, both qPCR analyses 
suggest that Usf1 mRNA levels but not Usf2 mRNA levels increase during Sertoli cell 
differentiation and this increase correlates with the increase in USF DNA binding 11 days after 
birth. 
The expression of mRNAs encoding E-box proteins was also assayed by qPCR in 
cultured Sertoli cells to determine whether mRNA expression patterns during Sertoli cell 
differentiation were maintained in culture. ∆∆Ct qPCR analysis of mRNA preparations from 
cultured Sertoli cells showed statistically significant increases in Usf1 (1.41 ± 0.03-fold, p<  
Table 4. Comparison of bHLH mRNA Levels Using the ∆∆Ct Method and the Efficiency-corrected ∆Ct 
Method of qPCR Analysis in Rat Sertoli Cells Assayed Immediately After Isolation. 
 Sertoli Cell 
Age Usf1 Usf2 Tcfe2a (E47) Trf 
Row 
Number 
∆∆Ct Relative 
Fold Change 
Compared to 5 
Day-old Sertoli 
Cells 
(Figure 8)* 
5 Days 1.00 ± 0.0 1.00 ± 0.0 1.00 ± 0.0 1.00 ± 0.0 1 
11 Days 1.73 ± 0.32* 1.23 ± 0.19 1.27 ± 0.14 2.88 ± 0.76* 2 
Relative 
Quantity Using 
the Efficiency-
Corrected ∆Ct 
Method Relative 
to Ppia 
5 Days 0.00862 ± 0.00198 
0.00862 
± 0.00198 
0.01460 
± 0.00087 
0.02360 
± 0.00055 3 
11 Days 0.01609 ± 0.00715 
0.07138 
± 0.01540 
0.01838 
± 0.00156 
0.06236 
± 0.01410 4 
Average Fold 
Change in 
Relative 
Quantity 
Compared to 5 
Day-old Sertoli 
Cells* 
5 Days 1.00 ± 0.0a 1.00 ± 0.0 1.00 ± 0.0 1.00 ± 0.0 5 
11 Days 1.76 ± 0.37 1.21 ± 0.17 1.48 ± 0.14 2.66 ± 0.63* 6 
Average Fold 
Change in 
Relative 
Quantity Over 
Usf1 
5 Days -- 7.31 ± 2.08** 1.81 ± 0.37 2.92 ± 0.59 7 
11 Days -- 5.35 ± 2.10 1.37 ± 0.37 4.34 ± 0.77** 8 
*Change between 5 and 11 days is significantly different (p < 0.05). 
**Change between relative quantities when comparing gene to Usf1 is significantly different (p < 0.05). 
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0.05), Usf2 (1.42 ± 0.12-fold, p < 0.05), and 
Tcfe2a (E47; 1.59 ± 0.15-fold, p < 0.05) 
mRNA levels in cells isolated from 11 day-old 
rats  when compared to mRNA levels from 5 
day-old Sertoli cells (Figure 9A-C). Trf mRNA 
levels also increased 2.79 ± 0.31-fold from 5 to 
11 days and from 11 to 20 days after birth 
(Figure 9D) in agreement with studies in 
Sertoli cells assayed immediately after 
isolation showing that Trf mRNA levels 
increase in cells isolated during three key time 
periods in Sertoli cell differentiation (Figure 
8D).  The mRNA levels of the housekeeping 
gene Ppia did not change over the course of 
differentiation (data not shown).  
Efficiency-corrected ∆Ct analysis of 
mRNA levels in cultured Sertoli cells revealed 
similar results.  The relative quantities of Usf1, Usf2, and Trf increased significantly between 5 
and 11 days after birth: 1.39 ± 0.03-fold, 1.39 ± 0.12-fold, and 2.60 ± 0.27-fold respectively 
(Table 5, Rows 7-8).  The relative quantities of Usf1 and Usf2 significantly decreased  by 0.55 ± 
0.07 and 0.36 ± 0.06-fold (p< 0.05) between 11 and 20 days after birth while the relative 
quantities of Trf increased by 0.61 ± 0.20-fold (p < 0.05; Table 5, Rows 8-9). In contrast to the 
∆∆Ct analysis, relative quantities of Tcfe2a (E47) were not significantly elevated in cultured  
 
Figure 9. E-box Protein mRNAs Increase 11 Days 
After Birth in Cultured Sertoli Cells via qPCR.   
mRNA isolated from cultured 5, 11, and 20 day-old 
Sertoli cells was analyzed by qPCR using primers for 
Usf1 (A), Usf2 (B), Tcfe2a (E47) (C), and  Trf (D). 
Data was analyzed using the ∆∆Ct method and 
quantitation of the mean (±SE) of three individual 
experiments for each condition is provided for each 
primer set.  The relative mRNA levels were normalized 
to Ppia levels and made relative to 5 day-old Sertoli 
cells (=1). Values with different lowercase letters differ 
significantly (p < 0.05). 
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Sertoli cells isolated from 11 day-old rats (Table 5, Rows 7-8), although the average fold-
changes were comparable (Table 5, Row 1-2).  Relative quantities of all mRNA transcripts were 
comparable to Usf1 at all ages with the exception of Trf 20 days after birth, which were 
significantly increased (Table 5, Rows 10-12). The large average fold changes and standard 
errors for Usf2 are due to the smaller Ct values (approximately 19) from one experiment when 
averaged with two experiments with larger Ct values (approximately 25) (Table 5, Columns 10-
12). Additional experiments should be repeated to reduce the variability detected in Usf2 mRNA 
levels in cultured Sertoli cells. Based on the qPCR data, the increase in DNA binding of USF1 
and USF2 from cultured Sertoli cells corresponds with changes in Usf1 and Usf2 mRNA 
expression. 
Table 5. Comparison of mRNA Levels of bHLH Proteins by the ∆∆Ct Method and Efficiency-Corrected ∆Ct 
Method of qPCR Analysis in Cultured Rat Sertoli Cells. 
 Sertoli Cell 
Age Usf1 Usf2 Tcfe2a (E47) Trf 
Row 
Number 
∆∆Ct Relative 
Fold Change 
Compared to 5 
Day-old Sertoli 
Cells 
(Figure 9)* 
5 Days 1.00 ± 0.0a 1.00 ± 0.0a 1.00 ± 0.0a 1.00 ± 0.0a 1 
11 Days 1.41 ± 0.03b 1.42 ± 0.13b 1.59 ± 0.15b 2.79 ± 3.52b 2 
20 Days 0.86 ± 0.07a 1.03 ± 0.07a 0.78 ± 0.04a 3.52 ± 0.24c 3 
Relative 
Quantity Using 
the Efficiency-
Corrected ∆Ct 
Method Relative 
to Ppia 
5 Days 0.01609  ± 0.01123 
0.30215  
± 0.35748 
0.02170 ± 
0.00751 
0.01882  
± 0.00058 4 
11 Days 0.02275  ± 0.01621 
0.38223  
± 0.44987 
0.03513 
 ± 0.01468 
0.04905 ± 
0.00618 5 
20 Days 0.01272  ± 0.00811 
0.30085  
± 0.35523 
0.01709  
± 0.00623 
0.06061  
± 0.00515 6 
Average Fold 
Change in 
Relative 
Quantity 
Compared to 5 
Day-old Sertoli 
Cells* 
5 Days 1.00 ± 0.0a 1.00 ± 0.0a 1.00 ± 0.0 1.00 ± 0.0a 7 
11 Days 1.39 ± 0.03b 1.39 ± 0.12b 1.57 ± 0.15 2.60 ± 0.27b 8 
20 Days 0.84 ± 0.07c 1.03 ± 0.06a 0.78 ± 0.04 3.21 ± 0.20c 9 
Average Fold 
Change in 
Relative 
Quantity Over 
Usf1 
5 Days -- 37.44 ± 44.60 1.89 ± 0.70 2.02 ± 0.97 10 
11 Days -- 34.83 ± 41.43 2.12 ± 0.84 3.91 ± 2.14 11 
20 Days -- 45.11 ± 53.74 1.70 ± 0.54 7.12 ± 2.86** 12 
*Values with different lowercase letters differ significantly within this category (p < 0.05). 
**Change between relative quantities when comparing gene to Usf1 is significantly different (p < 0.05). 
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4.2.2 USF1 Protein Levels Increase Between 5 and 11 Days After Birth in Whole Cell 
Extracts from Sertoli Cells Assayed Immediately After Isolation  
Western blotting analysis of USF1 and USF2 in whole cell extracts prepared from Sertoli 
cells immediately after isolation demonstrated that USF1 protein levels increased between 5 and 
11 days after birth by 3.3 ± 1.1-fold (p < 0.05; Figure 10 A, C).  USF2 protein levels did not  
 
Figure 10. USF1 Protein Levels Increase During Differentiation in Sertoli Cells Assayed Immediately After 
Isolation.  
Western immunoblotting of whole cell extracts from 5 and 11 day-old Sertoli cells was performed sequentially with 
antisera specifically recognizing USF1 (A) or USF2 (B) followed by β-actin. Arrowheads denote band of interest. 
The normalized USF1 and USF2 levels for 5 day-old Sertoli cells were arbitrarily set equal to 1. The mean fold 
induction (±SE) of 11 day-old Sertoli cells over 5 day-old Sertoli cells from 3 independent experiments for USF1 
and USF2, respectively, is reported (C&D). Values that are significantly different (p < 0.05) are indicted with an 
asterisk (*). 
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change (Figure 10 B, D).  β-actin levels were assayed to ensure equal protein loading. Detection 
of USF1 required 5-fold more protein extract than that needed for USF2 protein detection. 
Although the efficiency of the USF1 and USF2 antibodies may vary, the need for less protein to 
provide a USF2 Western signal is consistent with previous qPCR results demonstrating that Usf2 
mRNA levels are greater than those of Usf1 (Table 4, Row 5-6). The observed increase in Usf1 
mRNA and USF1 protein levels between 5 and 11 days after birth is likely a major contributor to 
the increase in DNA binding to USF consensus sites observed 11 days after birth.  
4.2.3 USF1 Protein Localizes to the Nuclei of Differentiating Cultured Sertoli Cells 
 It was hypothesized that an increase in USF1 protein levels within the nuclei of Sertoli 
cells would contribute to an increase in DNA-binding activity to E-box motifs. To verify the 
location of E-box proteins within Sertoli cells during differentiation, immunofluorescence 
analysis was conducted on cultured primary Sertoli cells from 5 and 11 day-old rats (Figure 11). 
Cells were incubated with antisera against USF1 (top) or USF2 (bottom) and nuclei were stained 
with Hoechst. Antiserum against vimentin, a Sertoli cell-specific marker, revealed that all USF-
positive cells are also Sertoli cells (Appendix A, Figures 34 and 35).  USF1 is present in the 
Sertoli cell cytoplasm, but rarely in the nucleus of 5 day-old cells (Figure 11 top).  By 11 and 20 
days after birth, USF1 is predominantly nuclear (Figure 11, top). USF2 immunostaining levels 
were similar in both the cytoplasm and nuclei of Sertoli cells at all stages of differentiation 
(Figure 11, bottom). These data support the hypothesis that USF1 and USF2 binding increases to 
E-box binding sites during differentiation due to an increase in USF1 protein within the nucleus 
of Sertoli cells. 
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4.3 CONCLUSIONS 
USF binding to E-box motifs increases in differentiating Sertoli cells (Figures 5 and 6). A 
hypothesis was proposed that the increase in USF binding to E-box motifs was due to increases 
in USF mRNA and protein levels during Sertoli cell differentiation. Support for this hypothesis 
included qPCR studies that demonstrated an increase in Usf1 mRNA levels between 5 and 11 
days after birth (Figures 8 and 9; Tables 4 and 5). Using ∆∆Ct analysis of qPCR results, it was 
found that Usf1 mRNA levels were increased 1.73 ± 0.32-fold (p < 0.05) in Sertoli cells 
immediately after isolation (Figure 8A; Table 4, Row 1) and 1.4 ± 0.03-fold (p < 0.05) in 
cultured Sertoli cells (Figure 9A; Table 5, Row 2) from 11 day-old rats when compared with 
mRNA levels in Sertoli cells isolated from 5 day-old rats. Usf2 and Tcfe2a (E47) mRNA levels 
 
Figure 11. USF1 Protein Localizes to the Nucleus During Differentiation in Cultured Sertoli Cells.  
Immunofluorescence of cultured 5, 11 and 20 day-old Sertoli cells was performed with antisera recognizing USF1 
(top) or USF2 (bottom) as visualized with Alexa 488 fluorophore (red). Hoechst stains nuclei (blue). Scale bars = 
100 µm. Control immunostaining with the Sertoli cell specific anti-vimentin antiserum is provided in Appendix A, 
Figures 34 and 35. 
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remained unchanged in immediately assayed cells (Figure 8B,C; Table 4, Row 1) but increased 
between 5 and 11 days after birth in cultured Sertoli cells (1.42 ± 0.12-fold and 1.59 ± 0.15-fold, 
respectively (p < 0.05); Figure 9B,C; Table 5, Row 2). In contrast, mRNA studies of cultured 
Sertoli cells revealed a significant increase in mRNA levels of not only Usf1, but also Usf2 and 
Tcfe2a (E47) between 5 and 11 days after birth (Figure 9B,C; Table 5, Row 2). The positive 
control gene, Trf, was also found to increase significantly during Sertoli cell differentiation in 
both cells assayed immediately after isolation and cultured Sertoli cells (Figure 8 and 9; Table 4, 
Row 1; Table 5, Row 2). 
The efficiency-corrected ∆Ct method revealed similar increases in fold-change of RNA 
from cells assayed immediately after isolation for Usf1, Usf2, Tcfe2a (E47), and Trf but only the 
increased Trf levels from 5 to 11 days after birth reached statistical significance (Table 4).  The 
data also revealed that Usf2 mRNA is expressed 7.31 ± 2.08-fold (p <0.05) greater then Usf1 in 5 
day-old Sertoli cells (Table 4, Row 5).  By 11 days, Usf2 mRNA levels were still 5.35 ± 2.10 
greater then Usf1 but the difference was no longer statistically significant.  In cultured Sertoli 
cells, all transcripts were expressed at comparable levels to Usf1. 
mRNA levels were measured in both Sertoli cells assayed immediately after isolation and 
in cultured Sertoli cells.  The results vary between the two populations of cells although similar 
trends are retained (Table 4 vs. Table 5). For example, Usf1 mRNA levels increased in cells 
assayed immediately after isolation 1.73 ± 0.32-fold (p < 0.05; Table 4, Rows 1-2) and in 
cultured cells by 1.41 ± 0.03-fold (p < 0.05; Table 5, Row 1-2).  Both are statistically significant 
increases although cultured Sertoli cells have a reduced level of Usf1 induction. In contrast, Usf2 
and Tcfe2a (E47) mRNA levels trend upward in both Sertoli cell populations but only in cultured 
Sertoli cells are the increases significant (Table 4, Rows 1-2 vs. Table 5, Rows 1-2).  The 
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variance in mRNA levels may be explained by the differences in the type of isolation used to 
study Sertoli cells.  Studies of Sertoli cells that are immediately assayed after isolation remain 
unaltered by culture conditions, whereas cultured Sertoli cells are allowed time to recover from 
isolation and may be induced by culture conditions to up-regulate expression of Usf2 and Tcfe2a 
(E47). Regardless of the difference in cell population used, both assays reveal an increase in 
Usf1 mRNA levels.  
The use of the two methods of qPCR analysis was initially conducted to exploit the 
strengths of each analysis. The ∆∆Ct method allows comparisons between mRNA levels of 
different samples for a single transcript [209]. The efficiency-corrected ∆Ct method also allows 
comparisons between samples but the strength of this method lies in the ability to compare 
mRNA levels of different transcripts within the same sample [209]. However, both analyses can 
provide “fold-changes” and differ slightly in the results. The difference seen in the two data sets 
can be attributed to the ∆∆Ct method reliance on “perfect” amplification of the primer set.  
Primer designing for several genes proved difficult; as such the stringency was relaxed from the 
recommended slope of -3.3 ± 0.1 (efficiency 2.0 ± 0.05). The primers were allowed to have an 
efficiency of 2.0 ± 0.2 (See Material and Methods, Table 10) which equates to a slope of -3.3 ± 
0.5 of the line from a standard serial dilution, created by the plot of the Ct value vs. the log of the 
input (See Materials and Methods, 10.8).  If the primer efficiency was maintained within the 
recommended range, the values would be expected to be more closely correlated for the two 
methods of analysis.  However, Irregardless of some minor differences in specific mRNA 
quantities, as a whole, both ∆∆Ct and efficiency-corrected ∆Ct analysis of mRNA from cells 
assayed immediately after isolation and in culture suggest that there is an increase in Usf1 or 
Usf2 mRNA levels that correlates with an increase in USF DNA binding.  
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Because mRNA levels do not always correspond to increases in protein levels, USF1 and 
USF2 protein levels were analyzed. Western blot analysis from Sertoli cells assayed immediately 
after isolation revealed a 3.3-fold increase in USF1 protein between 5 and 11 days after birth 
(Figure 10A, C). It is possible that the increases in Usf mRNA levels and the subsequent increase 
in USF1 protein expression could account for the elevation of USF-DNA binding observed in 
Sertoli cells during differentiation when immediately assayed, a 2-fold increase (Figure 5), or 
cultured, a 7- to 10-fold increase (Figure 6) between 5 and 11 days after birth. Additionally, 
USF1 protein accumulates in the nucleus of differentiating Sertoli cells (Figure 11, top).  In 
contrast, the levels of USF2 protein expression remain constant during this stage in postnatal 
Sertoli cell differentiation and maintain their cellular localization (Figure 11, bottom).  
Therefore, an increase in USF1 protein expression and an increase of levels of protein in the 
nucleus during differentiation suggest that increases in the availability of USF1 protein in the 
nucleus contributes to and correlates with an increase in USF binding to E-box motifs in Sertoli 
cells.  An increase in binding may in turn lead to an increase in gene transcription. It is 
interesting to note that USF1 levels are up-regulated during differentiation; however, expression 
of the Usf2 gene containing two E-box motifs in its promoter [192] is not altered.  These data 
suggest that factors in addition to USF1 are required to activate the Usf2 promoter in 
differentiating Sertoli cells.  
Data presented thus far support the following model. During proliferation there are low 
levels of USF1 present within Sertoli cells. With the onset of differentiation, Usf1 mRNA and 
USF1 protein production is enhanced. The increased availability of USF1 may lead to the 
formation of more USF1 homodimers and USF1/USF2 heterodimers.  It has been shown that 
USF1/USF2 heterodimers are the most abundant dimer pair within the testis and ovary of 21 
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day-old mice, with the second most prevalent dimer pair being USF1 homodimers [210]. The 
preference for USF1 dimers does not explain why Sertoli cells express 5- to 7-fold more Usf2 
mRNA (Table 4, Rows 7-8) or why detection of USF1 protein by Western blot required 5-fold 
more protein extract compared to USF2. However, the increase in dimers containing USF1 may 
lead to more efficient transcriptional activation of USF target genes within Sertoli cells. 
Therefore, understanding how USF1 is regulated may provide further insights into gene 
transcription of genes required for Sertoli cell differentiation and differentiated Sertoli cell 
function. 
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5.0  ID PROTEINS:  INHIBITORS OF SERTOLI CELL DIFFERENTIATION? 
Hypothesis: ID proteins inhibit USF1 and USF2 DNA binding during Sertoli cell proliferation. 
5.1 INTRODUCTION  
5.1.1 Class D bHLH Proteins 
Potential regulators of Sertoli cell proliferation and E-box protein actions include the 
members of the class D bHLH family of transcription factor repressors named inhibitors of cell 
differentiation or inhibitors of DNA binding (ID) (reviewed in [211-213]). In mammals, ID 
proteins inhibit class A and class B bHLH proteins. Four ID proteins have been characterized in 
mammalian cells, ID1, ID2, ID3, and ID4 [155, 214-216].   All four ID proteins contain a 
conserved helix-loop-helix (HLH) dimerization motif that mediates interactions with other HLH 
proteins [211, 212, 217].  However, these proteins lack the basic DNA binding domain and 
function as dominant negative repressors of bHLH transcription factors by forming non-DNA 
binding, inactive heterodimers [212].   A major consequence of ID protein expression is the 
inhibition of bHLH protein-mediated activation of genes required for the differentiation of 
tissues during development [218]. Differentiation of oligodendrocytes [219, 220] and 
 48 
granulocytes [221] is known to be inhibited by ID proteins. Also, ID proteins promote 
proliferation through the regulation of cell cycle control proteins [222-225].   
5.1.2 ID Protein Localization and Post-translational Regulation 
ID proteins require localization to the nucleus to function in the inhibition of DNA 
binding and thus differentiation. All four ID proteins are small enough to move through nuclear 
pores by diffusion [226, 227]. ID1 and ID2 have nuclear export signals [226, 227]. No known 
nuclear export signal has been found for ID3 or ID4 [227]. Although there is not a consensus 
nuclear localization signal, the presence of the HLH domain is enough to facilitate nuclear 
localization of the ID proteins [227]. Interaction of ID3 with E47 and ID1 with MyoD allows 
transport of the ID proteins to the nucleus via the nuclear localization signal of the bHLH 
proteins [228, 229].  
Export to the cytoplasm may allow ID proteins to become sequestered or degraded. ID2 
transport from the nucleus requires exportin-1 (XPO1, also known as CRM1) [227]. The 
blockage of XPO1-mediated export results in ID2 retention to the nucleus [227]. However, when 
ID2 is present in the cytoplasm, diffusion into the nucleus does not occur suggesting that a 
regulator may sequester ID2 within the cytoplasm [227]. ID2 associates with three proteins that 
function to sequester ID2 within the cytoplasm and facilitate its degradation: PDZ and LIM 
domain 5 [PDLIM5 also known as Enigma homolog (ENH)] [230, 231], interferon inducible 
protein 204 (IFI204) [232-234], and polycystin-2 (PKD2) [235]. The presence of ID proteins in 
the cytoplasm facilitates their degradation through the ubiquitin-proteasome system to induce 
differentiation [236-239]. ID protein function and degradation may be regulated through cell 
cycle-specific post-translational modifications. ID proteins can be phosphorylated by CDK2 
 49 
[240], PKA [241], PKC [241], or CDK1 [241].  These data suggest that cellular localization, 
turnover rate, and phosphorylation state may all alter the ability of ID proteins to perform as 
inhibitors of differentiation.  
5.1.3 ID Proteins in Sertoli Cells 
All four ID proteins have been detected in cultured 20 day-old Sertoli cells [178].  In 
vivo, only ID2 and ID3 were expressed in adult Sertoli cells, as detected by 
immunohistochemistry of tissue sections, representing all stages of the seminiferous epithelium 
[242]. Stimulation of cultured Sertoli cells for 72 hours with FSH or cAMP inhibited the 
expression of the Id1 gene while inducing the expression of the Id4 gene [178]. Id3 gene 
expression was not affected by stimulation of FSH or cAMP [178]. The expression of ID2 is 
transiently up-regulated by FSH or cAMP within 6 hours of stimulation with FSH or cAMP 
[243, 244] while 72 hours of stimulation has no effect on Id2 gene expression [178]. 
Overexpression of ID1 or ID2 was found to induce and maintain proliferation of cultured post-
mitotic Sertoli cells from 20 and 60 day-old rats [166]. In a more recent study, Sertoli cells 
placed in culture were found to induce ID2 expression and begin proliferating despite being 
“quiescent” within the testis [130]. ID proteins were found to regulate E-box motifs in the 
promoters of Fshr [172], Trf [167], Fos [169], and Shbg [245] in Sertoli cells. Together, these 
data support the hypothesis that ID proteins are important inhibitors of differentiation in Sertoli 
cells and regulate the expression of genes required for differentiated Sertoli cell functions. 
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5.2 RESULTS 
5.2.1 Id2, Id3, and Id4 mRNA Levels Increase During Sertoli Cell Differentiation 
To gain understanding of the ability 
of ID proteins to inhibit USF binding to E-
box motifs during Sertoli cell 
differentiation, the levels of Id mRNAs 
were analyzed by qPCR. Examination of 
Id1 mRNA levels from Sertoli cells 
assayed immediately after isolation 
revealed no significant differences in the 
levels of mRNA expression between 5 and 
11 days after birth using both ∆∆Ct (Figure 
12A; Table 6, Rows 1-2) and efficiency-
corrected ∆Ct analyses (Table 6, Rows 5-
6). The mRNA levels increased for Id2 [3.0 
± 0.6-fold (Figure 12 B)], Id3 [1.3 ± 0.01 
(Figure 12C)], and Id4 [1.4 ± 0.1 (Figure 12D)] during this period using both qPCR analyses 
(Table 6, Rows 1-2 and 5-6; p < 0.05 for all).  The increase in expression of the ID inhibitor 
mRNA is not consistent with the hypothesis that decreased ID levels cause the up-regulation of 
USF binding activity during differentiation.  
Efficiency-corrected ∆Ct analysis revealed that the relative Id2 and Id3 mRNA levels 
(Table 6, Rows 7-8) in Sertoli cells are similar to that of Usf1 (Table 4), but the levels of Id1 and  
 
Figure 12. ID Protein mRNAs Increase During 
Development in Sertoli Cells Assayed Immediately After 
Isolation via qPCR.  
The mRNAs isolated from 5 and 11 day-old Sertoli cells 
were analyzed by qPCR using primers for Id1 (A), Id2 (B), 
Id3 (C), and Id4 (D). Data were analyzed using the ∆∆Ct 
method, and quantitation of the mean (±SE) of three 
individual experiments for each condition is provided for 
each primer set. The relative mRNA levels were normalized 
to Ppia levels and were made relative to 5 day-old Sertoli 
cells (=1). Statistically significant differences (p < 0.05) are 
indicated by an asterisk (*). 
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Id4 mRNAs are 100- and 1,000-fold lower, respectively (Table 6, Rows 7-8). These data suggest 
that Id2 and Id3 are expressed in ratios similar to Usf1. Furthermore, if mRNA levels reflect 
protein levels, ID2 and ID3 may be expressed in levels comparable to USF1 and thus ID2 and 
ID3 may be present at sufficient levels to inhibit USF binding to DNA. Together, these data 
suggest that Id2 is the most abundantly expressed Id gene and is greatly induced during the onset 
of Sertoli cell differentiation (Table 6).  Therefore, studies of ID proteins began with ID2. 
Table 6. Comparison of Id mRNA Levels Using the ∆∆Ct Method and the Efficiency-corrected ∆Ct Method of 
qPCR Analysis in Isolated Rat Sertoli Cells Assayed Immediately After Isolation. 
 Sertoli Cell 
Age Id1 Id2 Id3 Id4 
Row 
Number 
∆∆Ct Relative 
Fold Change 
Compared to 5 
Day-old Sertoli 
Cells 
(Figure 12)* 
5 Days 1.00 ± 0.0 1.00 ± 0.0 1.00 ± 0.0 1.00 ± 0.0 1 
11 Days 0.99 ± 0.06 3.03 ± 0.57* 1.30  ± 0.09* 1.37 ± 0.14* 2 
Relative 
Quantity Using 
the Efficiency-
Corrected ∆Ct 
Method Relative 
to Ppia 
5 Days 0.00058 ± 0.00004 
0.01232 
± 0.00201 
0.00861 
±0.00200 
0.00001 
±0.000003 3 
11 Days 0.00057 ± 0.00009 
0.03675 
±0.00643 
0.01122 
± 0.00288 
0.00001 
± 0.00000381 4 
Average Fold 
Change in 
Relative 
Quantity 
Compared to 5 
Day-old Sertoli 
Cells* 
5 Days 1.00 ± 0.0 1.00 ± 0.0 1.00 ± 0.0 1.00 ± 0.0 5 
11 Days 0.98 ± 0.09 3.04 ± 0.63* 1.29 ± 0.09* 1.39 ± 0.18* 6 
Average Fold 
Change in 
Relative 
Quantity Over 
Usf1 
5 Days 0.07 ± 0.01** 1.57 ± 0.54 1.08 ± 0.41 0.0007 ± 0.0005** 7 
11 Days 0.04 ± 0.01** 2.67 ± 0.78  0.84 ± 0.37 
0.0006 ± 
0.0004** 8 
*Change between 5 and 11 days is significantly different (p < 0.05). 
**Change between relative quantities when comparing gene to Usf1 is significantly different (p < 0.05). 
 
 52 
5.2.2 Id1 and Id3 mRNA Levels Decrease with the Termination of Differentiation in 
Cultured Sertoli Cells 
The mRNA levels for ID protein encoding 
genes were also assayed for cultured Sertoli cells. 
Analysis of Id mRNA levels in cultured Sertoli cells 
through the use of qPCR revealed a similar increase in 
Id3 mRNA levels in cells isolated from 11 day-old 
rats compared to cells isolated from 5 day-old rats 
(Figure 13C; Table 7, Rows 1 and 2). In contrast, Id1 
and Id2 mRNA levels did not change between 5 and 
11 days after birth (Figure 13 A,B; Table 7, Rows 1 
and 2). Id2 mRNA levels did significantly increase 
between 11 and 20 days after birth by 0.29 ± 0.05 (p < 
0.05; Figure 13B; Table 7, Row 3). Interestingly, Id1 
and Id3 mRNA levels significantly decreased to less 
then 20% and 35% of 5 day mRNA levels, 
respectively (Figure 13A,C; Table 7, Row 3 and 9). 
Id4 mRNA levels did not change significantly at any 
time period (Figure 13D; Table 7, Rows 1-3, 7-9). 
Efficiency-corrected ∆Ct analysis revealed that only 
Id2 mRNA was expressed at levels similar to Usf1 with Id1, Id3, and Id4 mRNA levels 
significantly lower at all ages (Table 7, Rows 10-12). Together, mRNA analysis of the Id genes 
in cultured Sertoli cells suggest that only Id2 levels increase during differentiation and that Id2 is 
 
Figure 13. Id1 and Id3 mRNA Levels 
Decrease Whereas Id2 mRNA Levels 
Increase 20 Days After Birth in Cultured 
Sertoli Cells via qPCR.   
mRNA isolated from cultured 5, 11, and 20 
day-old Sertoli cells was analyzed by qPCR 
using primers for Id1 (A), Id2 (B), Id3 (C), and 
Id4 (D). Data was analyzed using the ∆∆Ct 
method and quantitation of the mean (±SE) of 
three individual experiments for each condition 
is provided for each primer set.  The relative 
mRNA levels were normalized to Ppia levels 
and made relative to untreated 5 day-old 
Sertoli cells (=1). Values with different 
lowercase letters differ significantly (p < 0.05). 
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expressed at levels comparable to Usf1. Id1 and Id3 mRNA levels decrease 20 days after birth, 
leading to a hypothesis that after differentiation the functions of ID1 and ID3 within the cell are 
less important. 
 
5.2.3 Nuclear ID2 Protein Expression Decreases During Differentiation in Sertoli Cells 
ID2 protein expression was investigated to determine whether a decrease in ID2 protein 
levels could contribute to the increase in USF DNA binding in 11 day-old Sertoli cells despite 
the detected overall increase in Id2 mRNA levels. To determine ID2 protein expression levels 
and localization during differentiation, immunofluorescence of cultured Sertoli cells was  
Table 7. Comparison of Id mRNA Levels Using the ∆∆Ct Method and Efficiency-Corrected ∆Ct Method of 
qPCR Analysis in Cultured Rat Sertoli Cells. 
 Sertoli Cell 
Age Id1 Id2 Id3 Id4 
Row 
Number 
∆∆Ct Relative 
Fold Change 
Compared to 5 
Day-old Sertoli 
Cells 
(Figure 13)* 
5 Days 1.00 ± 0.0a 1.00 ± 0.0a 1.00 ± 0.0a 1.00 ± 0.0 1 
11 Days 1.05 ± 0.04a 1.10 ± 0.13a 1.83 ± 0.34b 0.87 ± 0.25 2 
20 Days 0.16 ± 0.03b 1.39 ± 0.05b 0.34 ± 0.03c 0.78 ± 0.06 3 
Relative 
Quantity Using 
the Efficiency-
Corrected ∆Ct 
Method Relative 
to Ppia 
5 Days 0.00048  ± 0.00025 
0.01968  
± 0.00457 
0.00291  
± 0.00114 
0.00020  
± 0.00002 4 
11 Days 0.00049 ± 0.00024 
0.02203 
± 0.00792 
0.00550  
± 0.00249 
0.00018  
± 0.00006 5 
20 Days 0.00006  ± 0.00004 
0.02748  
± 0.00705 
0.00103  
± 0.00045 
0.00016  
± 0.00003 6 
Average Fold 
Change in 
Relative 
Quantity 
Compared to 5 
Day-old Sertoli 
Cells* 
5 Days 1.00 ± 0.0a 1.00 ± 0.0a 1.00 ± 0.0a 1.00 ± 0.0 7 
11 Days 1.01 ± 0.04a 1.08 ± 0.13a 1.80 ± 0.33b 0.84 ± 0.25 8 
20 Days 0.14 ± 0.03b 1.39 ± 0.05b 0.34 ± 0.03c 0.76 ± 0.06 9 
Average Fold 
Change in 
Relative 
Quantity Over 
Usf1 
5 Days 0.07 ± 0.05** 2.15 ± 1.05 0.27 ± 0.15** 0.02 ± 0.01** 10 
11 Days 0.05 ± 0.04** 1.78 ± 1.01 0.32 ± 0.18** 0.01 ± 0.00** 11 
20 Days 0.01 ± 0.01** 3.53 ± 1.79 0.11 ± 0.07** 0.02 ± 0.01** 12 
*Values with different lowercase letters differ significantly within this category (p < 0.05). 
**Change between relative quantities when comparing gene to Usf1 is significantly different (p < 0.05). 
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conducted using antisera against ID2. Nuclei were stained with Hoechst. Cells were also 
incubated with antiserum against the Sertoli cell-specific vimentin and revealed that all ID2 
positive cells were also Sertoli cells (Appendix A, Figure 36). Initially, analysis of 
immunofluorescence data revealed that ID2 is highly expressed in nearly all of the nuclei of 5 
day-old Sertoli cells (Figure 14 left). By 20 days after birth, overall ID2 immunostaining is 
decreased and primarily localized to the cytoplasm (Figure 14 right). These data raise the 
possibility that a high level of ID2 protein expression within the nuclei of 5 day-old Sertoli cells 
is required to maintain Sertoli cells in a proliferative state, whereas the reduction in ID2 protein 
expression in the nucleus contributes to the termination of differentiation.  
To quantify the changes in ID protein expression, analysis was performed using the 
Metamorph software package.  This application allows the measurement of pixel intensity within 
a given area as specified by the user. Analysis of whole cell and nuclear pixel intensity was 
measured.  Whole cell area was estimated based on immunostaining from vimentin-positive 
cells.  Anti-vimentin antiserum was incubated with the cells as a Sertoli cell-specific marker. 
Nuclear area was established by the threshold of positive nuclear staining as revealed by Hoechst 
dye. Analysis was conducted for immunostaining of ID2 in 5, 11, and 20 day-old cultured Sertoli 
 
Figure 14. ID2 Protein Decreases Within the Nucleus During Sertoli Cell Differentiation.  
Immunofluorescence of cultured 5, 11, and 20 day-old Sertoli cells was performed with antisera recognizing ID2 as 
visualized with Alexa 488 fluorophore (red). Hoechst stains nuclei (blue). Arrowheads indicate lack of ID2 
immunostaining in the nucleus. Scale bars = 100 µm. Control immunostaining with the Sertoli cell specific anti-
vimentin antiserum is available in Appendix A, Figure 36. 
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cells. A decrease in ID2 immunostaining was observed for the total cellular and nuclear intensity 
during differentiation. A decrease of 23.7 ± 6.1% and 41.8 ±2.5%, respectively (p < 0.05 for 
both) was observed when comparing immunostaining in 20 day-old cells when compared with 5 
day-old cells (Figure 15A, B). Normalization of cellular and nuclear intensity to measured area 
revealed a decrease of 27.9 ± 3.7 % and 24.1 ± 3.6%, respectively (p < 0.05), for both 
measurements in 20 day-old cells when compared with 5 day-old cells (Figure 15C, D).  As a 
whole, these results suggest that ID2 levels decrease within Sertoli cell nuclei during 
differentiation. 
 
Figure 15. ID2 Immunostaining Decreases by 20 Days After Birth in Cultured Sertoli Cells. 
Immunostaining of ID2 in 5, 11, and 20 day-old cultured Sertoli cells was quantified using Metamorph. For each 
measurement at least 450 cells per age were counted from six independent experiments. (A) The mean cell intensity 
was determined by measuring the total pixel intensity within the border of the cell. (B) The mean nuclear intensity 
was determined by measuring the total pixel intensity within the thresholded border of the nucleus, based on 
Hoechst staining. (C) The mean total cell intensity normalized to the total cell area or (D) the mean total nuclear 
intensity was normalized to the total nuclear area. Values with different lowercase letters differ significantly (p < 
0.05). 
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5.2.4 ID Proteins are Detected in 
Liver Nuclear Extracts but Not 
Extracts from Isolated Sertoli 
Cells or Whole Testis 
To compliment the 
quantitation of ID2 levels observed 
by immunofluorescence, Western 
blotting assays were undertaken. 
Endogenous and radiolabeled ID 
proteins by Western blot was 
previously shown to be possible by 
other groups studying other tissues 
[246, 247].  However, attempts to 
detect ID proteins in extracts from 
cultured Sertoli cells by Western 
blot were not successful with 
antisera against ID2 (Santa Cruz, sc-
489). Others have also reported an 
inability to detect endogenous ID 
proteins in primary Sertoli cells 
utilizing this antibody [166]. 
To verify and troubleshoot 
 
Figure 16. ID Proteins in Whole Testis or Isolated Sertoli Cell 
Extracts are Undetectable by Western Blotting. 
(A) Western immunoblotting of 1 mg, 100 µg, and 10 µg of nuclear 
(top) and cytoplasmic extracts (bottom) from liver performed with 
antisera recognizing ID2 (1:500). Antiserum against ID2 but not 
non-immune serum was able to immunoprecipitate protein from the 
liver nuclear extracts. (B) ID2 protein was undetectable when 
Western immunoblotting was conducted of 500 µg, 100 µg, and 10 
µg of nuclear (top) and cytoplasmic extracts from whole testis. (C) 
Western immunoblotting of 10 µg of MSC-1 cell extracts 
transfected with adenovirus expressing ID2 and 10 µg whole cell 
extracts or 10 µg nuclear extracts from isolated Sertoli cells with 
the ID2 antisera from Biocheck, Inc. at a dilution of 1:2000 (top) or 
1:300 (bottom).  
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Western detection of ID proteins, studies utilizing liver extracts were conducted.  Liver extracts 
express ID2 protein as detected utilizing the Santa Cruz antibody (sc-489) [246]. The protocol of 
nuclear extraction from Rodriguez, et al. (2006), was followed for ID Western analysis of 
extracts from liver tissue [246]. Liver extracts were homogenized and nuclei were isolated from 
the cytoplasm of liver homogenate.  Varying concentrations of protein were analyzed by Western 
blotting with antiserum against ID2. ID2 was present in a titratable amount and detectable with 
as little as 10 µg of protein in both nuclear and cytoplasmic fractions of the liver homogenate 
(Figure 16A). It should be noted that the excessive amount of protein loaded in the first lane (1 
mg) caused the band to spread out within the gel.  This was anticipated prior to loading of 
samples and lanes were skipped between samples. Immunoprecipitation of 1 mg of liver 
homogenate with antiserum against ID2 resulted in a band of expected size whereas an 
immunoprecipitation utilizing non-immune serum did not result in a band of the appropriate size 
(Figure 16A).  Whole cell extracts of testis tissue were then prepared according to the same 
protocol used for the liver extracts to determine if ID2 could be detected.  Whole testis extracts 
were resolved by Western blotting; however, ID2 remained undetectable in both nuclear and 
cytoplasmic fractions of the testis homogenate after loading as much as 500 µg of extract (Figure 
16B).  
Because the ID2 antiserum used did not allow detection of ID2 in testis extracts, a second 
antiserum was obtained from Dr. John Chen of Biocheck, Inc. The efficiency of 
immunoprecipitation of this new ID2 antiserum was tested using extracts from MSC-1 cells that 
were infected with an adenovirus expressing ID2. These extracts were immunoprecipitated with 
decreasing amounts of antibody. Immunoprecipitation of 10 µg of MSC-1 cells extracts 
containing over-expressed ID2 with 5 µl or 2 µl of ID2 antiserum resulted in 42% or 26% 
 58 
recovery of protein when compared to a non-immunoprecipitated input by densitometry (Figure 
16C).  ID2 from over-expressed protein was clearly detectable at a 1:2000 dilution of ID2 
antisera. Using the new, more specific ID2 antiserum, ID2 expression within Sertoli cell extracts 
was still below the level of detection (Figure 16C). Therefore, with the antisera available, it is 
not possible to determine by Western blotting whether ID2 protein expression levels change 
during Sertoli cell differentiation via Western blotting.  
5.2.5 ENH Protein Levels Increase in Cultured Sertoli Cells During Differentiation 
ENH associates with ID1, ID2, and ID3 through their HLH domains [231]. ENH 
expression increases during neural differentiation and sequesters ID2 in the cytoplasm 
preventing proliferation and the inhibition of bHLH-mediated transcription via ID2 [231]. As an 
actin cytoskeleton binding protein, ENH may also perform similar functions in Sertoli cells 
[230]. Immunofluorescence analysis of ENH in cultured Sertoli cells revealed a dramatic 
increase in ENH immunoreactivity in the cytoplasm of Sertoli cells between 5 and 20 days after 
birth (Figure 17). The up-regulation of ENH in the cytoplasm of differentiated Sertoli cells and 
 
Figure 17. ENH Protein is Up-Regulated During Differentiation in Cultured Sertoli Cells. 
Immunofluorescence of cultured 5, 11, and 20 day-old Sertoli cells was performed with antiserum recognizing ENH 
as visualized with Alexa 488 fluorophore (red). Antisera against vimentin was used as a Sertoli cell-specific marker 
as visualized with a Cy5 fluorophore (green). Hoechst stains nuclei (blue). Scale bars = 100 µm. 
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the reduction of ID expression in the nucleus is consistent with the idea that localization of ID 
proteins in the cytoplasm of differentiated Sertoli cells relieves ID-mediated inhibition of USF 
binding to E-box motifs. Possibly, this relief occurs through the sequestration of ID proteins in 
the cytoplasm of differentiating Sertoli cells by ENH. Further studies are needed to test this 
hypothesis. 
5.3 CONCLUSIONS 
The binding of USF E-box proteins increases during Sertoli cell differentiation to E-box 
motifs.  It was hypothesized that during Sertoli cell proliferation, ID proteins, known inhibitors 
of E-box binding proteins, inhibit USF1 and USF2 binding to E-box motifs. Studies presented 
here did not directly address this hypothesis but rather attempted to characterize ID protein 
expression during Sertoli cell differentiation.  Direct examination of the hypothesis was not 
completed due to technical difficulties that will be addressed below. 
Analysis of Id gene expression within Sertoli cells during differentiation were examined 
by qPCR analysis.  Based on the hypothesis, it was expected that Id mRNA levels would 
decrease during Sertoli cell differentiation. However, instead of observing decreased Id mRNA 
expression during differentiation, the levels of all Id mRNAs either remained constant or 
increased between 5 and 11 days after birth (Figures 12 and 13; Tables 6 and 7). In isolated rat 
Sertoli cells in culture or assayed immediately after isolation, Id1 mRNA levels are maintained 
between 5 and 11 days after birth (Figure 12A, 13A; Table 6, Rows 1-2; Table 7, Rows 1-2), 
whereas Id3 mRNA levels increased 11 days after birth (Figure 12C, 13C; Table 6, Rows 1-2; 
Table 7, Rows 1-2). However, both Id1 and Id3 mRNA levels decreased 20 days after birth in 
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cultured Sertoli cells (Figure 13A,C; Table 7, Row 3). Id2 and Id4 mRNA levels increase from 5 
to 11 days after birth in immediately assayed Sertoli cells (Figure 12B,D; Table 6, Rows 1-2) but 
the levels of these mRNAs do not change significantly in cultured cells (Figure 13B,D; Table 7, 
Rows 1-2). Rather, only Id2 mRNA levels increase in cultured cells isolated from 20 day-old rats 
(Figure 13D; Table 7, Row 3). The discrepancy in the timing of Id2 up-regulation for the two 
cell models is not clear, but the delayed elevation of Id2 mRNA levels in cultured cells may be 
related to short-term loss of contact inhibition and the resumption of proliferation during the 
initiation of Sertoli cell culture [130]. In contrast, Id1 and Id3 mRNA levels decreased 
dramatically [84 ± 3% and 66 ± 3% (p < 0.05 for both), respectively] during the later stages of 
differentiation between 11 and 20 days after birth (Figure 13A,C; Table 7, Row 3). Efficiency-
corrected ∆Ct analysis revealed comparable results to the ∆∆Ct analysis and revealed that only 
Id2 mRNA relative quantities were expressed at comparable quantities to Usf1 in both cell 
models (Table 6, Row 7-8; Table 7, Rows 10-12). Id3 mRNA relative quantities were expressed 
in similar quantities to Usf1 in cells assayed immediately after isolation only (Table 6, Rows 7-
8). These data suggest that lower Id mRNA expression and subsequent lower levels of ID1 and 
ID3 proteins could contribute to increased USF DNA binding in Sertoli cells isolated from 20 
day-old rats. Taken in sum, these data suggest that changes in Id mRNA expression do not 
account for the increase in DNA binding of USF1 and USF2 during Sertoli cell development 
between 5 and 11 days after birth.  
ID2 protein levels were examined to determine whether protein levels reflected mRNA 
levels.  In contrast to the qPCR results, immunofluorescence studies revealed that ID2 protein 
levels decreased within Sertoli cells during differentiation (Figure 14).  Although the Sertoli cells 
from the three developmental time points were isolated, cultured, and fixed concurrently, it is 
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possible that differing cell morphologies contribute to the changes detected in ID2 
immunostaining. Nevertheless, quantitation of immunostaining intensity supports the idea that 
ID2 levels decrease within the nucleus and the whole cell by 20 days after birth (Figure 15). 
Interestingly, the decrease in ID2 immunostaining is coincident with the increase in Id2 mRNA 
levels (Figure 13D).  It is possible that mRNA production is stimulated to compensate for a 
down-regulation in ID2 protein during differentiation; however, further studies are required to 
examine this hypothesis. Overall, in contrast to the Id2 mRNA expression findings, the 
immunostaining results raise the possibility that decreasing ID2 protein expression contributes to 
the increase in USF binding to E-box motifs during Sertoli cell differentiation.  
Western blot analysis of ID2 protein levels were conducted to reconcile the conflicting 
results found by mRNA and immunofluorescence analysis in isolated Sertoli cells (Figure 16). A 
protocol for detection of ID2 proteins by Western blot was established with liver and over-
expressed ID2 in MSC-1 cells [246] (Figure 16A,C).  Despite having an established Western blot 
protocol, ID2 protein could not be detected in extracts from isolated Sertoli cells or whole testis 
(Figure 16B,C). Therefore, Western blotting studies cannot be used to assess ID protein 
expression during Sertoli cell differentiation with the reagents available for these studies. Further 
studies addressing ID protein levels in Sertoli cells will require greater sensitivity and specificity.  
Sensitivity could be increased through concentration of protein from large amounts of tissue or 
cells.  Metabolic labeling of cultured Sertoli cells or whole testis could also be used to increase 
detection abilities. However, any assay will be limited by the lack of specificity of the antibodies 
used in this dissertation.  The acquisition of the more specific antisera from Biocheck, Inc. 
provides one avenue for continued studies (Figure 16C). The inability to conduct Western blots 
hinders studies of USF and ID2 protein-protein interactions which are necessary to definitively 
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confirm if ID2 can bind to USF1 or USF2. Recent studies in Sertoli cells have shown that ID2 
can inhibit USF DNA binding and USF-mediated activation of the Fshr promoter in cells from 
15 day-old rats [244]. 
 With the possibility raised that ID2 may inhibit USF binding during proliferation, the 
down-regulation of ID2 protein levels during Sertoli cell differentiation was preliminarily 
evaluated.  ID2 degradation in Sertoli cells has not been examined previously.  It was 
hypothesized that the decrease of ID2 protein levels that was observed may be accounted for by 
sequestration and degradation within the cytoplasm. ENH could function to sequester ID proteins 
in the cytoplasm [230, 231].  ENH was found to be up-regulated within the cytoplasm of Sertoli 
cells during differentiation (Figure 17).  This data suggests that increased ENH expression within 
Sertoli cells is consistent with the idea that ENH could sequester ID2 within the cytoplasm.  
However, due to the inability to conduct ID2 Westerns, determination of ENH interactions with 
ID2 in Sertoli cells was not possible.  Also, the degradation of ID2 protein cannot be evaluated in 
the presence of increasing amounts of ENH.  
 A model has been proposed regarding the onset of Sertoli cell differentiation.  During 
proliferation there are low levels of USF1 present within Sertoli cells and that with the onset of 
differentiation, USF1 levels are enhanced. The induction of USF1 levels within the cell 
contributes to increased USF binding to E-box motifs which may lead to transcriptional 
activation of USF target genes within Sertoli cells. ID proteins were investigated as a potential 
regulatory mechanism of USF binding.  ID proteins were hypothesized to inhibit USF binding 
during proliferation.  Immunofluorescence data raised the possibility that ID2 may inhibit USF 
binding in proliferating Sertoli cells and that the up-regulation of ENH during differentiation 
may cause the down-regulation of ID2 to allow USF binding.  However, this data is correlative 
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and requires further studies to confirm the hypothesis that ID proteins inhibit USF1 and USF2 
binding in proliferating Sertoli cells. 
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6.0  THYROID HORMONE:  REGULATOR OF SERTOLI CELL NUMBER 
Hypothesis: Thyroid hormone induces differentiation through the induction of USF DNA 
binding. 
6.1 INTRODUCTION 
A central dogma of male fertility is that the final number of Sertoli cells dictates the total 
number of sperm that can be produced within the testis [1, 79]. In rodents, all Sertoli cell 
proliferation occurs during the fetal and neonatal period, predominantly during the first two 
postnatal weeks ending between 15 and 21 days in rat [78, 85]. How Sertoli cells decide to stop 
proliferating and begin differentiating is largely unknown.  Postnatal Sertoli cells are direct 
targets of gonadotropins, estrogens, thyroid hormones, and androgens (reviewed in [4, 16, 91, 99, 
100, 112, 248-254]).  However, thyroid hormone appears to be the most direct regulator of 
Sertoli cell proliferation and differentiation (reviewed in [252]).  
6.1.1 Thyroid Hormone Production in the Rat 
Thyroid hormone is secreted under control of the hypothalamo-pituitary-thyroid axis 
(reviewed in [255]). Thyroid-releasing hormone (TRH) from the hypothalamus is detectable at 
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birth in the rat and peaks between 16 and 28 days after birth in the rat [256]. TRH stimulates 
release of thyroid-stimulating hormone (TSH) from the pituitary, which peaks between 7 and 22 
days after birth in the rat [256].  TSH then acts on the thyroid to stimulate iodine uptake, 
thyroglobulin production, and release of iodothyronines from the gland [255]. Iodinated 
thyroglobulin is degraded intracellularly to release thyroxine (T4) and triiodothyronine (T3) 
[257]. When stimulated with TSH, stored thyroglobulin from the colloid of the thyroid gland are 
phagocytosed or endocytosed into the thyrotropes surrounding the colloid stores [255]. 
Thyroglobulin is degraded through the lysosomal pathway to result in the emergence of T4 
which can be further cleaved to T3 by type I or type II 5’-iodothyronine deiodinases within the 
thyroid or in target tissues [252, 257]. In the rat, T4 levels increase between 4 and 16 days to 6 
µg/100 ml of serum then decreases to adult levels of 4 µg/100 ml of serum [256].  T3 peaks 28 
days after birth at 108 ng/100 ml of serum then decreases to adult levels at 70 ng/100 ml of 
serum [256]. 
6.1.2 Thyroid Hormone Receptors and Deiodinases in the Testis 
The testis is a target tissue of thyroid hormones. Thyroid hormone receptors (TR) are 
present in high quantities in neonatal Sertoli cells and at lower levels in adult Sertoli cells of the 
rat (reviewed in [88, 252]). TRα1 is present in proliferating Sertoli cells and decreases with the 
onset of differentiation [258, 259]. TRα2, TRα3, and TRβ1 are low during the developmental 
period of Sertoli cells [258]. TRα1 and TRα2 co-localize to Sertoli cells in prepubertal human 
testes but TRα2 is always expressed at higher levels and the levels of TRα1 decrease with age 
[260]. TRβ is not detected in human testes [260].  TRα1 is also in germ cells, from 
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spermatogonia to mid-cycle pachytene spermatocytes [258]. All three types of deiodinases (D) 
are expressed at different levels within the testis during postnatal development [252]. D3 levels 
are expressed highest in the testis during postnatal development and then dramatically decrease 
in the adult [261]. D1 and D2 are also expressed within the testis however D2 expression is 
highest during Sertoli cell differentiation, when the levels of TRs are also highly expressed 
[261]. In adults, D2 expression is limited mostly to elongated spermatids whereas expression in 
other testicular cells types is almost completely abrogated [262]. Expression levels of the 
deiodinases have not been studied in extracts specific to Sertoli cells.  
6.1.3 Thyroid Hormone Effects on Sertoli Cell Number 
Thyroid hormone was implicated in determining Sertoli cell number during studies of 
hyper- and hypothyroid animals (reviewed in [88, 100, 254, 263]). Hyperthyroidism enhanced 
Sertoli cell differentiation and shortened the period of Sertoli cell proliferation, resulting in 
accelerated tubular lumen formation, a smaller testis and a lower daily sperm count [264]. The 
effects of hypothyroidism were induced neonatally using propylthiouracil (PTU), which blocks 
the synthesis of thyroid hormones [265-267]. Hypothyroidism induced in neonatal animals 
results in an overall increase in the number of Sertoli cells in rats despite a delay in testicular 
growth, germ cell maturation, and tubule lumen formation [268-270]. The increase in Sertoli cell 
number also resulted in an increase in testicular size and a higher daily sperm count [269-271].  
The prolonged period of Sertoli cell proliferation induced by PTU treatment 
corresponded with prolonged expression of genes associated with Sertoli cell immaturity, 
including Amh and Thra (TRα) [272]. Administration of exogenous T3 to these PTU-treated 
animals caused Amh and Thra levels to return to control levels [272]. In the presence of PTU 
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alone, genes representative of Sertoli cell differentiation, Shbg, clusterin, and inhibin βB, were 
delayed in their expression patterns [272]. However, the mRNA levels of Sertoli cell 
differentiation-associated genes sulfated glycoprotein-1, Trf, and inhibin α did not differ in PTU-
treated rats when compared with control untreated animals [272].  
In sum, the studies of hypo- and hyperthyroid animals suggest that thyroid hormone is 
able to regulate the period of Sertoli cell proliferation. Thyroid hormone actions normally effect 
Sertoli cell proliferation between 4 and 8 days after birth [269].  However, artificially induced 
early onset of thyroid hormone actions inhibits Sertoli cell proliferation prematurely.  By 
contrast, lack of a thyroid hormone signal between 4 and 8 days after birth allows Sertoli cells to 
continue proliferating beyond the normal 20 days after birth. Studies of the thyroid hormone 
molecular actions in Sertoli cells are needed to elucidate the molecular mechanisms responsible 
for altering the timing of the switch between proliferation and differentiation in Sertoli cells 
during postnatal development.  
6.1.4 Molecular Mechanisms of Thyroid Hormone in Sertoli Cells 
The regulation of p21CIP1 and p27KIP1 in the testis are under the control of thyroid 
hormone and may provide some insights into a potential mechanism involved in the switch 
between Sertoli cell proliferation and differentiation [273-275]. T3 was found to induce p27KIP1 
and p21CIP1 levels in neonatal Sertoli cells [273-275]. T3 was unable to induce p27KIP1 
expression in Thra-/- animals, suggesting that thyroid hormone is required to induce this cell 
cycle inhibitor [276]. Administration of PTU to Cdkn1a-/- or Cdkn1b-/- animals is still able to 
induce an increase in testis size compared with untreated knockout controls, suggesting that 
 68 
p21CIP1 and p27KIP1 are not the only effectors downstream of thyroid hormone to inhibit Sertoli 
cell proliferation and induce Sertoli cell differentiation [263, 274].  
p21CIP1 and p27KIP1 proteins are degraded through association with the E3 ubiquitin ligase 
S-phase kinase-associated protein 2 (SKP2) [277, 278]. SKP2-mediated degradation of p21CIP1 
and p27KIP1 may allow Sertoli cell proliferation until the onset of thyroid hormone actions [263]. 
A lack of SKP2 decreases testis weight by 80% and daily sperm production by 85% suggesting 
that p21CIP1 and p27KIP1 may inhibit the cell cycle prematurely within Sertoli cells in the absence 
of SKP2 [263]. The T3-mediated inhibition of Sertoli cell growth occurs coincidently with 
increased expression of connexin 43 [also known as gap junction protein, alpha 1 (GJA1)] in the 
Sertoli cell plasma membrane [279].  Increasing GJA1 allows an increase in gap junction 
communication and blockage of gap junction communication inhibits T3-mediated halting of 
Sertoli cell proliferation [279]. Studies of Sertoli cell-specific Gja1-/- mice, display increased 
Sertoli cell proliferation and delayed Sertoli cell maturation in adulthood resulting in a loss of 
germ cells and reduced fertility [252, 279]. Further studies of thyroid hormone contributions to 
the onset of Sertoli cell differentiation need to be conducted.  Studies presented in this 
dissertation explore the ability of T4 to increase USF DNA binding during Sertoli cell 
differentiation. 
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6.2 RESULTS 
6.2.1 Thyroid Hormone Induces USF-DNA binding in Proliferating Sertoli Cells 
To determine whether thyroid hormone, a known Sertoli cell differentiating agent, could 
increase the DNA binding of USF proteins, cultured Sertoli cells were incubated with vehicle or 
T4 (10-6 M).   T4 was used because T4 levels are 100-fold greater than T3 in the testis during the 
period of Sertoli cell differentiation [256]. Furthermore, Sertoli cells express iodothyronine 
deiodinase type 2 (D2) that converts T4 to T3, the form able to interact with the thyroid hormone 
receptor [262, 280]. Finally, by using T4, the effects of both T3 and T4 can be assayed. The dose 
of T4 that was used is 12.5-fold greater than the peak T4 serum level (8 x 10-8 M) reached in rats 
during differentiation [256].  
A 24 hour stimulation of cultured Sertoli cells from 5 day-old rats with T4 resulted in 
induced protein binding to the USF consensus and Fshr promoter E-box probes (Figure 18A,B). 
T4 stimulation for 24 hours was unable to further induce E-box protein binding in Sertoli cells 
from 11 and 20 day-old rats.  At 11 days, T4 caused a significant reduction in protein binding to 
the USF consensus and Fshr promoter E-box probes (Figure 18A,B). Supershift analysis of 5 
day-old Sertoli cells treated with T4 confirmed that USF1 and USF2 were the proteins whose 
DNA binding was augmented (Figure 18C).  T4 stimulation of Sertoli cells induced the 
formation of a second, larger DNA protein complex to the USF consensus binding sites (Figure 
18C). The components of the second, upper band are not known and supershift results do not 
identify a component of the complex (Figure 18C). These studies suggest that T4 is able to 
promote USF DNA binding in Sertoli cells prior to the commitment to differentiation. 
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6.2.2 Thyroid Hormone Does Not Greatly Alter the Expression of mRNAs Encoding E-
box or ID Proteins 
The ability of thyroid hormone to regulate E-box and ID protein gene expression was 
tested using cultured Sertoli cells.  Using qPCR with ∆∆Ct analysis, T4 stimulation (10-6 M) did 
not significantly alter the expression of Usf2, E47, or Trf compared with basal levels (Figure 
19B-D). However, T4 stimulation for 24 hours increased Usf1 mRNA levels by approximately 
19.8 ± 3.8%  (p < 0.05) in cells isolated from 11 day-old rats (Figure 19A). This increase in Usf1 
mRNA does not correlate to the T4-induced decrease in USF binding to E-box consensus sites 
(Figure 18A,B). However, basal Usf1 and Usf2 mRNA levels are induced 11 days after birth 
 
Figure 18. Thyroid Hormone Induces USF DNA Binding in 5 Day-old Cultured Sertoli Cells.  
In EMSAs, radiolabeled probes containing a consensus E-box that is selective for USF binding (A) or a region of the 
Fshr promoter containing an E-box known to bind USF proteins (B) were incubated with nuclear extracts isolated 
from cultured 5, 11, and 20 day-old Sertoli cells that were treated with vehicle or T4 (10-6 M) for 24 hours. The 
results of vehicle treated cells were previously shown in Figure 6. Representative images of the resulting DNA 
protein complexes are shown, and quantitation of the mean (±SE) of three independent experiments is provided. 
Free probe has been run off the gel. The relative binding activity for each condition is normalized to that of vehicle-
treated 11 day-old Sertoli cells (=1). Values with different lowercase letters differ significantly (p < 0.05). C) USF1 
and USF2 are responsible for the increase in DNA-binding activity during Sertoli cell differentiation. DNA-protein 
complexes from nuclear extracts isolated from cultured 11 day-old Sertoli cells were incubated with non-immune 
sera or antisera for USF1, USF2, E47, E2A, or MYC. Supershifted DNA protein complexes containing USF1 or 
USF2 are indicated. Exposure times for all complexes are less than 48 h. 
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(Figure 19A,B) coincident with 
increased DNA binding 11 days after 
birth when compared with extracts from 
5 day-old rats (Figure 18A,B).  
Id2 and Id3 mRNAs in are 
induced in isolated Sertoli cells from 6 
day-old rats that were cultured for 4 days 
in the presence of T3 [275]. Stimulation 
of the cultured Sertoli cells with T4 for 
24 hours resulted in a slight further 
stimulation of Id2 mRNA levels (21 ± 
12%, p < 0.05) in cells isolated 11 days 
after birth but not from cells isolated 5 
or 20 days after birth (Figure 20B). It is 
possible that an increase in ID2 levels 
could contribute to the decrease in USF binding 11 days after birth in the presence of thyroid 
hormone. T4 stimulation did not result in any significant changes to Id1, Id3, or Id4 basal mRNA 
expression at any time point (Figure 20A,C-D). The mRNA levels of the housekeeping gene, 
Ppia, did not change upon stimulation with T4 (data not shown).  
 
Figure 19. Thyroid Hormone Induces Usf1 mRNA levels 11 
Days After Birth in Cultured Sertoli Cells.   
mRNA isolated from cultured 5, 11, and 20 day-old Sertoli 
cells treated with vehicle (-) or T4 (10-6 M) for 24 hours were 
analyzed by qPCR using primers for Usf1 (A), Usf2 (B), 
Tcfe2a (E47) (C), and  Trf (D). Vehicle treated values were 
previously shown in Figure 9. Data was analyzed using the 
∆∆Ct method and quantitation of the mean (±SE) of three 
individual experiments for each condition is provided for each 
primer set.  The relative mRNA levels were normalized to Ppia 
levels and made relative to untreated 5 day-old Sertoli cells 
(=1). Values with different lowercase letters differ significantly 
(p < 0.05). 
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6.2.3 Thyroid Hormone can Induce 
Premature Nuclear Localization of USF1 
in Cultured Sertoli Cells from 5 Day-old 
Rats 
To determine whether T4 could 
induce USF protein expression in cultured 
Sertoli cells, immunofluorescence analysis 
was conducted on cultured primary Sertoli 
cells from 5 day-old rats. Cells were stained 
with antisera against USF1 (Figure 21, top) 
or USF2 (Figure 21, bottom). Nuclei were 
stained with Hoechst. Antiserum against 
vimentin was used as a Sertoli cell-specific 
marker (Appendix A, Figures 34 and 35). 
T4 stimulation of Sertoli cells from 5 day-old rats for 24 hours resulted in increased USF1 
expression in the nucleus and a staining pattern similar to that observed in cells cultured from 20 
day-old animals (Figure 21).  USF2 immunostaining intensity was similar in both the cytoplasm 
and nuclei of Sertoli cells in the presence and absence of thyroid hormone (Figure 21, left vs. 
right panels). These data support the hypothesis that thyroid hormone is able to induce USF1 
binding to E-box binding sites due to an increase in USF1 protein within the nucleus of 
proliferating Sertoli cells. 
 
Figure 20. Thyroid Hormone Does Not Alter ID Protein 
mRNA Levels in Cultured Sertoli Cells.   
mRNA isolated from cultured 5, 11, and 20 day-old Sertoli 
cells treated with vehicle (-) or T4 (10-6 M) for 24 hours 
were analyzed by qPCR using primers for Id1 (A), Id2 (B), 
Id3 (C), and Id4 (D).  Vehicle-treated values were 
previously shown in Figure 13. Data was analyzed using 
the ∆∆Ct method and quantitation of the mean (±SE) of 
three individual experiments for each condition is provided 
for each primer set.  The relative mRNA levels were 
normalized to Ppia levels and made relative to untreated 5 
day-old Sertoli cells (=1). Values with different lowercase 
letters differ significantly (p < 0.05). 
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6.2.4 Thyroid Hormone Induces ENH Expression in 5 Day-old Sertoli Cells 
ENH protein levels were up-regulated in cultured Sertoli cells during differentiation 
(Figure 17).  To determine whether thyroid hormone was able to induce the up-regulation of 
ENH protein within cultured proliferating Sertoli cells, immunofluorescence analysis of ENH 
levels in 5 day-old Sertoli cells was evaluated in the presence and absence of thyroid hormone 
for 24 hours (Figure 22). Stimulation of cultured Sertoli cells from 5 day-old rats with thyroid 
hormone increased ENH expression to levels similar to 20 day-old cultured Sertoli cells 
predominantly within the cytoplasm. These data suggest that thyroid hormone can up-regulate 
ENH during Sertoli cell differentiation.  
 
Figure 21. USF1 Protein is Up-regulated in the Nucleus of 5 Day-old Sertoli Cells in the Presence of Thyroid 
Hormone.  
Immunofluorescence of cultured 5, 11, and 20 day-old Sertoli cells was performed with antisera recognizing USF1 
(top row) or USF2 (bottom row) as visualized with Alexa 488 fluorophore (red). Hoechst stains nuclei (blue). 
Cultured 5 day-old Sertoli cells were incubated with or without T4 (10-6 M) for 24 hours prior to fixation and 
staining as above. Panels of vehicle treated cells were previously shown in Figure 11 and are provided here again for 
reference. Scale bars = 100 µm. Control immunostaining with the Sertoli cell specific anti-vimentin antiserum is 
provided in Appendix A, Figures 34 and 35. 
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6.3 CONCLUSIONS 
Thyroid hormone, a known inducer of 
Sertoli cell differentiation, was proposed to 
induce USF binding to E-box motifs.  T4 
stimulation of cultured Sertoli cells induced USF 
DNA binding in undifferentiated Sertoli cells 
from 5 day-old rats (Figure 18A,B).  T4 also 
induced USF1 protein expression within the 
nucleus of proliferating Sertoli cells to the levels 
of cells that have already differentiated, 20 days 
after birth (Figure 21). Although T4 did not alter 
Id gene mRNA levels (Figure 20), T4 induced 
the up-regulation of an inhibitor of ID proteins, 
ENH, in 5 day-old Sertoli cells (Figure 22). 
Together, these data support the hypothesis that 
T4 can promote Sertoli cell differentiation 
through the induction of USF DNA binding due 
to the enhanced expression of ENH to sequester 
the ID2 inhibitor.  Further evaluation of protein 
levels by Western blotting are required to support 
the immunofluorescence and mRNA data.  
At later time points, in cells that were 
 
Figure 22. ENH is Up-regulated in the Presence 
of Thyroid Hormone in 5 Day-old Cultured 
Sertoli Cells. 
Immunofluorescence of cultured 5, 11, and 20 day-
old Sertoli cells was performed with antiserum 
recognizing ENH as visualized with Alexa 488 
fluorophore (red). Antiserum against vimentin was 
used as a Sertoli cell-specific marker as visualized 
with a Cy5 fluorophore (green). DAPI stains nuclei 
(blue). Cells were cultured in the presence or 
absence of 10-6 M T4 for 24 hours. Vehicle treated 
controls were previously shown in Figure 17.  
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differentiating (11 days after birth) or differentiated (20 days after birth), T4 had alternative 
effects. T4 stimulation of cultured 11 day-old Sertoli cells decreased USF binding to a consensus 
E-box probe and the Fshr probe (Figure 18A,B).  The decrease in binding activity occurred in 
correlation with an induction of Id2 mRNA levels (Figure 20B).  In contrast, Usf1 mRNA levels 
were induced by T4 in cells isolated 11 days after birth (Figure 19A).  These results are difficult 
to interpret because protein levels were not assayed in cells from 11 day-old rats treated with T4.  
It is possible that if USF1 levels are increasing, ID2 levels may be sufficient to inhibit USF DNA 
binding or that other mechanisms, such as post-translational modifications, may contribute to 
decreased USF binding [281-284]. T4 did not appear to have any effects on E-box or ID protein 
mRNA levels or USF binding in Sertoli cells from 20 day-old rats. 
The timing of the T4-mediated increases in USF DNA binding is consistent with previous 
data showing that thyroid hormone promotes Sertoli cell differentiation between 4 and 8 days 
after birth in the rat [264, 269]. Returning to the model of USF-mediated Sertoli cell 
differentiation, thyroid hormone can now be added as an inducer of USF binding in proliferating 
Sertoli cells.  During proliferation, low levels of USF1 are present within Sertoli cells and ID 
proteins may be elevated to inhibit USF binding.  Signals, such as thyroid hormone, then activate 
Sertoli cells to begin differentiating.  ID protein actions may be inhibited through the up-
regulation of ENH. USF binding is up-regulated at E-box motifs, which is expected to activate 
transcription of genes required for differentiated Sertoli cell functions. Thyroid hormone is one 
of many signals that could induce Sertoli cell differentiation.  The effects of other hormones 
known to contribute to Sertoli cell differentiation, including T and FSH (reviewed in [100, 112, 
253, 254]), need to be evaluated for their ability to induce USF DNA binding in undifferentiated 
Sertoli cells.  
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7.0  UP-REGULATION OF USF TARGET GENES, Nr5a1 AND Shbg, 
CORRELATES WITH THE ONSET OF DIFFERENTIATION IN RAT 
SERTOLI CELLS 
Hypothesis: USF1 and USF2 up-regulate target genes during Sertoli cell differentiation by 
binding to E-box consensus motifs within target gene promoter regions. 
7.1 INTRODUCTION 
7.1.1 Known USF Target Genes in Sertoli Cells 
USF1 and USF2 have been identified as potential mediators of Sertoli cell differentiation 
signals (Chapter 3 and 4). E-box motifs having consensus USF binding sites are present in the 
promoters of a number genes that are markers for differentiated Sertoli cell status including Fshr, 
nuclear receptor subfamily 5, group A, member 1 [Nr5a1, also known as steroidogenic factor 1 
(SF1)] and GATA binding protein 4 (Gata4) [168, 171-173].  USF1 and USF2 binding to the 
Fshr promoter has already been discussed in previous chapters (Figures 5 and 6). USF1 and 
USF2 contribute to an increase in DNA binding to the E-box within the Fshr promoter during the 
postnatal differentiation of Sertoli cells (Figure 5). The transcription of Nr5a1 requires USF1 and 
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USF2 within Sertoli cells and Leydig cells [171]. Nr5a1 expression within the rat testis is 
maintained through 21 days after birth and then decreases in adulthood when NR5A1 is detected 
primarily in Leydig cells [285]. Gata4 contains an E-box through which USF1 and USF2 induce 
transcription [286]. However, the expression pattern of Gata4 within the testes remains 
controversial. Studies investigating the levels of Gata4 mRNA in whole testis revealed that 
Gata4 mRNA expression is maintained through days 7 to 14 after birth and then decreases [287, 
288]. Immunohistochemical studies suggest that GATA4 is present through 25 days after birth 
albeit at a reduced level after 14 days [287, 288]. However, studies conducted in germ cell-
deficient mice suggest that observed reductions in GATA4 expression were due to dilution by 
developing germ cells and found that GATA4 levels remained constant in Sertoli cells despite 
postnatal age or stage of spermatogenesis [289]. Both Nr5a1 and Gata4 encode transcription 
factors that can lead to downstream regulation of other key genes during the onset of 
differentiation in Sertoli cells. 
7.1.2 E-box Regulated Genes that are Up-regulated During Differentiation in Sertoli Cells 
Trf and Shbg have E-box motifs within their promoters and are expressed within the 
testis.  Transferrin, secreted by Sertoli cells, facilitates iron transport to cells beyond the blood-
testis barrier [28]. It has been shown that E47 regulates this promoter in fully-differentiated 
Sertoli cells [168]. However, increased binding of E47 to the E-box region of the Trf promoter 
does not occur during the switch between Sertoli cell proliferation and differentiation (Figure 4). 
Shbg expression is a marker of Sertoli cell differentiation and its product within the testis, 
androgen binding protein, functions to carry testosterone through the lumen of the seminiferous 
tubules and throughout the male reproductive tract [101, 103]. Three E-box motifs have been 
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detected within the Shbg promoter [245]. Studies in fully-differentiated Sertoli cells revealed that 
the proximal E-box (-36 to -31 bp) and the distal E-box (-268 to -263 bp) within the promoter are 
necessary for Shbg expression [245]. The third E-box overlaps with a CREB binding site and is 
capable of binding the bHLH protein, E47  [245]. ID1, an inhibitor of bHLH proteins, inhibits 
the responsiveness of the Shbg promoter to FSH and cAMP  [245]. The identities of the bHLH 
proteins that are capable of binding to the distal and proximal E-boxes are not known. The USF-
mediated regulation of Fshr, Nr5a1, Gata4, and Shbg during Sertoli cell differentiation is not 
known.  
7.2 RESULTS 
7.2.1 The DNA Binding of USF Proteins Increase During Sertoli Cell Differentiation on 
Target Gene Promoters 
Because USF1 and USF2 contribute to increased binding at the Fshr promoter E-box 
(Figures 5 and 6), it is hypothesized that USF binding to the promoters of other USF target genes 
would also increase in differentiating Sertoli cells. The Gata4 promoter was found to contain an 
E-box within -118 bp upstream of the transcription start site that is also regulated by USF1 and 
USF2 [286]. The Nr5a1 promoter contains an E-box at -82 to -77 bp from the transcription start 
site and binds USF1 and USF2 in rat Sertoli cells and whole testis [171, 173]. Nuclear extracts 
prepared from Sertoli cells immediately after isolation from 5 and 11 day-old rats were incubated 
with radiolabeled, double-stranded oligonucleotide probes containing E-box motifs from the 
Nr5a1 and Gata4 promoters. For probes containing the USF  
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binding site from the Nr5a1 
promoter or the Gata4 
promoter, protein binding was 
low in extracts from 5 day-old 
Sertoli cells but binding 
activity increased 
approximately 3-fold at both 
promoter regions at 11 days 
(Figure 23A, B). To confirm 
that USF proteins are 
responsible for forming the 
DNA-protein complexes, 
supershift studies were 
performed.  Sertoli cell 
nuclear extracts from 5 and 11 
day-old testes were 
preincubated with non-
immune serum or antisera 
against USF1, USF2, E47, 
E2A, or MYC E-box binding 
transcription factors before 
incubation with probes 
containing the E-box regions 
 
Figure 23. USF1 and USF2 DNA Binding Increases at E-box Motifs in 
the Nr5a1 and Gata4 Promoters in Sertoli Cells Assayed Immediately 
After Isolation.  
In EMSAs, radiolabeled probes containing E-box regions of the Nr5a1 
promoter (A) or the Gata4 promoter (B) were incubated with nuclear 
extracts of Sertoli cells immediately assayed after isolation from 5 and 11 
day-old testis. Representative images of the resulting DNA-protein 
complexes are shown, and quantitation of the mean (±SE) of three 
independent experiments is provided. The relative binding for each 
condition is normalized to that of 11 day-old Sertoli cells (=1). Statistically 
significant differences (p < 0.05) are indicated by an asterisk (*). C) DNA-
protein complexes from nuclear extracts of Sertoli cells isolated from 5 and 
11 day-old Sertoli cells were incubated with non-immune sera or antisera 
for USF1, USF2, E47, E2A, or MYC immediately after isolation. 
Supershifted DNA-protein complexes containing USF1 or USF2 are 
indicated. Exposure times for all complexes are less than 48 h. Free probe 
was run off the gel. 
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of the Nr5a1 or Gata4 promoters (Figure 23C). The supershift assay demonstrated that both USF 
antisera supershifted DNA-protein complexes, whereas the E47, E2A, and MYC antisera had 
little effect.   These data confirm that USF1 and USF2 binding to E-box motifs within target 
promoters increases during Sertoli cell differentiation.  
7.2.2 Expression of the USF Target Gene Nr5a1 Increases During Sertoli Cell 
Differentiation 
To determine whether 
increased USF DNA binding 
during Sertoli cell differentiation 
corresponded with increased USF 
target gene expression for Sertoli 
cell- or testis-specific genes, the 
expression of mRNAs encoding 
Fshr, Gata4, and Nr5a1 were 
assayed during Sertoli 
development using qPCR with 
∆∆Ct analysis. Fshr and Gata4 
are Sertoli cell-specific genes 
within the testes whose levels are 
known to increase or are 
maintained throughout Sertoli cell postnatal differentiation [18, 289]. Nr5a1 is expressed in 
Sertoli cells and Leydig cells within the testis.  The expression of NR5A1 peaks 7 days after 
 
Figure 24. Nr5a1 and Shbg mRNA Levels Significantly Increase 
During Differentiation in Sertoli Cells Assayed Immediately After 
Isolation.  
The mRNAs isolated from 5 and 11 day-old Sertoli cells were analyzed 
by qPCR using primers for Fshr (A), Gata4 (B), Nr5a1 (C), and Shbg 
(D). Data were analyzed using the ∆∆Ct method, and quantitation of 
the mean (±SE) of three individual experiments for each condition is 
provided for each primer set. The relative mRNA levels were 
normalized to Ppia levels and were made relative to 5 day-old Sertoli 
cells (=1). Statistically significant differences (p < 0.05) are indicated 
by an asterisk (*). 
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birth [285]. Assays of mRNA preparations from Sertoli cells immediately after isolation revealed 
that the mRNA levels of Fshr and Gata4 do not increase between 5 and 11 days after birth in the 
rat (Figure 24A,B). In contrast, Nr5a1 mRNA levels increased 1.37 ± 0.13-fold (p < 0.05) from 5 
to 11 days after birth (Figure 24C).  For all studies, the mRNA levels of the housekeeping gene 
Ppia did not change over the course of differentiation (data not shown). Based on these data, the 
increase in DNA binding of USF1 and USF2 from Sertoli cells assayed immediately after 
isolation to the Nr5a1 promoter E-box (Figure 23A) correlates to an increase in mRNA 
expression of Nr5a1 (Figure 24A). These studies identify Nr5a1 as a USF target gene during 
postnatal Sertoli cell differentiation between 5 and 11 days after birth. 
7.2.3 The Shbg Promoter is a Novel Target of USF1 and USF2 Action Through Binding to 
the Proximal E-box 
Shbg mRNA levels are known to increase during Sertoli cell differentiation. Shbg levels 
are expressed at low levels from 0 to 15 days after birth with increasing levels between 15 and 60 
days after birth [272]. mRNA levels of Shbg were confirmed to increase 3.2 ± 1.0-fold (p < 0.05) 
between 5 and 11 days after birth in Sertoli cells assayed immediately after isolation (Figure 
24D). Previously, the only evidence for E-box involvement in the regulation of the Shbg gene 
suggested that E47 bound to the E-box between -129 and -124 bp upstream of the transcription 
start site within the promoter region in fully-differentiated rat Sertoli cells [245]. Therefore, to 
determine whether USF1 and USF2 were able to act on one of the two other E-box regions 
within the Shbg promoter, EMSA analysis of nuclear extracts from Sertoli cells immediately 
assayed after isolation from 5 and 11 day-old rats was conducted using probes containing E-box 
motifs for each of the three E-box regions within the Shbg promoter (Figure 25). For the  
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Figure 25. USF1 and USF2 Exhibit Increasing DNA Binding at the Proximal E-box of the Shbg Promoter in 
Differentiating Sertoli Cells Assayed Immediately After Isolation. 
A) A schematic of the Shbg promoter showing the presence of three E-box motifs: the proximal E-box motif from -
36 to -31 bp, the central E-box motif from -129 to -124 bp, and the distal E-box from -268 to -163 bp [245]. 
Promoter region is not drawn to scale. B) In EMSAs, radiolabeled probes containing a region of the Shbg promoter 
containing the proximal E-box, the central E-box, or the distal E-box (B, top) were incubated with nuclear extracts 
from 5 and 11 day-old Sertoli cells immediately after isolation. Representative images of the resulting DNA-protein 
complexes are shown, and quantitation of the mean (±SE) of three independent experiments is provided. The 
relative binding for each condition is normalized to that of 11 day-old Sertoli cells (=1). Statistically significant 
differences (p < 0.05) are indicated by an asterisk (*) (B, Bottom). BD = below detection limit of the assay. C) 
DNA-protein complexes from nuclear extracts isolated from cultured 11 day-old Sertoli cells were incubated with 
non-immune sera or antisera for USF1, USF2, E47, E2A, or MYC. Supershifted DNA-protein complexes containing 
USF1 or USF2 are indicated. Exposure times for all complexes are less than 48 h. Free probe was run off of the gel. 
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probes containing the proximal (-36 to -31 bp) and distal (-268 to -263 bp) E-box motifs, protein 
binding was low in extracts from 5 day-old Sertoli cells but DNA binding increased 2.5 ± 0.004-
fold and 3.3 ± 0.05-fold, respectively (p < 0.05 for both), in extracts from 11 day-old Sertoli cells 
(Figure 25A).   DNA binding was not detected at the central E-box from -129 to -124 bp at either 
5 or 11 days after birth where E47 binds in fully-differentiated Sertoli cells [245]. To determine 
whether USF1 or USF2 contributed to the DNA-protein complexes at either the proximal or 
distal E-box motifs, supershift studies were performed (Figure 25B).  Sertoli cell nuclear extracts 
from assayed immediately after isolation from 5 and 11 day-old rats were preincubated with non-
immune serum or antisera against USF1, USF2, E47, E2A, or MYC before incubation with 
probes containing the proximal or distal E-box regions of the Shbg promoter (Figure 25B). The 
supershift assay demonstrated that both USF antisera supershifted DNA-protein complexes only 
at the proximal E-box motif, whereas the E47, E2A, and MYC antisera had little effect. None of 
the antibodies shifted the lower band whose protein components are unknown. In contrast, none 
of the antibodies tested were able to shift or disrupt the DNA-protein complexes detected for the 
distal E-box. Additionally, the upper-most DNA-protein complex formed at the distal E-box 
motif migrated faster than that usually observed for USF bound probes suggesting that an 
alternative protein or protein complex is bound at the site. These data suggest that USF1 and 
USF2 may be involved in the transcriptional activation of Shbg through the proximal E-box 
region and that this increase in DNA binding correlates with an increase in Shbg mRNA levels. 
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7.2.4 Chromatin Immunoprecipitation Studies Confirm the Presence of USF1 and USF2 
at the Nr5a1 Promoter Region 5 and 11 Days After Birth in Whole Testes 
To confirm that USF1 and USF2 occupy the promoters of USF target genes during 
Sertoli cell differentiation in vivo, chromatin immunoprecipitation (ChIP) analysis was employed 
to analyze USF1 and USF2 binding to the Nr5a1 promoter E-box. Formaldehyde cross-linked 
chromatin from whole testes of 5 and 11 day-old rats was used for immunoprecipitation with 
antibodies to several members of the bHLH transcription factor family, CREB, and non-immune 
serum (Figure 26). Whole testes were used to ensure that enough material could be obtained for 
the assay.  
Eluates from USF1 and USF2 immunoprecipitates of chromatin prepared from 5 and 11 
day-old testes were significantly enriched for DNA containing the E-box region of the Nr5a1 
promoter in three independent trials (Figure 26, solid bars). In contrast, no such enrichment was 
observed for DNA containing a region downstream of the E-box within the Nr5a1 coding 
sequence (Figure 26, hatched bars). Immunoprecipitation with antisera against E47, E2A.E12, 
MYC, and CREB did not enrich eluates with DNA from either the E-box region of the Nr5a1 
promoter or a region downstream of the E-box within the Nr5a1 coding sequence demonstrating 
the specificity of the E-box interaction with USF1 and USF2. In two out of three experiments, 
the binding of USF1 and USF2 to the E-box region of the Nr5a1 promoter appeared to decrease 
in testes from 11 day-old rats (Figure 26A, B).  However, only in one trial was USF1 binding 
greater than USF2 binding (Figure 26C). These data confirm that USF1 and USF2 bind to the 
Nr5a1 promoter between -130 bp and -10 bp upstream of the transcription start site in which the 
E-box is located at both 5 and 11 days after birth in the testis in vivo [171, 173].  
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Figure 26. USF1 and USF2 are Enriched at the E-
box Within the Nr5a1 Promoter at Both 5 and 11 
Days After Birth In Vivo.  
Interactions between the USF proteins and Nr5a1 
promoter, in vivo, were evaluated using ChIP with 
cross-linked chromatin from whole testes at 5 and 11 
days after birth. In DNA isolated from each 
immunoprecipitated chromatin sample, the promoter 
region (solid bars) and a negative control region 
located 5000 bp downstream of the E-box (hatched 
bars) were amplified by qPCR. Immunoprecipitations 
for USF1 or USF2 were compared with 
immunoprecipitations with antisera against E47, 
E2A.E12, and MYC. Antisera against CREB, which 
does not bind the Nr5a1 E-box, and normal rabbit IgG 
were used as controls. Three independent trials are 
shown. 
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7.3 CONCLUSIONS 
USF1 and USF2 are hypothesized to up-regulate target genes during Sertoli cell 
differentiation by binding to E-box motifs within target gene promoter regions.  Fshr, Nr5a1 and 
Gata4 were identified as potential USF target genes during Sertoli cell differentiation, based on 
previous studies [168, 171-173]. EMSA analyses revealed that USF1 and USF2 bind to E-box 
regions within the Fshr (Figures 5 and 6), Nr5a1 and Gata4 promoters (Figure 23A,B). Only 
Nr5a1 mRNA levels were up-regulated in rat Sertoli cells isolated between 5 and 11 days after 
birth (Figure 24C), thus identifying Nr5a1 as a potential USF target gene during the onset of 
differentiation in rat Sertoli cells.  Studies of the Nr5a1 promoter by ChIP revealed that USF1 
and USF2 bind to the Nr5a1 promoter in 5 and 11 day-old testes, in vivo (Figure 26). However, it 
is not possible to confirm that the DNA binding by USF increased in vivo during this stage of 
Sertoli cell differentiation.  
Studies of USF DNA binding through the use of EMSA and ChIP would be expected to 
reveal similar results.  However, it is possible that these two methods could provide different 
outcomes.  Cell extracts analyzed by EMSA are incubated with a buffer that can be altered to 
favor the binding of different transcription factors.  This in vitro system also provides binding 
sites in excess without chromatin structure and in the absence of in vivo regulators. ChIP assays 
allow evaluation of proteins bound to native chromatin, in the context of the intrinsic cell 
environment.  Therefore, results obtained from ChIP assays reveal the in vivo ability of a given 
protein to recognize and bind a consensus motif with the added dimension of chromatin 
structure.  Whereas the results of an EMSA are quantitative [290], the quantitative capability of 
ChIP assays [291] are limited to studies involving homologous cell populations.  When 
comparing DNA binding of a given protein to the same region of chromatin in samples arising 
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from a homologous or similar cell population (i.e. a cell line or isolated cell type), ChIP may 
allow relative quantitative comparisons.  However, using cells derived from heterogeneous cell 
populations of whole testis at different developmental stages may introduce unknown variables 
and may not truly reveal quantitative differences.  Whole testes are a heterogeneous population 
of cells with varying contributions from germ cells during Sertoli cell development. Testes in 5 
day-old mice are composed of approximately 85% Sertoli cells whereas testes from 11 day-old 
mice contain approximately 45% Sertoli cells [292].  Similar studies of testis cellular 
composition in rat do not provide the total percentage of Sertoli cells in the testis but would be 
expected to yield similar results [8, 81, 293]. Therefore, if the amount of total chromatin isolated 
from 11 day-old cells was diluted in half by chromatin from developing germ cells in rat testes 
and if the DNA binding was normalized to the percentage of Sertoli cell DNA, then the ChIP 
assays would reveal approximately equal DNA binding for USF1 and USF2. Future studies of 
isolated Sertoli cells are required to better test the hypothesis that USF protein binding increase 
in vivo during differentiation. Nevertheless, the data obtained indicate that USF proteins bind to 
the Nr5a1 promoter E-box and Nr5a1 mRNA expression increases during the onset of Sertoli 
cell differentiation (Figure 26).  
Shbg was identified as a potential target of USF proteins during differentiation based on 
the presence of three E-box motifs within the promoter and the knowledge that Shbg expression 
increases during Sertoli cell differentiation [245, 272]. Shbg mRNA levels were confirmed to 
increase between 5 and 11 days after birth in isolated Sertoli cells (Figure 24D). In EMSA 
studies of the Shbg promoter, DNA-binding activity to both the proximal and distal E-box motif 
increased between 5 and 11 days after birth (Figure 25A). USF1 and USF2 were only found to 
bind to the proximal E-box (Figure 25B). The data provide a hypothesis that the binding of two 
 88 
complexes, a USF containing complex at the proximal E-box and an unknown complex at the 
distal E-box, could synergize to induce Shbg mRNA expression during Sertoli cell 
differentiation. Future studies should investigate the components of the protein-DNA complex 
bound at the distal E-box and its involvement in Shbg regulation. Additionally, it is interesting to 
note that no binding was found at the central E-box at -129 and -124 bp upstream of the 
transcription start site (Figure 25A). This E-box motif was previously shown to bind E47 and 
may suggest an alternative mechanism of regulation for Shbg which occurs in fully-differentiated 
Sertoli cells [245].  
A model has been proposed to describe the actions of USF-mediated transcription during 
the onset of Sertoli cell differentiation. During proliferation, USF1 levels are low and ID protein 
levels may be elevated to inhibit USF binding to E-box motifs within the promoters of genes 
required for differentiated Sertoli cell functions.  A differentiating promoting signal, such as T4, 
is received by the Sertoli cell and USF1 levels are up-regulated while ID levels are down-
regulated. These changes in USF1 and ID proteins allows an increase in USF binding to E-box 
motifs during the onset of Sertoli cell differentiation in the promoter regions of USF target genes, 
including Nr5a1 and Shbg. The ensuing transcription of Nr5a1 and Shbg genes would allow 
genes to be expressed that are required for Sertoli cell differentiated functions.  Future studies are 
required to determine if USF proteins directly mediate Nr5a1 and Shbg promoter activity.  Also, 
the ability of T4 and ID proteins to induce or inhibit promoter activity, respectively, needs to be 
investigated. Finally, USF-mediated NR5A1 and SHBG protein production should be assessed to 
determine if protein levels are elevated to reflect changes in mRNA levels to contribute to the 
onset of Sertoli cell differentiation. 
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8.0  FSHR: REGULATION OF A USF TARGET GENE IN DIFFERENTIATED 
SERTOLI CELLS 
Hypothesis:  FSH-induced up-regulation of ID2 inhibits USF-mediated transcription of Fshr in 
Sertoli cells. 
8.1 INTRODUCTION 
To this point USF has been identified as a potential mediator of gene transcription that 
may facilitate the onset of differentiation in Sertoli cells. This chapter will explore the regulation 
of Fshr in fully-differentiated Sertoli cells. Previous studies showed that FSH down-regulates its 
receptor within four hours of induction and that Id mRNA levels are induced by FSH [243, 294].  
Therefore, this chapter discusses a possible regulatory mechanism of USF-mediated Fshr 
transcription as regulated by FSH and ID proteins. Although these studies were conducted in 
differentiated Sertoli cells, this chapter will bring together the ideas of USF binding, hormonal 
regulation, and ID protein inhibitors at a USF target gene. Specifically, a mechanism is identified 
to explain the cyclic regulation of Fshr during spermatogenesis in fully-differentiated Sertoli 
cells. 
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8.1.1 Molecular Mechanisms of FSHR Actions 
FSHR is a G-protein coupled receptor (GPCR) that can mediate multiple signaling 
cascades within the Sertoli cell [21]. FSH stimulation can lead to the regulation of multiple genes 
required by the Sertoli cell, including: Fshr, Shbg, Trf, and Ar [245, 295-297]. The most well 
studied pathway of FSHR downstream signaling is the ligand-induced activation of adenyl 
cyclase by the GPCR to induce cAMP and PKA (reviewed in [21]). FSH binds to FSHR, which 
leads to the dissociation of the α subunit of receptor-associated Gs protein [21] and the activation 
of adenyl cyclase to produce cAMP [298]. cAMP production is highest between stages XIII and 
IV and is  lowest between stages VII and IX [299]. Accumulation of cAMP leads to the release 
of the catalytic subunit of PKA. PKA then goes on to phosphorylate CREB, a transcription factor 
[21]. Phosphorylation of CREB can lead to the activation of downstream target genes within 
Sertoli cells.  
8.1.2 Fshr Gene Regulation by cAMP in Differentiated Sertoli Cells 
The exact mechanisms of Fshr gene regulation are not yet understood. Fshr gene 
expression is decreased upon FSH stimulation for 4 hours by 90% through a cAMP-dependent 
mechanism [294]. FSH stimulation for 16 hours allowed Fshr mRNA levels to return to control 
levels [294].  Stimulation with cAMP or forskolin also produce similar results and treatments in 
the presence of the phosphodiesterase inhibitor, isobutylmethylxanthine (IBMX), can prolong the 
actions of FSH [294]. A region of the Fshr promoter between -100 and +123 relative to the first 
transcriptional start site was identified as the minimal promoter region needed for transcription 
[163, 172, 300]. Block mutations of the minimal promoter identified an E-box, an E2F binding 
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site, and an inverted GATA binding site that may be involved in promoter activation [172, 300]. 
However, only the E-box motif has significant effects in Sertoli cells and is conserved in the 
promoter of all species [163].  
USF1 and USF2 bind to the E-box within the Fshr promoter (Figures 5 and 6). In 
cultured Sertoli cells, FSH stimulation transiently represses binding to a consensus E-box, 
decreasing 85% after 12 hours and returning to 45% of basal binding levels within 24 hours 
[243]. FSH-mediated transient up-regulation of Id2 gene expression within 2 hours of 
stimulation coincided with the inhibition of E-box binding [243]. Id2 mRNA levels then peaked 
between 6 and 12 hours and decreased by 24 hours after stimulation with FSH [243]. In transient 
transfections of Id2 promoter driven reporters, forskolin, FSH, and PKA induced Id2 promoter 
activity in primary Sertoli cells [243]. In contrast, after prolonged stimulation (72 hours) of 20 
day-old Sertoli cells with FSH or cAMP, Id1 mRNA decreased and Id4 mRNA increased while 
no change was observed in the mRNA levels of Id2 or Id3 [169]. Together, these data suggest 
that FSH activation of FSHR may lead to transient down-regulation of the Fshr gene promoter 
through the up-regulation of ID proteins within Sertoli cells to negatively regulate USF-mediated 
gene transcription.  
8.2 RESULTS 
8.2.1 FSH Transiently Decreases Fshr mRNA Levels 
To confirm the transient down-regulation of Fshr mRNA levels upon stimulation with 
FSH, Sertoli cells from 15 day-old rats were stimulated with FSH+IBMX for 0, 2, 6, 12, 24, or  
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48 hours (Figure 27).  Previous studies 
revealed decreased Fshr expression after 4 
hours and increased Fshr expression after 16 
hours of stimulation with FSH [294]. Studies 
of Fshr mRNA levels through the use of qPCR 
with ∆∆Ct analysis revealed a significant 
decrease in Fshr mRNA levels 6 hours after 
stimulation (-66 ± 1.4%, p < 0.05), reaching a 
nadir at 12 hours (-88 ± 4.1%, p< 0.05), and 
recovering to control levels within 48 hours 
(Figure 27). The mRNA levels of Ppia were 
studied as a control gene and mRNA levels 
were not found to change upon stimulation 
with FSH + IBMX (data not shown).  All 
mRNA levels were normalized to that of Ppia. These data suggest that FSH-mediates the 
transient down-regulation of Fshr mRNA. 
8.2.2 FSH Stimulation Transiently Decreases Usf1 Gene Expression 
USF1 and USF2 are known to bind to the E-box within the Fshr promoter (Figures 5 and 
6).  Therefore, it was hypothesized that FSH+IBMX would transiently down-regulate Usf gene 
expression to contribute to the transient decrease in Fshr gene expression (Figure 27). Cultured 
Sertoli cells from 15 day-old rats were stimulated with FSH + IBMX for 0, 2, 6, 12, 24, and 48  
 
Figure 27. Transient Down-regulation of Fshr 
mRNA with FSH Stimulation in Cultured 15 Day-
old Sertoli Cells. 
mRNA isolated from cultured 15 day-old Sertoli cells 
treated vehicle or FSH (100 ng/ml) + IBMX (0.5 mM) 
for 2 to 24 h were analyzed by qPCR using primers for 
Fshr. Data was analyzed using the ∆∆Ct method and 
quantitation of the mean (±SE) of three experiments is 
presented. The relative mRNA levels were normalized 
to Ppia levels and made relative to vehicle-treated 
Sertoli cells (=100%). Values with different lowercase 
letters differ significantly (p < 0.05). Figure modified 
from [244] with permission from the Endocrine Society 
(Copyright 2009). 
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hours (Figure 28). qPCR with ∆∆Ct analysis 
revealed that Usf1 mRNA levels decreased 
significantly after 6 hours of stimulation (-63 ± 
3.1%, p < 0.05), remained decreased through 12 
hours (-42 ± 17.5%, p < 0.05), and returned to 
control levels within 24 hours (Figure 28A).  In 
contrast, Usf2 mRNA levels were not found to 
change significantly in Sertoli cells stimulated with 
FSH + IBMX (Figure 28B). The mRNA levels of 
Ppia were studied as a control gene and mRNA 
levels were not found to change upon stimulation 
with FSH+IBMX (data not shown).  All mRNA 
levels were normalized to that of Ppia. These data 
suggest that FSH induced a decrease in Usf1 
mRNA and may contribute to the transient decrease 
in Fshr expression. 
8.2.3 FSH Transiently Up-regulates Id2 mRNA 
Levels 
 Id2 gene expression is transiently up-
regulated in cultured Sertoli cells when stimulated 
by FSH [243]. To confirm this result, mRNA levels from cultured rat Sertoli cells isolated from 
15 day-old rats stimulated with FSH+IBMX for 0, 2, 6, 12, 24, and 48 hours were evaluated by  
 
Figure 28. FSH Stimulation Transiently 
Decreases Usf1 mRNA Levels in Cultured 15 
Day-old Sertoli Cells.  
mRNA isolated from cultured 15 day-old Sertoli 
cells treated with vehicle or FSH (100 ng/ml) + 
IBMX (0.5 mM) for 2 to 24 h were analyzed by 
qPCR using primers for Usf1 (A) or Usf2 (B). 
Data was analyzed using the ∆∆Ct method and 
quantitation of the mean (±SE) of three 
experiments is presented. The relative mRNA 
levels were normalized to Ppia levels and made 
relative to vehicle-treated Sertoli cells (=100%). 
Values with different lowercase letters differ 
significantly (p < 0.05).  Figure modified from 
[244] with permission from the Endocrine Society 
(Copyright 2009). 
 94 
qPCR with ∆∆Ct analysis (Figure 29). Id2 
mRNA levels were transiently up-regulated 
after 2 hours of stimulation (+279 ± 101%, p< 
0.05) and returned to basal levels within 12 
hours (Figure 29). This data reveals a more 
immediate response to FSH compared to 
previous studies which found that Id2 mRNA 
expression in Sertoli cells peaked between 6 
and 12 hours [243], although both increases in 
Id2 mRNA were transient. Together, these data 
suggest that if ID2 protein levels reflect Id2 
mRNA levels, then increases in ID2 protein 
could inhibit USF-mediated DNA binding at the 
Fshr promoter E-box to result in a transient 
decrease of Fshr expression. 
Efficiency-corrected ∆Ct analysis of the qPCR data was used to evaluate the relative 
quantities of Usf1 to Id2 within the Sertoli cells after FSH stimulation (Table 8).  At all time 
points, Id2 mRNA was expressed at equal or greater levels compared to Usf1 (Table 8, Column 
5).  From 2 to 12 hours, Id2 mRNA levels were 5 to 15-fold greater then Usf1, only reaching 
significance 6 hours after FSH stimulation, a 14.69 ± 7.22-fold increase (p < 0.05) (Table 8, 
Column 5). This increased ratio of Id2:Usf1 within the Sertoli cell corresponds to the time period 
when Id2 mRNA levels are up-regulated (Figure 29) and when Usf1 mRNA levels are at their 
lowest (Figure 28A).  Together, this data suggests that, if protein levels follow mRNA 
 
Figure 29. FSH Stimulation Transiently Increases 
Id2 mRNA Levels in 15 Day-old Cultured Sertoli 
Cells.  
mRNA isolated from cultured 15 day-old Sertoli cells 
treated vehicle or FSH (100 ng/ml) + IBMX (0.5 mM) 
for 2 to 24 h were analyzed by qPCR using primers 
for Id2. Data was analyzed using the ∆∆Ct method 
and quantitation of the mean (±SE) of three 
experiments is presented. The relative mRNA levels 
were normalized to Ppia levels and made relative to 
vehicle treated Sertoli cells (=100%). Values with 
different lowercase letters differ significantly (p < 
0.05). 
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expression patterns, ID2 is present in sufficient quantities to inhibit USF binding to an E-box 
motif.  
8.3 CONCLUSIONS 
FSH was hypothesized to induce the up-regulation of ID2 to inhibit USF-mediated 
transcription of Fshr in differentiated Sertoli cells.  This hypothesis was proposed to investigate 
a potential regulatory mechanism involving hormonal signals and inhibitor ID proteins that may 
regulate USF binding to E-box motifs at multiple target genes. Stimulation of cultured Sertoli 
cells for 0, 2, 6, 12, 24, or 48 hours with FSH+IBMX revealed a transient decrease in Fshr 
mRNA expression at 6 and 12 hours after stimulation (Figure 27). This is consistent with 
Table 8. Comparison of Usf1 and Id2 mRNA Levels in 15 Day-old Cultured Sertoli Cells Stimulated with FSH 
and IBMX. 
Duration of 
FSH+IBMX 
Stimulation 
Gene 
∆∆Ct Relative 
Fold Change 
(Figure 24A)* 
Relative 
Quantity 
Using 
Efficiency 
Corrected 
∆Ct Method 
Compared to 
Ppia 
Gene 
∆∆Ct 
Relative 
Fold Change 
(Figure 24)* 
Relative 
Quantity 
Using 
Efficiency 
Corrected 
∆Ct 
Method 
Compared 
to Ppia 
Average Fold 
Change in 
Relative 
Quantity of 
Id2 Over Usf1 
No treatment Usf1 1.00 ± 0a,d 0.124± 0.026 Id2 1.00 ± 0a 0.188  
± 0.080a 
1.67 ± 0.75 
2 hours  0.70 ± 0.08b,c,d 0.083 ± 0.010  3.79 ± 1.10b,c 0.670  
± 0.231b,c 
8.62 ± 3.50 
6 hours  0.37 ± 0.03c 0.044 ± 0.006  2.93 ± 0.88c 0.598 
 ± 0.286a,b 
14.69 ± 7.22** 
12 hours  0.58 ± 0.18b,c 0.067 ± 0.008  1.66 ± 0.89a,c 0.342  
± 0.184a,c,d 
5.34 ± 3.03 
24 hours  1.11 ± 0.15a 0.138 ± 0.030  0.90 ± 0.52a 0.163  
± 0.088a,d 
1.38 ± 0.79 
48 hours  0.93 ± 0.24a,b 0.107 ± 0.007  1.45 ± 0.59a,c 0.280  
± 0.130a,c 
2.63 ± 1.23 
Column 
Number  1 2  3 4 5 
*Values with different lower case letters are significantly different from other values in the same column (p < 0.05). 
**Change between relative quantities when comparing gene to Usf1 is significantly different (p < 0.05). 
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previous studies that showed decreased Fshr expression after 4 hours and increased expression 
of Fshr after 16 hours of stimulation with FSH [243]. This data also correlates with a decrease in 
USF binding to the Fshr promoter E-box 6 hours after stimulation with FSH+IBMX and an 
increase in USF binding 48 hours after stimulation with FSH+IBMX [244]. 
USF levels were investigated as a cause for the FSH-mediated transient down-regulation 
of USF binding to the E-box within the Fshr promoter and a subsequent decrease in Fshr gene 
expression.  Usf1 mRNA levels were found to decrease upon stimulation of Sertoli cells with 
FSH+IBMX with similar kinetics as the decrease in the expression of Fshr (Figure 28A). In 
contrast, Usf2 mRNA levels were not found to decrease upon stimulation with FSH+IBMX 
(Figure 28B). This data is supported by a decrease in USF1 protein between 2 and 12 hours after 
stimulation with FSH+IBMX [244]. Together, these data support the hypothesis that FSH 
induces an inhibition of USF-mediated transcription of Fshr in Sertoli cells. 
ID2 was hypothesized to be an inhibitor that is responsible for the down-regulation of 
USF-mediated Fshr expression based on previous studies showing that Id2 mRNA is transiently 
up-regulated upon stimulation with FSH+IBMX [243]. Id2 mRNA levels were confirmed to be 
transiently up-regulated within 2 hours of stimulation with FSH+IBMX and returned to basal 
levels within 12 hours (Figure 29). ID2 protein levels also increase transiently within the nuclei 
of Sertoli cells after 6 hours of stimulation with FSH+IBMX and ID2 levels begin to decrease 
within the nuclei after 24 hours [244]. Additionally, Id2 mRNA levels are expressed at quantities 
similar to or greater then Usf1 (Table 8). If mRNA levels reflect protein expression levels, then 
ID2 would be expected to be expressed at comparable levels to USF1 and could inhibit USF 
binding. This data supports the hypothesis that ID2 is up-regulated with FSH+IBMX and may 
inhibit USF binding to the E-box within the Fshr promoter.  
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The ability of ID2 to inhibit USF-mediated Fshr transcription was not directly addressed 
in this dissertation; however, recent studies further support this hypothesis. In vitro, increasing 
levels of ID2 are able to inhibit USF binding to the Fshr promoter E-box in Sertoli cells [244]. In 
addition, ID2 is able to inhibit USF-mediated Fshr promoter activity in a dose-dependent manner 
in Sertoli cells [244].  As a whole, these data support the hypothesis that FSH-induced up-
regulation of ID2 inhibits USF-mediated transcription of Fshr in Sertoli cells. FSH binding to the 
FSHR allows internalization of the receptor for either recycling or degradation [21, 294, 297, 
301]. Thus, decreased Fshr transcription may lead to the down-regulation of the FSHR at the cell 
surface. ID2-mediated mechanisms of FSHR down-regulation may be involved in the cyclical 
control of FSHR levels during the stages of spermatogenesis in differentiated Sertoli cells [19]. 
Further studies need to be conducted in Sertoli cells isolated from staged tubules in order to 
confirm these ideas. 
This data can also provide a model for the regulation of other USF target genes. In this 
model, USF binds to the E-box motif of the target gene, allowing transcription.  FSH signaling 
acts on the Sertoli cell to transiently down-regulate USF levels and up-regulate ID protein levels.  
These changes inhibit USF binding to E-box motifs within the promoters of target genes. Upon 
prolonged signaling or loss of the signal that caused the down-regulation, USF and ID protein 
expression returns to basal levels. The return to basal levels again allows USF binding to the E-
box within the target gene promoter and activates gene transcription.  Future studies of other 
USF target genes are required to determine if this proposed model is maintained across USF-
regulated gene promoters. 
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9.0  A PROPOSAL OF HOW USF REGULATES THE ONSET OF SERTOLI CELL 
DIFFERENTIATION 
Sertoli cells divide until the onset of puberty after which time they never divide again [1, 
79]. Sertoli cells are required for the maintenance of male fertility.  Each Sertoli cell can only 
support a given number of germ cells [79].  Therefore, the number of Sertoli cells establishes the 
upper level of male fertility [1].  The molecular mechanisms that regulate the terminal 
differentiation of Sertoli cells are only beginning to be investigated.  The studies presented in this 
dissertation identify one potential mechanism that contributes to the onset of Sertoli cell 
differentiation and the initiation of transcription of genes required for Sertoli cell differentiated 
functions. 
The data presented in this dissertation support the following model.  In undifferentiated 
Sertoli cells, USF1 levels are low and ID protein levels may be elevated to prevent USF binding 
to E-box motifs.  The Sertoli cell receives signals, including those from thyroid hormone, to 
initiate differentiation.  This signal up-regulates USF expression and down-regulates ID2 
expression levels to induce USF binding to E-box motifs.  USF binding to E-box motifs in the 
promoters of USF target genes can activate transcription of genes required for Sertoli cell 
differentiation and differentiated Sertoli cell functions. 
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9.1 ISOLATION OF SERTOLI CELLS FOR BIOCHEMICAL ANALYSIS 
To study Sertoli cells, the cells were isolated from the testis.  A protocol was adapted in 
order to assay cells immediately after isolation from testis tissue allowing Sertoli cells to be 
studies as close to the in vivo conditions as possible (Figure 3). The purity of the Sertoli cells as 
85 ± 0.03 % (Figure 3). The studies were also conducted in cultured Sertoli cells, which are 
routinely 95% pure [302].  Studies conducted in cultured Sertoli cells allow manipulation of the 
cells for studies of hormonal actions and allows the use of immunodetection to determine protein 
localization and levels within the cell. A caveat of Sertoli cell isolation is that the cell 
populations are not pure and the other cell types present may affect the results of biochemical 
assays.  Additionally, the effects of the enzymatic digestion of the testis and removal of Sertoli 
cells from the surrounding germ cells and interstitial cells are unknown.  These actions may 
activate signaling cascades that are not part of the Sertoli cells’ endogenous biochemical make-
up. However, better techniques have not been developed and isolated Sertoli cells are routinely 
used for biochemical assays. Sertoli cells used for these studies were isolated from 5, 11, or 20 
day-old rats representative of proliferating, differentiating, or differentiated Sertoli cells, 
respectively. These time points allowed biochemical analysis of the molecular changes that are 
occurring during the onset of Sertoli cell differentiation. Studies utilizing both Sertoli cells 
assayed immediately after isolation and those that were cultured revealed overall similar results. 
The results suggest that cultured Sertoli cells are effective tools for biochemical analysis of 
Sertoli cells. 
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9.2 THE DNA BINDING OF BHLH PROTEINS INCREASES DURING SERTOLI 
CELL DIFFERENTIATION 
bHLH proteins are known contributors of cell differentiation (reviewed in [131, 141]). 
The presence of Class A and B bHLH proteins were previously shown to be important in the 
regulation of the differentiation associated genes: Trf and Fshr [168, 177, 179, 296]. Class A and 
B bHLH proteins were investigated to determine if their actions could influence the onset of 
Sertoli cell differentiation.  The Class A proteins [TCFE2A (E47), etc.] investigated were not 
found to bind to E-box consensus sites in differentiating Sertoli cells (Figure 4) in contrast to 
what had previously been found in differentiated Sertoli cells [168, 169, 174]. The binding of 
Class B bHLH proteins, specifically USF1 and USF2, was found to increase during Sertoli cell 
differentiation between 5 and 11 days after birth to E-box consensus motifs in vitro (Figures 5 
and 6). Class D bHLH proteins were also investigated (see 9.3.2 below). Other classes of bHLH 
proteins were not evaluated in these studies as prior evidence was not available indicating their 
involvement in the regulation of genes associated with differentiation in Sertoli cells. These data 
support the hypothesis that DNA binding of bHLH proteins increases during Sertoli cell 
differentiation.  The increase in USF1 and USF2 binding to E-box motifs during the onset of 
Sertoli cell differentiation may activate transcription of genes required for Sertoli cell 
differentiation and differentiated Sertoli cell functions.  
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9.3 MECHANISMS OF USF REGULATION 
USF1 and USF2 binding increased at E-box motifs during the onset of Sertoli cell 
differentiation (Figures 5 and 6). Therefore, three potential regulatory mechanisms of USF 
binding were investigated.  First, the mRNA and protein levels of the USF proteins were 
evaluated (Chapter 4). Second, the ability of ID proteins to prevent USF binding in proliferating 
Sertoli cells was evaluated as an inhibitor of bHLH proteins (Chapter 5). Finally, the ability of 
thyroid hormone to induce USF binding in proliferating Sertoli cells was evaluated as a known 
inducer of Sertoli cell differentiation (Chapter 6). 
9.3.1 Usf1 mRNA and Protein Expression Levels Increase During Differentiation  
The mRNA and protein levels of USF1 and USF2 were evaluated. Usf1 mRNA and 
USF1 protein levels were found to increase during the onset of Sertoli cell differentiation 
(Figures 8-10; Tables 4-5).  This increase also corresponded to an up-regulation of USF1 protein 
in the nuclei of Sertoli cells (Figure 11).  In contrast, the mRNA and protein levels of USF2 were 
not altered between 5 and 11 days after birth during Sertoli cell differentiation. USF1 and USF2 
are capable of activating transcription as homodimers or heterodimers. USF1 containing dimers 
are thought to be the preferred dimer pair for the initiation of Fshr gene expression [179].  
Studies presented here did not evaluate the relative quantity of dimer pairs present in Sertoli cells 
during Sertoli cell differentiation or their relative binding affinities. However, the increase in 
USF1 protein availability within the Sertoli cell may allow the formation of more USF1 
containing dimers to initiate transcription of genes required for Sertoli cell differentiation or 
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differentiated Sertoli cell functions.  Thus, USF1 homodimers or USF1:USF2 heterodimers may 
be required to promote Sertoli cell differentiation. 
9.3.2 ID2 Proteins May Inhibit USF1 and USF2 Binding During Sertoli Cell Proliferation. 
The second regulatory mechanism investigated was the ability of USF binding to be 
inhibited by Class D bHLH proteins, specifically the ID proteins.  The ID proteins are present in 
Sertoli cells and induce terminally differentiated Sertoli cells to begin proliferating [166, 178]. 
The results of studies involving ID proteins are difficult to interpret.  Id mRNA levels were 
found to remain constant or increase during Sertoli cell differentiation (Figures 12, 13 and Tables 
6, 7).  In contrast, ID2 protein levels were found to decrease within the nucleus of the Sertoli cell 
during differentiation by immunofluorescence (Figures 14, 15).  Western blots were not able to 
be conducted with the available reagents to confirm either result (Figure 16).  Although these 
data cannot definitely determine the expression patterns of ID proteins in Sertoli cells, this data 
raises the possibility that ID protein levels decrease during differentiation. Recent studies 
provide evidence that ID2 is able to inhibit USF binding in differentiated Sertoli cells under 
hormonal control [244]. Studies presented here do not investigate the ability of ID proteins to 
inhibit USF binding to E-box motifs or USF-mediated transcription.  If ID proteins are inhibitors 
of USF binding in proliferating Sertoli cells, the decrease in ID protein levels would allow an 
increase in USF binding during Sertoli cell differentiation resulting in the transcription of genes 
required for Sertoli cell differentiation or differentiated Sertoli cell functions. 
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9.3.3 Thyroid Hormone Induces USF Binding in Proliferating Sertoli Cells. 
The final regulatory mechanism investigated was the ability of thyroid hormone, a known 
inducer of Sertoli cell differentiation, to induce USF binding to E-box motifs in proliferating 
Sertoli cells.  Stimulation of cultured Sertoli cells with thyroid hormone for 24 hours induced 
USF binding in 5 day-old Sertoli cells (Figure 18).  In contrast, thyroid hormone was unable to 
induce USF binding, but rather inhibited or did not alter binding, in Sertoli cells isolated from 11 
and 20 day-old rats, respectively (Figure 18). Thyroid hormone also induced USF1 within the 
nuclei of 5 day-old Sertoli cells to levels comparable with differentiated Sertoli cells (Figure 21).  
In contrast, Usf1 mRNA levels were not altered by thyroid hormone 5 days after birth (Figure 
19) and suggest that thyroid hormone regulation of USF binding is through a post-transcriptional 
mechanism. These data are consistent with previous data in which thyroid hormone is thought to 
contribute to Sertoli cell differentiation between 4 and 8 days after birth in the rat [264, 269].  
Thyroid hormone induces USF binding during the onset of differentiation and may promote gene 
transcription of genes required for Sertoli cell differentiation or differentiated Sertoli cell 
functions. 
9.3.4 Future Studies Into the Regulation of USF Binding During Sertoli Cell 
Differentiation 
The data investigating the regulation of USF binding during differentiation supports the 
proposed model.  However, the data presented is largely correlative. Additional studies, will 
contribute to the understanding of USF regulation during differentiation. To determine whether 
USF1 is induced in Sertoli cell nuclei in vivo during differentiation, immunohistochemistry 
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should be conducted in whole tissue sections.  The ability of the different USF1 containing 
dimers to regulate gene expression through E-box motifs in proliferating and differentiating 
Sertoli cells could determine the relevance of the increase in USF1 protein levels. If USF1 
containing dimers preferentially bind to E-box motifs during differentiation, then the increase in 
USF1 protein would be a legitimate regulatory mechanism of USF binding.  If this was found to 
be true, additional studies into the regulation of the Usf1 gene transcription should be conducted. 
Similar immunohistochemical studies of testis tissue could also be performed to evaluate 
the levels of ID proteins present within Sertoli cells during the onset of differentiation. 
Additionally, the acquisition of other ID protein antisera or the concentration of more protein 
should facilitate Western blotting to support either the mRNA or immunofluorescence data. The 
ability of ID proteins to inhibit USF binding or USF-mediated gene transcription need to be 
evaluated in Sertoli cells isolated from 5 and 11 day-old rats. If ID proteins are unable to inhibit 
USF binding to E-box motifs or USF-mediated gene transcription during differentiation, then the 
changes in ID protein levels are irrelevant to the regulation of USF binding during 
differentiation.  
The ability of thyroid hormone to induce USF binding needs to be verified in vivo.  
Additionally, the ability of other hormones present during the onset of Sertoli cell differentiation 
to induce USF binding needs to be tested. How thyroid hormone induces USF binding is 
unknown.  It is not likely that the regulation is transcriptionally mediated because Usf1 mRNA 
levels were not affected by the addition of thyroid hormone in proliferating 5 day-old Sertoli 
cells.  It is possible that thyroid hormone causes post-translational modifications on USF to 
facilitate USF binding. The type of modification and the signaling mechanism that occurs will 
need to be investigated. Phosphorylation of USF can regulate USF binding to E-box motifs, 
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although no studies have been conducted in Sertoli cells [281, 282, 303, 304]. Thyroid hormone 
could induce changes in the chromatin structure of the E-box region or may negatively regulate 
ID proteins. Additionally, studies will need to evaluate the ability of thyroid hormone to induce 
USF-mediated gene transcription, perhaps through the use of reporter assays. The mechanisms 
involved in the regulation of USF binding during Sertoli cell differentiation remain to be 
completely understood and provides an area of much larger research that could be conducted. 
Understanding the regulation of USF binding and the downstream effects could provide 
important insights into the function of USF1 and USF2 transcription factors in the onset of 
Sertoli cell differentiation.  
9.4 USF BINDING TO TARGET GENE PROMOTER E-BOX MOTIFS 
9.4.1 Nr5a1 is a USF Target Gene During the Onset of Sertoli Cell Differentiation 
USF1 or USF2 are able to regulate the promoters of Fshr, Nr5a1, and Gata4, in Sertoli 
cells. Therefore, these genes were investigated as potential target genes regulated during 
differentiation by USF1 or USF2.  USF binding was found to increase in vitro at all three 
promoter E-box regions during Sertoli cell differentiation (Figures 5-6 and 23).  However, only 
the mRNA levels of Nr5a1 were found to increase during differentiation between 5 and 11 days 
after birth (Figure 24C). This identified Nr5a1 as a USF target gene during the onset of Sertoli 
cell differentiation.  As a result, USF binding to the Nr5a1 promoter E-box was evaluated in 
vivo.  ChIP assays confirmed that USF1 and USF2 bound to the Nr5a1 promoter E-box region 
but were unable to verify the increase between 5 and 11 days after birth (Figure 26).  These 
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studies established that USF binding increased the Nr5a1 promoter E-box in vitro during the 
onset of Sertoli cell differentiation. The induction of Nr5a1, if correlated with protein levels, 
could result in the activation of the SF1 transcription factor, which could regulate genes required 
for the onset of Sertoli cell differentiation and differentiated Sertoli cell functions. 
9.4.2 Shbg is Identified as a Novel USF Target Gene During the Onset of Sertoli Cell 
Differentiation 
Shbg was investigated as a potential USF target gene.  Shbg contains three E-box motifs 
within its promoter [245].  The central E-box was previously found to bind E47 in differentiated 
Sertoli cells [245].  Shbg levels increase during Sertoli cell differentiation (Figure 24D) [268].  
Protein binding was found to increase at the proximal and distal E-box site during the onset of 
Sertoli cell differentiation but only the proximal E-box was found to bind USF1 and USF2 
(Figure 25).  Interestingly, the lack of binding at the central E-box suggests differential 
regulation of the promoter in differentiating cells compared to fully differentiated cells.  It is also 
possible that during differentiation two protein complexes, the USF containing complex at the 
proximal E-box and an unknown complex at the distal E-box, synergize to induce Shbg gene 
expression.  These data identify Shbg as a novel USF target gene in differentiating Sertoli cells 
and confirm that USF binding increases to the proximal E-box motif within the promoter region 
during the onset of Sertoli cell differentiation. If USF binding to the proximal E-box contributes 
to Shbg gene expression, the induction of Shbg mRNA could correlate with an increase in ABP 
secretion from Sertoli cells to help facilitate androgen transport throughout the remainder of the 
male reproductive tract. 
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9.4.3 Future Studies of USF-mediated Gene Transcription During the Onset of Sertoli 
Cell Differentiation 
USF binding to E-box motifs within the promoters of Nr5a1 and Shbg was found to 
increase by in vitro methods (EMSA; Figures 23, 25), but not in vivo methods (ChIP; Figure 26).  
Isolated Sertoli cells will need to be utilized to conduct additional ChIP assays to determine if 
USF1 and USF2 bind to the E-box motifs within the Nr5a1 and Shbg promoters and if USF 
binding increases between 5 and 11 days after birth. The induction of USF binding in vitro 
correlated with an increase in mRNA levels between 5 and 11 days after birth for both genes 
(Figure 24C,D).  However, these data do not directly show that the induction of USF binding 
mediates an induction in mRNA expression.  Additional studies will need to evaluate the ability 
of USF to drive the transcription of Nr5a1 and Shbg in Sertoli cells. Since two target gene 
promoters have been identified as USF targets during the onset of Sertoli cell differentiation, 
further studies are required to determine if thyroid hormone and ID proteins are able to regulate 
USF binding to these promoter regions and regulate gene transcription. High-throughput 
methods can be used to identify more USF target genes during the onset of Sertoli cell 
differentiation. The use of microarray analysis or ChIP-sequencing of samples of Sertoli cells 
from 5 and 11 day-old rats will provide a large list of other USF regulated genes that may be 
essential during the onset of Sertoli cells differentiation.  The overall goal is to identify the role 
that USF has in regulating genes necessary for Sertoli cell differentiation and differentiated 
Sertoli cell functions.  
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9.5 FSHR: A MODEL FOR USF-MEDIATED GENE TRANSCRIPTION IN 
DIFFERENTIATED SERTOLI CELLS 
USF1 and USF2 are known to regulate the Fshr gene through the E-box motif within the 
minimal promoter [177, 179]. Additionally, it is known that during the cycle of the seminiferous 
epithelium, Fshr gene expression is cyclically regulated [19]. Studies presented in this 
dissertation provide a potential mechanism of Fshr gene regulation through transient inhibition 
of transcription as induced by FSH and ID proteins.   FSH stimulation of differentiated Sertoli 
cells over the course of 48 hours revealed a transient decrease in Fshr mRNA, Usf1 mRNA, and 
USF1 protein levels within 6 to 12 hours after stimulation (Figures 27, 28) [244]. Additionally, 
FSH transiently up-regulates Id2 mRNA (Figure 29) [243] and ID2 protein with similar kinetics 
[244]. Recent studies also confirmed that ID2 proteins can inhibit USF binding to the Fshr 
promoter E-box and USF-mediated Fshr promoter activity in isolated differentiated Sertoli cells 
[244]. Additional studies need to be conducted using immunostaining of testis tissue sections to 
determine whether USF and FSHR expression levels are similar over the prolonged 13 day cycle 
in rat Sertoli cells. The transient hormonal induction of the inhibitor ID2 and the transient 
inhibition of USF binding to the Fshr promoter E-box and USF expression provide a potential 
explanation for Fshr regulation during the cycle of the seminiferous epithelium. 
9.6 CONCLUSIONS 
Although numerous factors regulating Sertoli cell development have been identified, the 
molecular mechanisms that contribute to the onset of differentiation are complex and are only 
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beginning to be understood.  The importance of USF1 and USF2 transcription factors in Sertoli 
cell differentiation is not known.  The studies described here advance the understanding of one 
developmentally regulated molecular mechanism for Sertoli cells in which USF proteins regulate 
the onset of differentiation in rat Sertoli cells. The model proposes that during proliferation 
USF1 levels are low within the cell and ID protein levels are elevated to inhibit USF binding to 
E-box motifs.  When a signal such as thyroid hormone is received to initiate differentiation, 
USF1 levels are up-regulated and ID proteins are down-regulated to increase USF binding to E-
box motifs.  The increase in USF binding can lead to the transcription of USF target genes within 
the cell. Future studies of the downstream targets of USF target genes may provide key insights 
into the importance of the genetic program initiated by USF1 and USF2 during the onset of 
Sertoli cell differentiation. These studies identified the Nr5a1 gene as a USF target gene during 
this developmental time period. NR5A1 is also a transcription factor which can further activate 
other genes to perpetuate the differentiation signal.  It is possible that additional USF target 
genes also encode transcription factors.  Together, the actions of USF1, USF2, NR5A1, and yet 
unknown USF-mediated transcription factors, when appropriately up-regulated, will promote the 
onset of Sertoli cell differentiation. Proper timing of differentiation in Sertoli cells sets the final 
number of Sertoli cells and thus establishes the upper level of male fertility.  
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10.0  MATERIALS AND METHODS 
10.1 ANIMAL CARE AND USE 
Male Sprague Dawley rat pups were obtained from Charles River Laboratories (Boston, 
MA). Animals used in these studies were maintained and euthanized according to the principles 
and procedures described in the NIH Guide for the Care and Use of Laboratory Animals. These 
studies were approved by the University of Pittsburgh Institutional Animal Care and Use 
Committee.  
10.2 ISOLATION OF SERTOLI CELLS FOR DIRECT ASSAY 
Rats were euthanized 5 and 11 days after birth and Sertoli cells were isolated as described 
by Anway, et al. [127] with slight modifications. Briefly, decapsulated testes were digested with 
collagenase (0.5 mg/ml) in enriched Krebs-Ringer bicarbonate medium (EKRB; 118.5 mM 
NaCl, 4.7 mM KCl, 2.1 mM CaCl2-H2O, 1.0 mM KH2PO4, 1.2 mM MgSO4-7H2O, 25 mM 
NaHCO3, 10 mM Hepes, and 0.1% BSA) at 34°C for 10-15 minutes in shaking water bath (80 
oscillations/minute), followed by three settlings in EKRB to isolate seminiferous tubules. 
Tubules were dispersed through digestion with trypsin (0.5 mg/ml) in the presence of DNase (1 
µg/ml) for 5-10 minutes at 37˚C without shaking. Following the digestion, tubule fragments were 
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washed with soybean trypsin inhibitor (0.3 mg/ml) followed by two washes with EKRB. Sertoli 
cells were separated from germ cells by incubation with 0.1% collagenase, 0.2% hyaluronidase, 
0.04% DNase I, and 0.03% trypsin inhibitor in shaking water bath for 40 minutes at 34˚C (80 
oscillations/minute). Following digestion, cells were collected by centrifugation and washed 
three times with EKRB. To remove contaminating germ cells, the suspension of single cells and 
clusters of 5-10 cells were subjected to hypotonic shock by resuspending the pellet in EKRB 
diluted with water (final concentration 0.2x EKRB), gently inverting 3 times to disperse cells 
followed by immediate centrifugation at 700 rpm (63 x g) for 10 minutes. Cells were then 
washed three times with serum-free media containing 50% Dulbecco modified Eagle medium 
(DMEM), 50% Ham’s F-12, 5 mg/ml insulin, 5 mg/ml transferrin, 10 ng/ml epidermal growth 
factor, 3 µg/ml cytosine β-D-arabinofuranosidase, 1 mM sodium pyruvate, 200 units/ml 
penicillin, and 200 µg/ml streptomycin. The resuspended cells were counted and directly 
aliquoted for preparation of protein extracts, RNA, or plated for analysis of purity. 
10.3 ISOLATION OF SERTOLI CELLS FOR CELL CULTURE 
Rats were euthanized 5, 11, 15, and 20 days after birth, as described previously [123]. 
Decapsulated testes were digested with collagenase (0.5 mg/ml, 33°C, 12 minutes) in EKRB, 
followed by three settlings in EKRB to isolate seminiferous tubules. The tubules were digested 
with trypsin (0.5 mg/ml, 32°C, 12 minutes) in the presence of DNase (2 µg/ml), and cell 
aggregates were passed repeatedly through a Pasteur pipette. An equal volume of DMEM 
containing 10% fetal bovine serum was added to the Sertoli cells, which were then pelleted (500 
x g, 5 minutes) and resuspended in supplemented serum-free media used above. Sertoli cells 
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were cultured on Matrigel (Collaborative Research, Bedford, MA) coated dishes (33°C, 5% 
CO2). Sertoli cells were routinely 95% pure as determined by phase microscopy and alkaline 
phosphatase staining [305]. Cells were cultured three days prior to treatment. Sertoli cells were 
stimulated with vehicle (EtOH) or thyroxine (10-6 M) for 24 hours.  
10.4 DETERMINING PURITY OF SERTOLI CELLS FOR IMMEDIATE 
BIOCHEMICAL ANALYIS 
In a 24-well plate, 12 mm2 glass coverslips were coated with poly-L-lysine and allowed 
to dry after excess liquid was removed. Coverslips were washed with PBS and 2.5 x 104 cells 
were plated per well. Cells were allowed to attach to coverslips for approximately 2 hours after 
which Sertoli cells and peritubular cells were identified by immunofluorescence. Leydig cells 
were identified by lipid-specific staining. Briefly, coverslips were washed with PBS and fixed 
with 4% formalin for 15 minutes at room temperature and stored in 70% ethanol overnight. The 
coverslips were incubated with antiserum against Sertoli cell-specific vimentin (1:200 dilution; 
V6630, Sigma-Aldrich, St. Louis, MO) or antiserum against peritubular cell-specific alpha 
smooth muscle actin (1:2000 dilution; A2547, Sigma-Aldrich, St. Louis, MO).  Primary antisera 
were detected by secondary antibodies tagged with Alexa 488 or Cy5.  Nuclei were visualized 
using Hoechst 33258 (861405, Sigma-Aldrich, St. Louis, MO). Leydig cells were detected by 
staining with the lipid-specific stain Oil Red O (O0625, Sigma-Aldrich, St. Louis, MO). The 
cells were fixed in 2% paraformaldehyde for 5 minutes, washed three times with distilled water, 
incubated in propylene glycol for 5 minutes and stained with 0.5% Oil Red O in propylene 
glycol for 8 minutes at 60˚C. Cells were rinsed in 85% propylene glycol for 5 minutes and 
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washed with distilled water prior to staining with hematoxylin.  Cells were washed repeatedly 
with water over the course of 3 minutes followed by two changes of distilled water prior to 
mounting. All images were taken on an Olympus Provis AX70 Microscope with a 60x objective 
and quantification was performed using Northern Eclipse v. 7.0 Software (MVIA Inc., Monaca, 
PA).  Ten random fields from multiple coverslips were analyzed to determine the total number of 
nuclei and the number of cells expressing each marker. The mean percentage of cells expressing 
the cell-specific marker (± SE) was calculated. Greater then 500 cells for each detection method 
were counted. 
10.5 CELL CULTURE FOR CELL LINES, TRANSFECTION, AND WHOLE CELL 
LYSATES 
The mouse-derived Sertoli cell line, MSC-1, was cultured at 33˚C and COS7 cells were 
maintained at 37˚ C in culture.  Both cell lines were cultured in DMEM supplemented with 10% 
fetal bovine serum, 100 units/ml penicillin, 100 μg/ml streptomycin, and 2 mM glutamine. For 
studies involving over-expressed ID2, cells were transfected with 5 µl of an adenovirus 
expressing ID2 (1.9x1011 pfu) for 48 hours. COS7 or MSC-1 Sertoli cells were transfected with 
0.5 µg of expression vectors expressing USF1, USF2, or E47 (pSV-USF1, pSV-USF2, or 
pcDNA E47) using FUGENE reagent (Roche Applied Science, Indianapolis, IN) according to 
the manufacturer’s instructions.  Two days after transfection, cells were lysed in extract lysis 
buffer (ELB; 250 mM NaCl, 0.1% NP-40, 50 mM HEPES, pH 7.0, 5 mM EDTA, 0.5 mM DTT, 
and a cocktail of protease and phosphatase inhibitors) and then sonicated and subjected to 
centrifugation (12,000 x g, 10 min). Supernatants containing whole cell lysates were stored at -
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80˚C. Protein concentrations were determined by the Bradford method (Bio-Rad protein assay, 
Bio-Rad Laboratories, Inc., Hercules, CA). 
10.6 NUCLEAR PROTEIN EXTRACTS 
Sertoli cells for immediate assay (1.5x106 cells/sample) or three-100 mm2 plates of 
cultured Sertoli cells were collected in a total of 1 ml of 1x PBS and used for the preparation of 
nuclear extracts. Nuclear and cytoplasmic extracts were prepared by detergent lysis [306]. 
Briefly, after pelleting, the cells were incubated in buffer A (10 mM Hepes, pH 7.9, 10 mM KCl, 
0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 0.5 mM phenylmethylsulfonyl fluoride, and a 
protease inhibitor cocktail) for 15 minutes on ice followed by the addition of 0.06% Nonidet 
P40. Cells were vortexed for 10 seconds and nuclei were collected by centrifugation (12,000 x g, 
30 seconds). The nuclei pellet was then washed once with buffer A and resuspended in buffer C 
(20 mM Hepes, pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 20% glycerol, 1 mM DTT, 1 
mM phenylmethylsulfonyl fluoride, and protease inhibitor cocktail). Nuclei were incubated for 
15 minutes on shaking vortex platform at 50% power at 4˚C.  The cell debris was pelleted 
(12,000 x g, 5 minutes) and the supernatant containing nuclear proteins was stored at -80˚C.  
Protein concentrations were determined by the Bradford method (Bio-Rad protein assay, Bio-
Rad Laboratories, Inc., Hercules, CA).  
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10.7 DNA-PROTEIN BINDING STUDIES 
32P-radiolabeled DNA probes were generated by annealing 24-42 nucleotide templates 
containing protein binding motifs plus flanking promoter sequences to 10-nucleotide primers that 
are complimentary to the 5’ end of the templates (Table 9). The overhangs were filled in with 
Klenow in the presence of [α-32P]-dATP and 5 mM each of dCTP, dGTP, dTTP and 5-bromo-2’-
deoxyuridine-5’-triphosphate (BrdU) at 16˚C overnight. Electrophoretic mobility shift assays 
(EMSA) were performed as described [307]. Briefly, 32P-labeled probes were incubated with 
nuclear extracts (0.2-1.0 µg). Binding reactions were incubated 15 minutes at room temperature 
in the presence of 1 µg of poly (deoxyinosine-deoxycytosine), 0.25 mg/ml bovine serum 
albumin, 5 mM dithiothreitol, 50 to 100 mM KCl, 20 mM HEPES, pH 7.9, 20% glycerol, and 
0.2 mM EDTA. For supershift assays, 1 µl antiserum was added to the mixture for 15 minutes at  
room temperature prior to the addition of the probe. All antisera were obtained from Santa-Cruz 
Biotechnologies (Santa Cruz, CA): α-USF1 (sc-229), α-USF2 (sc-862), α-E47 (sc-763), α- 
Table 9. Electrophoretic Mobility Shift Assay Probes 
DNA Motif Template Reference 
USF Consensus E-box 5’ – CACCCGGTCACGTGGCCTACA – 3’  
Fshr Promoter E-box 5’ – GATCGGTGGGTCACGTGACTTTGC – 3’  
E47 Consensus E-box 5’ – AGCTTCCCAGCTGAGGAATTCCACAGCTGGGC – 3’  
Trf Promoter E-box 5’ – GATCGCCCAAGCAGCTGTACCATGC – 3’  
Id2 Promoter E-box 5’ – CGGGGCGCGAGCCCAGCTGGGGTGGTAAATA- 3’  
CREB Consensus CRE 5’ – GATCCGGCTGACGTCATCAAGCTAGAA – 3’  
Nr5a1 Promoter E-box 5' - GTGCAGAGTCACGTGGGGGCAGAG - 3' [173] 
Gata4 Promoter E-box 5' - CGGGATCCCTTGCACGTGACTCCC - 3' [286] 
Shbg Promoter E-box 
(Proximal) 
5' – CCTTTAACCCTCCACCACCCATGTGAGAGGCTACCTACC 
CCC - 3' [245] 
Shbg Promoter E-box 
(Distal) 
5' – GAGAATTGTTTCCAGATCTCAAGTGTAACCTAGATAGCC 
TCC - 3' [245] 
Shbg Promoter E-box 
(Putative) 
5' – GGACTCTGTCCCTCATCTCATCTGCCTTCAGAGGGGCCGC 
ATGG - 3' [245] 
E-box motifs are underlined. 
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E2A.E12 (sc-349), α-MYC (sc-40). USF1 and USF2 antisera 
were specific for their respective proteins in preliminary 
experiments (Figure 30). DNA loading dye was added to the 
protein-DNA complexes, which were resolved via 5% 
polyacrylamide gel electrophoresis (PAGE) under non-
denaturing conditions in a Tris borate/EDTA buffer.  The gels 
were dried at 80˚C for 1 hour  and exposed to Classic X-Ray 
Film, Blue Sensitive (Laboratory Products Sales, Rochester, 
NY) at –80˚C for 1 hour to 1 week.  
10.8 QUANTITATIVE PCR ANALYSIS OF GENE 
EXPRESSION  
RNA was isolated from Sertoli cells using the RNeasy 
Mini Kit (Quiagen, Inc., Valencia, CA) according to 
manufacturer’s instructions. RNA was treated with RNase-
free RQ1 DNase (Promega, Madison, WI) for 2 hours at 37˚C 
and purified by phenol/chloroform extraction.  The RNA was subjected to reverse transcription 
using random hexamers [308].  For reverse transcription, 250 ng of RNA was incubated with 100 
µl of reaction mix containing 7.5 mM MgCl2, 400 µM deoxynucleotide triphosphates (Promega, 
Madison, WI), 10x PCR II Buffer (Applied Biosystems Foster City, CA), 40 U RNasin RNase 
inhibitor (Promega, Madison, WI), 2.25 µM random hexamers (Integrated DNA Technologies, 
Coralville, IA), 250 U Superscript reverse transcriptase II (Invitrogen), and nuclease-free water  
 
Figure 30. USF1 and USF2 
Antisera are Not Cross-reactive in 
Supershift Assays. 
Extracts from COS7 cells transfected 
with plasmids encoding USF1 (left) 
or USF2 (right) were incubated with 
radiolabeled oligos containing the E-
box region of the Fshr promoter. 
Supershift analysis determined that 
the antisera against USF1 or USF2 
did not cross-react with the other 
USF protein. Free probe was run off 
of the gel. 
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(Ambion). Parallel reactions were performed without reverse transcriptase to control for the 
presence of contaminant DNA. The samples were incubated at 25˚C for 10 min, at 48˚ C for 30 
min, and at 95˚C for 5 min followed by 4˚C for  5 min.  
Real-time PCR (qPCR) amplifications were performed in a 96-well plate in the ABI 
Prism 7900HT Sequence Detection System v 2.3 (Applied Biosystems, Foster City, CA). For 
studies of bHLH protein studies, reactions were conducted in a total volume of 25 µl, which 
included 2 µl of cDNA, 12.5 µl of ABsolute SYBR Green ROX Mix (ThermoFisher Scientific, 
ABgene House, Surrey, UK) and 30 µM of each primer. For studies of USF target genes, 
Table 10. Primers for Quantitative PCR 
Gene Accession Number Sequence Efficiency 
Region 
Amplified 
Reference 
(*) 
Usf1 NM_031777 Forward 5’ – AAGTCAGAGGCTCCCAGGA – 3’ Reverse 5’ – CGGCGCTCCACTTCGTTAT – 3’ 
2.05 693-761 [309] 
Usf2 NM_031139 Forward 5’ – AGACCAACCAGCGTATGCAG – 3’ Reverse 5’ – GCTCCTCGGATCTGCTGCCT – 3’ 
1.90 
 
1386-1473 [309] 
Tcfe2a 
(E47) NM_01107865 
Forward 5’ – CACCTTCGGGAGAGACACCA – 3’ 
Reverse 5’ – AGGAAGCCAGCCTGACTCAG – 3’ 
1.99 304-354  
Id1 NM_012797 Forward 5’ – CGACTACATCAGGGACCTGCA – 3’ Reverse 5’ – GAACACATGCCGCCTCGG – 3’   
2.12 336-479 [310] 
Id2 NM_013060 Forward 5’ – ATCCCCCAGAACAAGAAGGT – 3’ Reverse 5’ – CTGTCCAGGTCTCTGGTGGT – 3’ 
2.01 220-349 [311] 
Id3 NM_013058 Forward 5’ – GCATCTCCCGATCCAGACAG – 3’ Reverse 5’ – TTGGAGATCACAAGTTCCGGA – 3’ 
2.00 299-349  
Id4 NM_175582 Forward 5’ – CGATAACGTGCTGCAGGATCT – 3’ Reverse 5’ – AGGCTCGTGCCCACCAT – 3’ 
2.09 229-295 [312] 
Fshr NM_ 199237.1 Forward 5' - ACGCCATTTTCACCAAGAAC - 3' Reverse 5' - TGGGCTTGCATTTCATAACA - 3' 
1.86 1944-2022 
 
 
Nr5a1 XM_001072904.1 Forward 5' - ATTCCTGAACAACCACAGCC - 3' Reverse 5' - ACCTCCACCAGGCACAATAG - 3' 
1.94 1350-1481 
 
 
Gata4 NM_144730 Forward 5' - CCCTCTGTGTGGGAACAACT - 3' Reverse 5' - GTGCTCCACCTGGAAAGGTA - 3' 
2.00 1970-2081  
Dmrt1 NM_053706.1 Forward 5' - GAGTCTGCGTCCTCTGAACC - 3' Reverse 5’ - GCTCACTCGTCCTCATCCTC - 3' 
1.85 1159-1229  
Amh NM_012902.1 Forward 5' - GGAGACCTACCAAGCCAACA - 3' Reverse 5’ - CATTTTTAGCAGCAGCACCA - 3' 
2.00 1419-1518  
Shbg NM_012650.1 Forward 5' - GACGGACCCTGAGACACATT - 3' Reverse 5' - AGGGTTTGCTGATTTTGGTG - 3' 
2.01 116-244  
Trf NM_001013110 Forward 5’ – CTGTGACCTGTGTATTGGCCC – 3’ Reverse 5’ – CGTCTCCCTTCTCAACGAGG – 3’ 
1.90 1575-1675  
Ppia M19533.1 Forward 5’ – ATGGTCAACCCCACCGTGT – 3’ Reverse 5’ – TCTGCTGTCTTTGGAACTTTGTCT – 3’ 
1.93 43-143  
*Primers without a reference were designed for use in this study with the aid of Primer Express Software v 3.0 (Applied 
Biosystems, Foster City, CA). 
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reactions were conducted in a total volume of 20 µl, which included 2 µl of cDNA, 10 µl of 
PerfeCTa SYBR Green Fast Mix ROX (Quanta Biosciences, Inc., Gaithersburg, MD) and 30 µM 
of each primer.  Amplification reactions were also performed on samples containing no cDNA, 
either from reverse transcription reactions lacking reverse transcriptase or no template, were 
analyzed as negative controls. Primers used for each gene are listed in Table 10 and primer pairs 
were independently validated for use in the ΔΔCt method of gene expression analysis [209] 
through the use of a standard curve derived from serial dilutions of the cDNA obtained from the 
reverse transcription reactions. The resulting Ct values for each sample were plotted vs. the log 
of the mRNA concentration present in each cDNA dilution. The slope of the line was used to 
calculate the efficiency of amplification [efficiency = 10(1/-slope)]. Primers with an efficiency of 2 
± 0.2 were considered acceptable. Ppia (peptidylprolyl isomerase A, commonly known as 
cyclophillin) was used as an endogenous control. The qPCR analysis initiated with melting of 
cDNA at 95°C for 15 min, followed by 40 amplification cycles (15 sec at 95°C and 1 min at 
60°C). A dissociation curve was performed immediately after amplification to ensure there was 
only one (gene-specific) amplification peak.  
Ct values were recorded and analyzed via the ΔΔCt method and also via the efficiency-
corrected ΔCt method [209]. The ΔΔCt method was used to characterize relative fold changes in 
mRNA expression between treatment groups. The following terms were defined prior to 
calculation: GOI = gene of interest; Reference = Ct value for GOI of 5 day-old untreated sample; 
Unknown = Ct value for GOI of samples from any time point or treatment; Control = Ct value of 
Ppia for a given treatment. The ∆Ct was calculated for each sample according to the following 
formula: ∆Ct = Unknown - Control. The ∆∆Ct was calculated by comparing each sample to the 
Reference according to the following equation: ∆∆Ct = ∆CtUnknown - ∆CtReference. The Fold Change 
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was then calculated relative to the Reference according to the formula: Fold Change = 2(-∆∆Ct). 
The means (±SE) of 3 individual experiments were determined for each GOI in each treatment 
group. The relative quantity of mRNA for each GOI was determined through the efficiency-
corrected ΔCt method. The relative quantity is derived from the equation:  Quantity = 
(Efficiency)-Ct. For each sample, the calculated Quantity is then normalized to the quantity found 
for Ppia.   
10.9 WESTERN BLOTTING FOR USF PROTEINS 
  
Sertoli cells were prepared for immediate assay as above in ELB. Protein was 
concentrated when necessary using a Microcon Ultracel YM-3 Centrifugal Filter Unit (Millipore, 
Billerica, MA). For detection of USF1 and USF2, 50 µg and 10 µg of protein, respectively, were 
added to boiling 2x Laemmli sample buffer for 2 minutes. Lysates were fractionated by SDS-
PAGE, transferred to polyvinylidene difluoride membranes, and incubated with primary antisera  
against USF1 (1:1000 in TBS with 0.1% Tween-20; Santa Cruz Biotechnologies, Santa Cruz, 
CA, sc-229), USF2 (1:1000 in TBS with 0.1% Tween-20; Santa Cruz Biotechnologies, Santa 
Cruz, CA, sc-862), or β-actin (1:100,000 in TBS with 0.1% Tween-20; Sigma-Aldrich, St. Louis, 
MO, A1978), followed by either goat anti-rabbit antisera (1:20,000, Jackson ImmunoResearch 
Laboratories, Inc., West Grove, PA, 11-035-003) or goat anti-mouse antisera (1:50,000; Bio-Rad 
Laboratories, Inc., Hercules, CA, 170-6516). The antigen-antibody complex was visualized with 
Millipore Immobilon Western Chemiluminescent HRP substrate (Millipore Corporation, 
Billerica, MA). USF1 and USF2 antisera were specific and non-cross reactive in preliminary 
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experiments (Figure 31). The levels of USF1 and USF2 were 
normalized to β-actin expression levels. 
 
10.10 WESTERN BLOTTING FOR ID2 PROTEIN 
10.10.1 Whole Tissue Nuclear and Cytoplasmic 
Extracts 
Whole liver or testis tissues (approximately 1.5 g 
each) were washed twice with 10 ml of cold PBS and 
immersed in 8 ml of PBS supplemented with protease 
inhibitor and phosphatase inhibitors. Tissues were disrupted 
with a Dounce homogenizer and centrifuged at 1500 x g for 5 
min. The pellets were washed once with PBS and repelleted. The pellets were resuspended in 3 
ml of cell lysis buffer (5 mM Hepes, pH 8.0, 85 mM KCl and 0.5% Nonidet P40 supplemented 
with protease and phosphatase inhibitors), incubated at 4˚ C  for 15 min with rocking  and nuclei 
were pelleted by centrifugation at 3500 x g for 5 min. The supernatant was saved as the 
cytoplasmic fraction. The nuclei were resuspended in 3 ml of nuclear lysis buffer (1x PBS, 1% 
Nonidet P40, 0.5% sodium deoxycholate, and 0.1% SDS supplemented with the protease and 
phosphatase inhibitors). The samples were incubated at 4˚C for 15 min with rocking. Nuclei 
were examined under microscope to ensure lysis. Nuclear debris was collected by centrifugation 
at full speed. The supernatant was saved as the nuclear fraction. Lysates were stored at -80˚C. 
 
Figure 31. Antisera for USF1 and 
USF2 Do Not Cross-react with 
Each Other via Western Blotting. 
Extracts from COS7 cells transfected 
with plasmids encoding USF1 or 
USF2 were analyzed by Western 
blotting to determine if the antisera 
against USF1 (left) or USF2 (right) 
cross-reacted with the other USF 
protein. Arrows at the left indicate 
the desired USF band of interest.  
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Protein concentrations were determined by the Bradford method (Bio-Rad protein assay, Bio-
Rad Laboratories, Inc., Hercules, CA). Lysates were fractionated by SDS-PAGE, transferred to 
polyvinylidene difluoride membranes and incubated with primary antiserum against ID2 (1:500, 
Santa Cruz Biotechnologies, Santa Cruz, CA, sc-489) followed by goat anti-rabbit antiserum as 
above. Immunodetection was carried out as above. 
10.10.2 Assays MSC-1 Cell Extracts with ID2 Antisera from Biocheck, Inc. 
  MSC-1 whole cell lysates (10 µg) were immunoprecipitated with 2 or 5 µl of ID2 
antiserum (Biocheck, Inc.) overnight. Lysates were fractionated by Western blotting as above.  
Membranes were incubated with primary antiserum against ID2 (Biocheck, Inc.) diluted in 
0.015M NaPO4, 0.85% NaCl, 0.25% BSA, and 0.1% sodium azide, pH 7.4. Membrane washes 
were conducted in 0.015 M NaPO4, 0.85% NaCl, and 0.05% Tween-20, pH 7.4. Detection with 
goat anti-rabbit secondary antiserum was carried out as above.  
10.11 IMMUNOFLUORESCENCE 
Primary Sertoli cells were cultured in 35-mm2 plates containing coverslips three days 
prior to treatment as described. Sertoli cells were stimulated with vehicle (EtOH) or thyroxine 
(10-6 M) for 24 hours. The cells were then washed twice in ice-cold PBS and fixed with 2% 
paraformaldehyde in saline for 20 min, washed three times with PBS, blocked with goat serum 
(150 µl per 10 ml of 1x PBS/0.5% BSA/0.15% Glycine), and then incubated with a rabbit 
antiserum from Santa Cruz Biotechnologies, CA for USF1 (1:1000, sc-229), USF2 (1:1000, sc-
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862), ID1 (1:500, sc-488), or ID2 (1:500, sc-489). Sertoli cells were identified by co-staining 
with mouse antiserum against the vimentin (1:200; Sigma-Aldrich, St. Louis, MO, V6630). The 
cells were washed a total of six times for 3 minutes each with  1x PBS/0.5% BSA/0.15% Glycine 
and then incubated with fluorescent secondary goat anti-rabbit Alexa488 alone or also with goat 
anti-mouse Cy5. Following six washes for 3 minutes each of 1x PBS/0.5% BSA/0.15% Glycine, 
nuclei were visualized by staining with Hoechst 33258.  Hoechst was applied for 10 seconds and 
immediately washed two times with 1x PBS. Coverslips were then mounted onto glass slides 
with gelvatol. Images were obtained on an Olympus Provis AX70 Microscope with a 60x 
objective. All image files were digitally processed for presentation in Adobe Photoshop (Adobe 
Systems, Inc., San Jose, CA). 
Initial studies were conducted in 5 day-old Sertoli cells that were probed with ID2 
antisera pre-incubated with blocking peptides for 
ID1, ID2, ID3, and ID4 antisera. Control studies 
for ID2 immunostaining utilized blocking 
peptides at a ratio of 1 unit of antiserum to 5 unit 
of blocking peptide that were supplied by the 
manufacturer (Figure 32). When blocking 
peptides were incubated with ID2 antiserum, ID1 
blocking peptide was able to inhibit the 
immunofluorescence signal by approximately 
23.9 ± 7.0% (p < 0.05), whereas ID2 blocking 
peptide was able to reduce the 
immunofluorescence signal by 67.8 ± 1.7% (p < 
  
Figure 32. ID2 Antiserum is Specific in Cultured 5 
Day-old Sertoli Cells.  
Immunostaining of ID2 in 5 day-old cultured Sertoli 
cells were quantified using Metamorph. Antiserum 
was preincubated with or without blocking peptides 
(B.P.) for ID1, ID2, ID3, or ID4. The mean total cell 
intensity normalized to the total cell area was plotted 
on the graph (±SE). Values with different lowercase 
letters differ significantly (p < 0.05). 
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0.05; Figure 32). ID3 and ID4 blocking peptides were not able to diminish the 
immunofluorescence signal for ID2 antisera significantly. 
To quantify immunofluorescent signals, images were taken in a blind and random 
manner. Images were quantified utilizing Metamorph Software (Molecular Devices, 
Downingtown, PA). Within each field, the number of nuclei present and the number of vimentin-
positive cells were recorded.  Five vimentin-positive cells in each field were then analyzed by 
recording the nuclear area, nuclear intensity, cell area, and cell intensity. Nuclear area was 
determined by thresholding the nuclei based on Hoechst staining using the blue channel. The 
integrated value of staining for antisera against the protein of interest was established within the 
thresholded area on the red channel.  The integrated value indicates the sum of the intensity of all 
pixels within the designated area. Approximate cell area was estimated as best guess using 
present staining but was not exact as all cell borders were not clearly visible.  The integrated 
value of the approximate cell area was also recorded.  Calculations could then be conducted to 
determine the average pixel intensity for each cell and nuclei counted. Cells were categorized by 
age and density. Pixel intensity was analyzed from greater than 450 vimentin-positive cells for 
each age from six independent experiments.  
10.12 CHROMATIN IMMUNOPRECIPITATION 
Whole testes were removed from rats euthanized 5 and 11 days after birth. Testes were 
decapsulated before exposure to 1% formaldehyde for 10 min at room temperature. Glycine was 
added to a final concentration of 0.125 M, and, after 5 min, the samples were washed two times 
and harvested in cold PBS with protease inhibitors. Tubules were collected by centrifugation for 
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5 min at 1000 x g. Tubules were suspended in 1 ml swelling buffer (10 mM Hepes, 1.5 mM 
MgCl2, 100 mM KCl, 200 µM sodium orthovanadate, 150 µM spermine, 500 µM spermidine,  
1 mM DTT, 0.2% igepal, 1 mM EDTA, pH 8.0, 5% sucrose) per 100 µl of pellet. The sample 
was then homogenized ten times using a Dounce homogenizer and an A Pestle followed by ten 
strokes with a B Pestle. The sample was then layered onto 0.5 ml cushion buffer (10 mM Tris, 
pH 7.5, 15 mM NaCl, 60 mM KCl, 150 µM spermine, 500 µM spermidine, 1 mM EDTA, pH 
8.0, 10% Sucrose) into thick-walled centrifuge tubes and nuclei were pelleted by centrifugation 
for 1 hour at 30,000 x g in a Sorvall RC M120GX. The pellet was transferred to eppendorf tubes 
and was washed two times in ice cold PBS with protease inhibitors.  Nuclei were recollected by 
centrifugation at 13,000 x g for one minute between washes. The pellet was then suspended in 
lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris, pH 8.0).  
Chromatin immunoprecipitation (ChIP) assays were performed following the Upstate 
Biotechnology ChIP assay kit protocol, with modifications. Briefly, the 0.5 ml/tube of cell lysate 
was sonicated to yield 200–1,000 bp genomic DNA fragments utilizing the Bioruptor 
(Diagenode, Inc., Sparta, NJ) at 4˚C in ice water on high for 10 minutes of cycles: 30 seconds on, 
30 seconds off. Sonication parameters were determined in preliminary experiments (Figure 33). 
Each 0.5 ml sample was mixed with 2.5 ml of dilution buffer (16.7 mM Tris, pH 8.1, 167 mM 
NaCl, 0.01% SDS, 1.2 mM EDTA, pH 8.0, 1.1% Triton-X 100) and stored at -80˚C in 0.5 ml 
aliquots. Protein concentrations were determined using the BCA Protein Assay (Pierce, Thermo 
Fisher Scientific, Inc., Rockford, IL).  Fragmentation was verified by taking 10 µl of sample, 
reversing the cross-link (see below) and resolving the purified chromatin in 0.05% glycerol on a 
5% polyacrylamide gel electrophoresis (PAGE) under non-denaturing conditions in a Tris 
borate/EDTA buffer (Figure 33).   
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 The lysate (200 µg) in a total 
of 1000 µl of dilution buffer was 
precleared two times with 40 µl of a 
50% slurry of protein A sepharose in 
the presence of 20 µg of salmon sperm 
DNA. After centrifugation at 1,000 x g 
for 1 min, aliquots of the supernatant 
were incubated with 8 µg of antiserum 
directed against USF1 (Santa Cruz 
Biotechnologies, Santa Cruz, CA, sc-
229 Trans-X), USF2 (Santa Cruz 
Biotechnologies, Santa Cruz, CA, sc-
862 Trans-X), E47 (Santa Cruz 
Biotechnologies, Santa Cruz, CA, sc-
763), E2A.E12 (Santa Cruz Biotechnologies, Santa Cruz, CA, sc-349), MYC (Santa Cruz 
Biotechnologies, Santa Cruz, CA, sc-40), or CREB (Upstate, Lake Placid, NY, 06-863).  
Controls were also incubated with non-immune serum or without protein. Samples were 
incubated overnight with rocking at 4°C. Immunocomplexes were recovered by incubation with 
50 µl of 50% slurry of protein A sepharose for 1 h at 4°C. The beads were washed 5 min each 
with low-salt (20 mM Tris pH8.1, 150 mM NaCl, 2 mM EDTA, pH 8.0, 1% Triton-X 100, 0.1% 
SDS), high-salt (20 mM Tris, pH 8.1, 500 mM NaCl, 2 mM EDTA, pH 8.0, 1% Triton-X 100, 
0.1% SDS), and LiCl buffer (250 mM LiCl, 1% Igepal, 1% sodium deoxycholate, 10 mM Tris, 
pH 8.1, 1 mM EDTA, pH 8.0).  The beads were then washed two times in 10 mM Tris, pH 8.0, 1 
 
Figure 33. Sonciation of Chromatin for Chromatin 
Immunoprecipitation Assays. 
Chromatin isolated from whole testis (0.5 ml of cell lysate/tube) 
was sonicated to yield 200–1,000 bp genomic DNA fragments 
utilizing the Bioruptor on high, medium or low for 5, 10 or 15 
minutes of cycles: 30 seconds on, 30 seconds off. The optimal 
fragmentation was achieved with 10 minute cycles on the high 
setting. 
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mM EDTA buffer. The chromatin complexes were eluted by incubation with 250 µl freshly 
prepared elution buffer (1% SDS, 0.1 M NaHCO3) with rotation at room temperature for 15 min. 
The supernatant was saved to a new tube and the elution was repeated. The supernatant from the 
second elution was pooled with the first elution. The cross-linking was reversed by adding NaCl 
to a final concentration of 200 mM and heating at 65°C overnight. After incubation with 40 µg 
proteinase K for 1 h at 45°C, the DNA was purified using phenol/chloroform extraction.  
Immunoprecipitation of promoter regions were quantified by qPCR with PerfeCTa SYBR 
Green Fast Mix ROX (Quanta Biosciences, Inc., Gaithersburg, MD) using 2 µl of the purified 
DNA as template (see above). Primers are listed in Table 10. Standard curves for each primer set 
sample were constructed using two-fold serial dilutions of the unbound chromatin fragments for 
each sonicated sample as a reference input. The log of the percentage of input was plotted vs. Ct 
value to obtain a standard curve. Ct values for each samples were plotted on the line to determine 
the logarithmically transformed value of the percentage of input. The resulting value from the 
line was reverse transformed to obtain the percentage of input. The percentage obtained for the 
IgG control sample was subtracted from all other samples to account for non-specific binding. 
Average percentages of inputs were calculated for each antibody used.  
Table 11. Chromatin Immunoprecipitation Primers 
Gene Efficiency (*) 
Region 
Amplified Sequence 
Nr5a1CDS  2.03  +1350 to +1481 Forward 5’ – AAT CCT GAA CAA CCA CAG CC – 3’ 
Reverse 5’ – ACC TCC ACC AGG CAC AAT AG – 3’ 
Nr5a1 E-box  2.18  -130 to -10  Forward 5’ – CCC AAA TGA AGA GAA ACA CCA – 3’ 
Reverse 5’ – CGA TCG TCC TCT CCT CCT C – 3’  
*Efficiency determined by a standard curve of input cDNA. 
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10.13 STATISTICAL ANALYSIS 
DNA-protein complex formation and autoradiograms were quantified from digitized 
images of the X-ray films using ImageJ v1.37 software [313, 314]. Amplicons were quantified 
using Image J v 1.37 software from digital images of agarose gels visualized with 
AlphaEase®FC software version 4.1 (Alpha Innotech Corporation, San Leandro, CA).  For all 
studies, the mean (±SE) value or intensity of three individual experiments were determined for 
each sample group unless otherwise noted. Results were analyzed by ANOVA with Fisher’s 
PLSD at a 5% significance level utilizing Statview 4.5 (Abacus Concepts, Inc., Berkeley, CA).  
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APPENDIX A 
SERTOLI CELL POSITIVE IMMUNOSTAINING CONTROLS 
Immunofluorescent images presented throughout this dissertation have been shown without the 
presence of immunostaining with a Sertoli cell-specific marker.  The images provided in this 
appendix include immunostaining with antiserum against the Sertoli cell-specific vimentin 
cytoskeletal protein. Due to overexposure of the vimentin immunostaining, vimentin 
immunostaining was excluded in earlier figures to facilitate visualization of the proteins of 
interest. 
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A.1 USF1 PROTEIN IMMUNOSTAINING 
 
Figure 34. Immunostaining for USF1 Protein with Vimentin Co-localization in Cultured Sertoli Cells – 
Control for Figures 11 and 21.  
Immunofluorescence of cultured 5, 11 and 20 day-old Sertoli cells was performed with antisera recognizing USF1 
(top) as visualized with Alexa 488 fluorophore (red). Sertoli cells were identified by immunostaining with antisera 
against vimentin (middle) as visualized with the Cy5 fluorophore (green). Hoechst stains nuclei (blue). The bottom 
row of images merges the top two panels to show co-localization. The column on the right depicts 5 day-old Sertoli 
cells that were stimulated with T4 for 24 hours. Scale bars = 100 µm. 
 
 130 
A.2 USF2 PROTEIN IMMUNOSTAINING 
 
Figure 35. Immunostaining for USF2 Protein with Vimentin Co-localization in Cultured Sertoli Cells – 
Control for Figures 11 and 21.  
Immunofluorescence of cultured 5, 11 and 20 day-old Sertoli cells was performed with antisera recognizing USF2 
(top) as visualized with Alexa 488 fluorophore (red). Sertoli cells were identified by immunostaining with antisera 
against vimentin (middle) as visualized with the Cy5 fluorophore (green). Hoechst stains nuclei (blue). The bottom 
row of images merges the top two panels to show co-localization. The column on the right depicts 5 day-old Sertoli 
cells that were stimulated with T4 for 24 hours. Scale bars = 100 µm. 
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A.3 ID2 PROTEIN IMMUNOSTAINING 
 
Figure 36. Immunostaining for ID2 Protein with Vimentin Co-localization in Cultured Sertoli Cells – Control 
for Figure 14.  
Immunofluorescence of cultured 5, 11 and 20 day-old Sertoli cells was performed with antisera recognizing ID2 
(top) as visualized with Alexa 488 fluorophore (red). Sertoli cells were identified by immunostaining with antisera 
against vimentin (middle) as visualized with the Cy5 fluorophore (green). Hoechst stains nuclei (blue). The bottom 
row of images merges the top two panels to show co-localization. Scale bars = 100 µm. 
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